SampleID	Index	OlinkID	UniProt	Assay	MissingFreq	Panel	Panel_Version	PlateID	QC_Warning	LOD	NPX	Normalization
Sample_00001	1	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00002	2	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00003	3	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00004	4	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00005	5	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00006	6	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00007	7	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00008	8	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00009	9	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00010	10	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00011	11	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00012	12	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00013	13	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00014	14	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00015	15	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00016	16	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00017	17	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00018	18	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00019	19	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00020	20	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00021	21	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00022	22	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.2	Intensity Normalized (v.2)
Sample_00023	23	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00024	24	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00025	25	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00026	26	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00027	27	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00028	28	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00029	29	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00030	30	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.52	Intensity Normalized (v.2)
Sample_00031	31	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00032	32	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00033	33	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00034	34	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.24	Intensity Normalized (v.2)
Sample_00035	35	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00036	36	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00037	37	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00038	38	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00039	39	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00040	40	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00041	41	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Sample_00042	42	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00043	43	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00044	44	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00045	45	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00046	46	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00047	47	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00048	48	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00049	49	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00050	50	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00051	51	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00052	52	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.1	Intensity Normalized (v.2)
Sample_00053	53	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00054	54	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00055	55	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00056	56	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00057	57	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00058	58	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00059	59	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00060	60	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00061	61	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00062	62	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00063	63	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00064	64	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00065	65	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00066	66	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00067	67	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	10	Intensity Normalized (v.2)
Sample_00068	68	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00069	69	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00070	70	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00071	71	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00072	72	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00073	73	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00074	74	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00075	75	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00076	76	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00077	77	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00078	78	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00079	79	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00080	80	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00081	81	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00082	82	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00083	83	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00084	84	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00085	85	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00086	86	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.91	Intensity Normalized (v.2)
Sample_00087	87	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00088	88	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00089	89	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00090	90	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
CONTROL_0001	91	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
CONTROL_0002	92	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
CONTROL_0003	93	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
CONTROL_0004	94	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
CONTROL_0005	95	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Empty well_01	96	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Empty well_02	97	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Empty well_03	98	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Empty well_04	99	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Empty well_05	100	OID00001	P60800	Protein_1	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00001	101	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00002	102	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00003	103	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00004	104	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00005	105	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00006	106	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00007	107	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00008	108	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00009	109	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00010	110	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00011	111	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00012	112	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00013	113	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00014	114	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00015	115	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00016	116	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00017	117	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00018	118	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00019	119	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00020	120	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.51	Intensity Normalized (v.2)
Sample_00021	121	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00022	122	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00023	123	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00024	124	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00025	125	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00026	126	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00027	127	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00028	128	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00029	129	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00030	130	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00031	131	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00032	132	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00033	133	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00034	134	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00035	135	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00036	136	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00037	137	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00038	138	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00039	139	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00040	140	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00041	141	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00042	142	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00043	143	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00044	144	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00045	145	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00046	146	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00047	147	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00048	148	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00049	149	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00050	150	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00051	151	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00052	152	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00053	153	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00054	154	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00055	155	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00056	156	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00057	157	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00058	158	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00059	159	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00060	160	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Sample_00061	161	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00062	162	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00063	163	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00064	164	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00065	165	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00066	166	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00067	167	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00068	168	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00069	169	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00070	170	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00071	171	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00072	172	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00073	173	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00074	174	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00075	175	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Sample_00076	176	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00077	177	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00078	178	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00079	179	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00080	180	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00081	181	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00082	182	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Sample_00083	183	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00084	184	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00085	185	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00086	186	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00087	187	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00088	188	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00089	189	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00090	190	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
CONTROL_0001	191	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
CONTROL_0002	192	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
CONTROL_0003	193	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
CONTROL_0004	194	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
CONTROL_0005	195	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Empty well_01	196	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Empty well_02	197	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Empty well_03	198	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Empty well_04	199	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Empty well_05	200	OID00002	P69237	Protein_2	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00001	201	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00002	202	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00003	203	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00004	204	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
Sample_00005	205	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00006	206	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00007	207	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00008	208	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00009	209	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00010	210	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00011	211	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00012	212	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00013	213	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00014	214	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.01	Intensity Normalized (v.2)
Sample_00015	215	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00016	216	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00017	217	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00018	218	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00019	219	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00020	220	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00021	221	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
Sample_00022	222	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00023	223	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00024	224	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00025	225	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00026	226	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00027	227	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00028	228	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00029	229	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00030	230	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00031	231	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00032	232	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00033	233	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00034	234	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00035	235	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00036	236	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00037	237	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Sample_00038	238	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00039	239	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00040	240	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00041	241	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00042	242	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00043	243	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00044	244	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00045	245	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00046	246	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00047	247	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00048	248	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00049	249	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00050	250	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00051	251	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00052	252	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00053	253	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.96	Intensity Normalized (v.2)
Sample_00054	254	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00055	255	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00056	256	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00057	257	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00058	258	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00059	259	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00060	260	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00061	261	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00062	262	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00063	263	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00064	264	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00065	265	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00066	266	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00067	267	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.57	Intensity Normalized (v.2)
Sample_00068	268	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00069	269	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00070	270	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00071	271	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
Sample_00072	272	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00073	273	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.06	Intensity Normalized (v.2)
Sample_00074	274	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00075	275	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00076	276	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00077	277	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00078	278	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00079	279	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00080	280	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00081	281	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00082	282	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00083	283	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00084	284	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00085	285	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00086	286	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Sample_00087	287	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00088	288	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00089	289	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00090	290	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
CONTROL_0001	291	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
CONTROL_0002	292	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
CONTROL_0003	293	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
CONTROL_0004	294	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
CONTROL_0005	295	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Empty well_01	296	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Empty well_02	297	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Empty well_03	298	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5	Intensity Normalized (v.2)
Empty well_04	299	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Empty well_05	300	OID00003	P79933	Protein_3	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00001	301	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00002	302	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00003	303	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00004	304	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00005	305	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00006	306	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00007	307	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00008	308	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00009	309	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00010	310	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00011	311	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00012	312	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00013	313	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00014	314	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00015	315	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00016	316	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00017	317	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00018	318	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
Sample_00019	319	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00020	320	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Sample_00021	321	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00022	322	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00023	323	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00024	324	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Sample_00025	325	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00026	326	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00027	327	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00028	328	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00029	329	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00030	330	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00031	331	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00032	332	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00033	333	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00034	334	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00035	335	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00036	336	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00037	337	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00038	338	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00039	339	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00040	340	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.09	Intensity Normalized (v.2)
Sample_00041	341	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
Sample_00042	342	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00043	343	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00044	344	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00045	345	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00046	346	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00047	347	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00048	348	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00049	349	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00050	350	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00051	351	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00052	352	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00053	353	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00054	354	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00055	355	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Sample_00056	356	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00057	357	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00058	358	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00059	359	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00060	360	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00061	361	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.49	Intensity Normalized (v.2)
Sample_00062	362	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00063	363	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00064	364	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00065	365	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00066	366	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00067	367	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00068	368	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00069	369	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00070	370	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00071	371	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00072	372	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Sample_00073	373	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.37	Intensity Normalized (v.2)
Sample_00074	374	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00075	375	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00076	376	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00077	377	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00078	378	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00079	379	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00080	380	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00081	381	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00082	382	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00083	383	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00084	384	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00085	385	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00086	386	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00087	387	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00088	388	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00089	389	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00090	390	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
CONTROL_0001	391	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
CONTROL_0002	392	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
CONTROL_0003	393	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
CONTROL_0004	394	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
CONTROL_0005	395	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Empty well_01	396	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Empty well_02	397	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Empty well_03	398	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Empty well_04	399	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Empty well_05	400	OID00004	P90793	Protein_4	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00001	401	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00002	402	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00003	403	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00004	404	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00005	405	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00006	406	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00007	407	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00008	408	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00009	409	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00010	410	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00011	411	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00012	412	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00013	413	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00014	414	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00015	415	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00016	416	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00017	417	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00018	418	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00019	419	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00020	420	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00021	421	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00022	422	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00023	423	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00024	424	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00025	425	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00026	426	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00027	427	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00028	428	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00029	429	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00030	430	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00031	431	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00032	432	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00033	433	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00034	434	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00035	435	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00036	436	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00037	437	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.31	Intensity Normalized (v.2)
Sample_00038	438	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.95	Intensity Normalized (v.2)
Sample_00039	439	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00040	440	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00041	441	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00042	442	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00043	443	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00044	444	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00045	445	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00046	446	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00047	447	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00048	448	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00049	449	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00050	450	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00051	451	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00052	452	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00053	453	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00054	454	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00055	455	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00056	456	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00057	457	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00058	458	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.37	Intensity Normalized (v.2)
Sample_00059	459	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00060	460	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00061	461	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00062	462	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00063	463	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00064	464	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00065	465	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00066	466	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00067	467	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00068	468	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00069	469	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00070	470	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00071	471	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00072	472	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00073	473	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00074	474	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Sample_00075	475	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00076	476	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00077	477	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00078	478	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00079	479	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00080	480	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00081	481	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00082	482	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00083	483	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00084	484	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00085	485	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00086	486	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00087	487	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00088	488	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00089	489	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00090	490	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
CONTROL_0001	491	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
CONTROL_0002	492	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
CONTROL_0003	493	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
CONTROL_0004	494	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
CONTROL_0005	495	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Empty well_01	496	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Empty well_02	497	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Empty well_03	498	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Empty well_04	499	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Empty well_05	500	OID00005	P82972	Protein_5	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.41	Intensity Normalized (v.2)
Sample_00001	501	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00002	502	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00003	503	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00004	504	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00005	505	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00006	506	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00007	507	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00008	508	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00009	509	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00010	510	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00011	511	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00012	512	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00013	513	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00014	514	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00015	515	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00016	516	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00017	517	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00018	518	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.41	Intensity Normalized (v.2)
Sample_00019	519	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00020	520	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00021	521	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00022	522	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00023	523	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00024	524	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00025	525	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00026	526	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
Sample_00027	527	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00028	528	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00029	529	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00030	530	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00031	531	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00032	532	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00033	533	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00034	534	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00035	535	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00036	536	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00037	537	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00038	538	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00039	539	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00040	540	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00041	541	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00042	542	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00043	543	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00044	544	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00045	545	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00046	546	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00047	547	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00048	548	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00049	549	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00050	550	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00051	551	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00052	552	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00053	553	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00054	554	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00055	555	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00056	556	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00057	557	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00058	558	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00059	559	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00060	560	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00061	561	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00062	562	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00063	563	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00064	564	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00065	565	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00066	566	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00067	567	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00068	568	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00069	569	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00070	570	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00071	571	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00072	572	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00073	573	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00074	574	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00075	575	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00076	576	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00077	577	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00078	578	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00079	579	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00080	580	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00081	581	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00082	582	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00083	583	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00084	584	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00085	585	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00086	586	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00087	587	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00088	588	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00089	589	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00090	590	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
CONTROL_0001	591	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
CONTROL_0002	592	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
CONTROL_0003	593	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
CONTROL_0004	594	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
CONTROL_0005	595	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
Empty well_01	596	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Empty well_02	597	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Empty well_03	598	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.93	Intensity Normalized (v.2)
Empty well_04	599	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Empty well_05	600	OID00006	P22158	Protein_6	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00001	601	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00002	602	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00003	603	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00004	604	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00005	605	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00006	606	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00007	607	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00008	608	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00009	609	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00010	610	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00011	611	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00012	612	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.24	Intensity Normalized (v.2)
Sample_00013	613	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00014	614	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00015	615	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00016	616	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00017	617	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00018	618	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00019	619	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00020	620	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00021	621	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Sample_00022	622	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00023	623	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00024	624	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00025	625	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00026	626	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00027	627	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00028	628	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00029	629	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00030	630	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00031	631	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00032	632	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00033	633	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00034	634	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00035	635	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00036	636	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00037	637	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00038	638	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00039	639	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00040	640	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00041	641	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00042	642	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00043	643	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00044	644	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00045	645	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00046	646	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00047	647	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00048	648	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.55	Intensity Normalized (v.2)
Sample_00049	649	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00050	650	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00051	651	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00052	652	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00053	653	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00054	654	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00055	655	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00056	656	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00057	657	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00058	658	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00059	659	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00060	660	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00061	661	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00062	662	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00063	663	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00064	664	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00065	665	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00066	666	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00067	667	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00068	668	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00069	669	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00070	670	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00071	671	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00072	672	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00073	673	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00074	674	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00075	675	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00076	676	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Sample_00077	677	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00078	678	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00079	679	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00080	680	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00081	681	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00082	682	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00083	683	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00084	684	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00085	685	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00086	686	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00087	687	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00088	688	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00089	689	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00090	690	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
CONTROL_0001	691	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
CONTROL_0002	692	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
CONTROL_0003	693	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
CONTROL_0004	694	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
CONTROL_0005	695	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Empty well_01	696	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Empty well_02	697	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
Empty well_03	698	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
Empty well_04	699	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Empty well_05	700	OID00007	P78271	Protein_7	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00001	701	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00002	702	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00003	703	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00004	704	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00005	705	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00006	706	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00007	707	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00008	708	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00009	709	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00010	710	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00011	711	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00012	712	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00013	713	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00014	714	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00015	715	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00016	716	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00017	717	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00018	718	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00019	719	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00020	720	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00021	721	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00022	722	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.57	Intensity Normalized (v.2)
Sample_00023	723	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00024	724	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00025	725	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00026	726	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00027	727	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00028	728	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00029	729	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00030	730	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00031	731	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.47	Intensity Normalized (v.2)
Sample_00032	732	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00033	733	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00034	734	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00035	735	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00036	736	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00037	737	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00038	738	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00039	739	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00040	740	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00041	741	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00042	742	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00043	743	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00044	744	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Sample_00045	745	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00046	746	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00047	747	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00048	748	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00049	749	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00050	750	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00051	751	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00052	752	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00053	753	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00054	754	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00055	755	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00056	756	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00057	757	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00058	758	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00059	759	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00060	760	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
Sample_00061	761	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00062	762	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00063	763	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00064	764	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.06	Intensity Normalized (v.2)
Sample_00065	765	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00066	766	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00067	767	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00068	768	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00069	769	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00070	770	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00071	771	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.46	Intensity Normalized (v.2)
Sample_00072	772	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00073	773	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00074	774	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00075	775	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00076	776	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00077	777	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00078	778	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00079	779	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00080	780	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00081	781	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00082	782	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00083	783	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00084	784	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00085	785	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00086	786	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00087	787	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00088	788	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00089	789	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00090	790	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
CONTROL_0001	791	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
CONTROL_0002	792	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
CONTROL_0003	793	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
CONTROL_0004	794	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
CONTROL_0005	795	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Empty well_01	796	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Empty well_02	797	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Empty well_03	798	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Empty well_04	799	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Empty well_05	800	OID00008	P93130	Protein_8	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00001	801	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00002	802	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00003	803	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00004	804	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00005	805	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00006	806	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00007	807	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00008	808	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00009	809	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00010	810	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00011	811	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00012	812	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00013	813	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00014	814	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Sample_00015	815	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00016	816	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00017	817	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00018	818	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00019	819	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00020	820	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00021	821	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00022	822	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00023	823	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00024	824	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00025	825	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00026	826	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00027	827	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00028	828	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00029	829	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00030	830	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00031	831	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00032	832	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00033	833	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00034	834	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00035	835	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.09	Intensity Normalized (v.2)
Sample_00036	836	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00037	837	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00038	838	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00039	839	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00040	840	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00041	841	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00042	842	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00043	843	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00044	844	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00045	845	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00046	846	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00047	847	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00048	848	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00049	849	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00050	850	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00051	851	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00052	852	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00053	853	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00054	854	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00055	855	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00056	856	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00057	857	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00058	858	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00059	859	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00060	860	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00061	861	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00062	862	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00063	863	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00064	864	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00065	865	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00066	866	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00067	867	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00068	868	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00069	869	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00070	870	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00071	871	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00072	872	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00073	873	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00074	874	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00075	875	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00076	876	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00077	877	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00078	878	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00079	879	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00080	880	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00081	881	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00082	882	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00083	883	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00084	884	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00085	885	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00086	886	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00087	887	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00088	888	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00089	889	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00090	890	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
CONTROL_0001	891	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
CONTROL_0002	892	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
CONTROL_0003	893	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
CONTROL_0004	894	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
CONTROL_0005	895	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Empty well_01	896	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Empty well_02	897	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Empty well_03	898	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Empty well_04	899	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Empty well_05	900	OID00009	P38875	Protein_9	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00001	901	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00002	902	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00003	903	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00004	904	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00005	905	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00006	906	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00007	907	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00008	908	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00009	909	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00010	910	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00011	911	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00012	912	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00013	913	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00014	914	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00015	915	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00016	916	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00017	917	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00018	918	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.5	Intensity Normalized (v.2)
Sample_00019	919	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00020	920	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00021	921	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00022	922	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.95	Intensity Normalized (v.2)
Sample_00023	923	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00024	924	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00025	925	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00026	926	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00027	927	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00028	928	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00029	929	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00030	930	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00031	931	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00032	932	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00033	933	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00034	934	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00035	935	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00036	936	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00037	937	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00038	938	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00039	939	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00040	940	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00041	941	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00042	942	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00043	943	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00044	944	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00045	945	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00046	946	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00047	947	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00048	948	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00049	949	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00050	950	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00051	951	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Sample_00052	952	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00053	953	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00054	954	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00055	955	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00056	956	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00057	957	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00058	958	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00059	959	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00060	960	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00061	961	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00062	962	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00063	963	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00064	964	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00065	965	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00066	966	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00067	967	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00068	968	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00069	969	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00070	970	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00071	971	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00072	972	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00073	973	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00074	974	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00075	975	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00076	976	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00077	977	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
Sample_00078	978	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00079	979	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00080	980	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00081	981	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00082	982	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00083	983	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00084	984	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00085	985	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00086	986	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00087	987	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00088	988	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00089	989	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00090	990	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
CONTROL_0001	991	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
CONTROL_0002	992	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.47	Intensity Normalized (v.2)
CONTROL_0003	993	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
CONTROL_0004	994	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
CONTROL_0005	995	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Empty well_01	996	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Empty well_02	997	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Empty well_03	998	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Empty well_04	999	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Empty well_05	1000	OID00010	P33140	Protein_10	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00001	1001	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00002	1002	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00003	1003	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00004	1004	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00005	1005	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00006	1006	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00007	1007	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00008	1008	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00009	1009	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00010	1010	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00011	1011	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00012	1012	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00013	1013	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00014	1014	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00015	1015	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00016	1016	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00017	1017	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00018	1018	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00019	1019	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00020	1020	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00021	1021	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00022	1022	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00023	1023	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00024	1024	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00025	1025	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00026	1026	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00027	1027	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00028	1028	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00029	1029	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00030	1030	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00031	1031	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00032	1032	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00033	1033	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00034	1034	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00035	1035	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00036	1036	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00037	1037	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00038	1038	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00039	1039	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00040	1040	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00041	1041	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00042	1042	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00043	1043	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00044	1044	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00045	1045	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00046	1046	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00047	1047	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00048	1048	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00049	1049	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00050	1050	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00051	1051	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00052	1052	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.57	Intensity Normalized (v.2)
Sample_00053	1053	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00054	1054	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.97	Intensity Normalized (v.2)
Sample_00055	1055	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00056	1056	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00057	1057	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00058	1058	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00059	1059	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00060	1060	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00061	1061	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00062	1062	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00063	1063	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00064	1064	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00065	1065	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00066	1066	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00067	1067	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00068	1068	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00069	1069	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00070	1070	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00071	1071	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00072	1072	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00073	1073	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00074	1074	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00075	1075	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00076	1076	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00077	1077	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00078	1078	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00079	1079	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00080	1080	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00081	1081	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	10	Intensity Normalized (v.2)
Sample_00082	1082	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00083	1083	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00084	1084	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00085	1085	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00086	1086	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00087	1087	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00088	1088	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00089	1089	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00090	1090	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
CONTROL_0001	1091	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
CONTROL_0002	1092	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
CONTROL_0003	1093	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
CONTROL_0004	1094	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
CONTROL_0005	1095	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Empty well_01	1096	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Empty well_02	1097	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Empty well_03	1098	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Empty well_04	1099	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.11	Intensity Normalized (v.2)
Empty well_05	1100	OID00011	P92518	Protein_11	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00001	1101	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00002	1102	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00003	1103	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00004	1104	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00005	1105	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00006	1106	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.93	Intensity Normalized (v.2)
Sample_00007	1107	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00008	1108	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00009	1109	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00010	1110	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00011	1111	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00012	1112	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00013	1113	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00014	1114	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00015	1115	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00016	1116	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00017	1117	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00018	1118	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00019	1119	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00020	1120	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00021	1121	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00022	1122	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00023	1123	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00024	1124	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00025	1125	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00026	1126	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00027	1127	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00028	1128	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00029	1129	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00030	1130	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.96	Intensity Normalized (v.2)
Sample_00031	1131	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00032	1132	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00033	1133	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00034	1134	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00035	1135	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00036	1136	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00037	1137	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00038	1138	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00039	1139	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.95	Intensity Normalized (v.2)
Sample_00040	1140	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00041	1141	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00042	1142	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00043	1143	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00044	1144	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00045	1145	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00046	1146	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00047	1147	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00048	1148	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00049	1149	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00050	1150	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00051	1151	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00052	1152	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00053	1153	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00054	1154	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00055	1155	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00056	1156	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00057	1157	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00058	1158	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00059	1159	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00060	1160	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00061	1161	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00062	1162	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00063	1163	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00064	1164	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00065	1165	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00066	1166	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00067	1167	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Sample_00068	1168	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.09	Intensity Normalized (v.2)
Sample_00069	1169	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00070	1170	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00071	1171	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00072	1172	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00073	1173	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00074	1174	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00075	1175	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00076	1176	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00077	1177	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00078	1178	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.38	Intensity Normalized (v.2)
Sample_00079	1179	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00080	1180	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00081	1181	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00082	1182	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00083	1183	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00084	1184	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00085	1185	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00086	1186	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00087	1187	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00088	1188	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00089	1189	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00090	1190	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
CONTROL_0001	1191	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
CONTROL_0002	1192	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
CONTROL_0003	1193	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
CONTROL_0004	1194	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
CONTROL_0005	1195	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Empty well_01	1196	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Empty well_02	1197	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Empty well_03	1198	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Empty well_04	1199	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Empty well_05	1200	OID00012	P75035	Protein_12	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00001	1201	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00002	1202	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00003	1203	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00004	1204	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00005	1205	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00006	1206	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00007	1207	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00008	1208	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00009	1209	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00010	1210	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00011	1211	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00012	1212	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00013	1213	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00014	1214	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00015	1215	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00016	1216	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00017	1217	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00018	1218	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00019	1219	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00020	1220	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00021	1221	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00022	1222	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00023	1223	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00024	1224	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00025	1225	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
Sample_00026	1226	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00027	1227	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00028	1228	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00029	1229	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.03	Intensity Normalized (v.2)
Sample_00030	1230	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00031	1231	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00032	1232	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00033	1233	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00034	1234	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00035	1235	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00036	1236	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00037	1237	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00038	1238	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00039	1239	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00040	1240	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00041	1241	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00042	1242	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00043	1243	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00044	1244	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Sample_00045	1245	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00046	1246	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00047	1247	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00048	1248	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00049	1249	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00050	1250	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00051	1251	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00052	1252	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00053	1253	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00054	1254	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00055	1255	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.78	Intensity Normalized (v.2)
Sample_00056	1256	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00057	1257	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00058	1258	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00059	1259	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00060	1260	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00061	1261	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00062	1262	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00063	1263	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00064	1264	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00065	1265	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00066	1266	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00067	1267	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00068	1268	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00069	1269	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00070	1270	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00071	1271	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00072	1272	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00073	1273	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00074	1274	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Sample_00075	1275	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00076	1276	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00077	1277	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00078	1278	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00079	1279	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00080	1280	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00081	1281	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.18	Intensity Normalized (v.2)
Sample_00082	1282	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00083	1283	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00084	1284	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00085	1285	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00086	1286	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00087	1287	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00088	1288	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00089	1289	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00090	1290	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
CONTROL_0001	1291	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
CONTROL_0002	1292	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
CONTROL_0003	1293	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
CONTROL_0004	1294	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
CONTROL_0005	1295	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Empty well_01	1296	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Empty well_02	1297	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Empty well_03	1298	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Empty well_04	1299	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Empty well_05	1300	OID00013	P12362	Protein_13	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00001	1301	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00002	1302	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00003	1303	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00004	1304	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00005	1305	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00006	1306	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00007	1307	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00008	1308	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00009	1309	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00010	1310	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00011	1311	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00012	1312	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00013	1313	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00014	1314	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00015	1315	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00016	1316	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00017	1317	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00018	1318	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00019	1319	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00020	1320	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00021	1321	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00022	1322	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00023	1323	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00024	1324	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00025	1325	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00026	1326	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00027	1327	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00028	1328	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00029	1329	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00030	1330	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00031	1331	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00032	1332	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00033	1333	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00034	1334	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00035	1335	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00036	1336	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00037	1337	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00038	1338	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00039	1339	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00040	1340	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00041	1341	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00042	1342	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00043	1343	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00044	1344	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.48	Intensity Normalized (v.2)
Sample_00045	1345	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00046	1346	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00047	1347	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00048	1348	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00049	1349	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00050	1350	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00051	1351	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00052	1352	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00053	1353	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00054	1354	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00055	1355	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00056	1356	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00057	1357	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00058	1358	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00059	1359	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00060	1360	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00061	1361	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00062	1362	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00063	1363	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00064	1364	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00065	1365	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00066	1366	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00067	1367	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00068	1368	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00069	1369	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00070	1370	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00071	1371	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00072	1372	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00073	1373	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00074	1374	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00075	1375	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00076	1376	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00077	1377	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00078	1378	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00079	1379	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00080	1380	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00081	1381	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00082	1382	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00083	1383	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00084	1384	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00085	1385	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00086	1386	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00087	1387	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00088	1388	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.73	Intensity Normalized (v.2)
Sample_00089	1389	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00090	1390	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
CONTROL_0001	1391	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
CONTROL_0002	1392	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
CONTROL_0003	1393	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
CONTROL_0004	1394	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
CONTROL_0005	1395	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Empty well_01	1396	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Empty well_02	1397	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Empty well_03	1398	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Empty well_04	1399	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Empty well_05	1400	OID00014	P59278	Protein_14	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00001	1401	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00002	1402	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00003	1403	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00004	1404	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00005	1405	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00006	1406	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.52	Intensity Normalized (v.2)
Sample_00007	1407	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00008	1408	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00009	1409	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00010	1410	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00011	1411	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00012	1412	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00013	1413	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00014	1414	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00015	1415	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00016	1416	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00017	1417	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00018	1418	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00019	1419	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00020	1420	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00021	1421	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00022	1422	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00023	1423	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00024	1424	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00025	1425	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00026	1426	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00027	1427	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00028	1428	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00029	1429	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00030	1430	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00031	1431	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00032	1432	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00033	1433	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00034	1434	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00035	1435	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00036	1436	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00037	1437	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00038	1438	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00039	1439	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00040	1440	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00041	1441	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00042	1442	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00043	1443	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00044	1444	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00045	1445	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00046	1446	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00047	1447	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00048	1448	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00049	1449	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00050	1450	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00051	1451	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00052	1452	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00053	1453	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00054	1454	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00055	1455	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00056	1456	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00057	1457	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00058	1458	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00059	1459	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00060	1460	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00061	1461	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00062	1462	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00063	1463	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00064	1464	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00065	1465	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00066	1466	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00067	1467	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00068	1468	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00069	1469	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00070	1470	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00071	1471	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00072	1472	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00073	1473	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00074	1474	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00075	1475	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00076	1476	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00077	1477	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00078	1478	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00079	1479	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00080	1480	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00081	1481	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00082	1482	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00083	1483	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00084	1484	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00085	1485	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00086	1486	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00087	1487	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00088	1488	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00089	1489	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Sample_00090	1490	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
CONTROL_0001	1491	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
CONTROL_0002	1492	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
CONTROL_0003	1493	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
CONTROL_0004	1494	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
CONTROL_0005	1495	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Empty well_01	1496	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Empty well_02	1497	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Empty well_03	1498	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Empty well_04	1499	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Empty well_05	1500	OID00015	P17614	Protein_15	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00001	1501	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00002	1502	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00003	1503	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00004	1504	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00005	1505	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00006	1506	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00007	1507	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00008	1508	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00009	1509	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00010	1510	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00011	1511	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.71	Intensity Normalized (v.2)
Sample_00012	1512	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00013	1513	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00014	1514	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00015	1515	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00016	1516	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00017	1517	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00018	1518	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00019	1519	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00020	1520	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00021	1521	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00022	1522	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Sample_00023	1523	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00024	1524	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00025	1525	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00026	1526	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00027	1527	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00028	1528	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00029	1529	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00030	1530	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00031	1531	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00032	1532	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00033	1533	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00034	1534	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00035	1535	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00036	1536	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00037	1537	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00038	1538	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00039	1539	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00040	1540	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00041	1541	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00042	1542	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00043	1543	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00044	1544	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00045	1545	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00046	1546	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00047	1547	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00048	1548	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00049	1549	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00050	1550	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00051	1551	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00052	1552	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00053	1553	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00054	1554	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00055	1555	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00056	1556	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00057	1557	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00058	1558	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00059	1559	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00060	1560	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00061	1561	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00062	1562	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00063	1563	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00064	1564	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00065	1565	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00066	1566	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00067	1567	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00068	1568	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00069	1569	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00070	1570	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00071	1571	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00072	1572	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00073	1573	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00074	1574	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00075	1575	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00076	1576	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00077	1577	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00078	1578	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Sample_00079	1579	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00080	1580	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00081	1581	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00082	1582	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00083	1583	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00084	1584	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00085	1585	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00086	1586	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00087	1587	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00088	1588	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00089	1589	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00090	1590	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
CONTROL_0001	1591	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
CONTROL_0002	1592	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
CONTROL_0003	1593	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
CONTROL_0004	1594	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
CONTROL_0005	1595	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Empty well_01	1596	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Empty well_02	1597	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Empty well_03	1598	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Empty well_04	1599	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Empty well_05	1600	OID00016	P61452	Protein_16	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00001	1601	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00002	1602	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00003	1603	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00004	1604	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00005	1605	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00006	1606	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00007	1607	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00008	1608	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00009	1609	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00010	1610	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00011	1611	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00012	1612	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00013	1613	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00014	1614	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00015	1615	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00016	1616	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00017	1617	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00018	1618	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00019	1619	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00020	1620	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00021	1621	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00022	1622	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00023	1623	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00024	1624	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00025	1625	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00026	1626	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00027	1627	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00028	1628	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00029	1629	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00030	1630	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00031	1631	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Sample_00032	1632	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00033	1633	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00034	1634	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00035	1635	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00036	1636	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00037	1637	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00038	1638	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00039	1639	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00040	1640	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00041	1641	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00042	1642	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00043	1643	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00044	1644	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00045	1645	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00046	1646	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00047	1647	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00048	1648	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00049	1649	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00050	1650	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00051	1651	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00052	1652	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Sample_00053	1653	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00054	1654	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00055	1655	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00056	1656	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00057	1657	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00058	1658	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00059	1659	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00060	1660	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00061	1661	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00062	1662	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00063	1663	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00064	1664	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00065	1665	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00066	1666	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00067	1667	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00068	1668	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00069	1669	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00070	1670	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00071	1671	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00072	1672	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00073	1673	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00074	1674	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00075	1675	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00076	1676	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00077	1677	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00078	1678	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00079	1679	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00080	1680	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00081	1681	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00082	1682	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00083	1683	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00084	1684	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00085	1685	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00086	1686	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.92	Intensity Normalized (v.2)
Sample_00087	1687	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00088	1688	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00089	1689	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00090	1690	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.1	Intensity Normalized (v.2)
CONTROL_0001	1691	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
CONTROL_0002	1692	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
CONTROL_0003	1693	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
CONTROL_0004	1694	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
CONTROL_0005	1695	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Empty well_01	1696	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Empty well_02	1697	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Empty well_03	1698	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Empty well_04	1699	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Empty well_05	1700	OID00017	P79075	Protein_17	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00001	1701	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00002	1702	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00003	1703	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00004	1704	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00005	1705	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00006	1706	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.51	Intensity Normalized (v.2)
Sample_00007	1707	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00008	1708	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00009	1709	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00010	1710	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00011	1711	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00012	1712	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00013	1713	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00014	1714	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00015	1715	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00016	1716	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00017	1717	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00018	1718	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00019	1719	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00020	1720	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00021	1721	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
Sample_00022	1722	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00023	1723	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00024	1724	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00025	1725	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00026	1726	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00027	1727	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00028	1728	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00029	1729	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00030	1730	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00031	1731	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00032	1732	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00033	1733	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00034	1734	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00035	1735	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00036	1736	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00037	1737	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00038	1738	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00039	1739	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00040	1740	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00041	1741	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00042	1742	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00043	1743	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00044	1744	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00045	1745	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00046	1746	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00047	1747	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00048	1748	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00049	1749	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00050	1750	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00051	1751	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00052	1752	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00053	1753	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.49	Intensity Normalized (v.2)
Sample_00054	1754	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00055	1755	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00056	1756	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00057	1757	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00058	1758	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00059	1759	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00060	1760	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00061	1761	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00062	1762	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00063	1763	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00064	1764	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00065	1765	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00066	1766	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00067	1767	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00068	1768	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00069	1769	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00070	1770	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00071	1771	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00072	1772	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00073	1773	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00074	1774	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00075	1775	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00076	1776	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00077	1777	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00078	1778	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00079	1779	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00080	1780	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00081	1781	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00082	1782	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00083	1783	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00084	1784	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00085	1785	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00086	1786	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00087	1787	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00088	1788	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00089	1789	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00090	1790	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
CONTROL_0001	1791	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
CONTROL_0002	1792	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
CONTROL_0003	1793	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
CONTROL_0004	1794	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
CONTROL_0005	1795	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Empty well_01	1796	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Empty well_02	1797	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.69	Intensity Normalized (v.2)
Empty well_03	1798	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Empty well_04	1799	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Empty well_05	1800	OID00018	P71234	Protein_18	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00001	1801	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00002	1802	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00003	1803	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00004	1804	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00005	1805	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00006	1806	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00007	1807	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00008	1808	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00009	1809	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00010	1810	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00011	1811	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00012	1812	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00013	1813	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00014	1814	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00015	1815	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00016	1816	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00017	1817	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00018	1818	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00019	1819	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00020	1820	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00021	1821	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00022	1822	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00023	1823	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
Sample_00024	1824	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00025	1825	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00026	1826	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00027	1827	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00028	1828	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00029	1829	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00030	1830	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00031	1831	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00032	1832	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00033	1833	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00034	1834	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00035	1835	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00036	1836	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00037	1837	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00038	1838	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00039	1839	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00040	1840	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00041	1841	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00042	1842	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00043	1843	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00044	1844	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00045	1845	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00046	1846	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00047	1847	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.03	Intensity Normalized (v.2)
Sample_00048	1848	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00049	1849	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00050	1850	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.38	Intensity Normalized (v.2)
Sample_00051	1851	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00052	1852	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00053	1853	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00054	1854	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00055	1855	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00056	1856	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00057	1857	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00058	1858	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00059	1859	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00060	1860	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00061	1861	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00062	1862	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00063	1863	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00064	1864	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00065	1865	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00066	1866	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00067	1867	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Sample_00068	1868	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00069	1869	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00070	1870	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00071	1871	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00072	1872	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00073	1873	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00074	1874	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00075	1875	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00076	1876	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00077	1877	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
Sample_00078	1878	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00079	1879	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00080	1880	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00081	1881	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.51	Intensity Normalized (v.2)
Sample_00082	1882	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00083	1883	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00084	1884	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00085	1885	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00086	1886	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00087	1887	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00088	1888	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00089	1889	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00090	1890	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
CONTROL_0001	1891	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
CONTROL_0002	1892	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
CONTROL_0003	1893	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
CONTROL_0004	1894	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
CONTROL_0005	1895	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Empty well_01	1896	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Empty well_02	1897	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Empty well_03	1898	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Empty well_04	1899	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Empty well_05	1900	OID00019	P31441	Protein_19	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00001	1901	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00002	1902	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00003	1903	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Sample_00004	1904	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00005	1905	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00006	1906	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00007	1907	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00008	1908	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00009	1909	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00010	1910	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00011	1911	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00012	1912	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00013	1913	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00014	1914	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.09	Intensity Normalized (v.2)
Sample_00015	1915	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00016	1916	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00017	1917	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00018	1918	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00019	1919	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00020	1920	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00021	1921	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00022	1922	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00023	1923	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00024	1924	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00025	1925	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00026	1926	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00027	1927	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00028	1928	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00029	1929	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00030	1930	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00031	1931	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00032	1932	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00033	1933	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00034	1934	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00035	1935	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00036	1936	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00037	1937	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00038	1938	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00039	1939	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00040	1940	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00041	1941	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00042	1942	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00043	1943	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00044	1944	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00045	1945	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
Sample_00046	1946	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00047	1947	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00048	1948	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00049	1949	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00050	1950	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00051	1951	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00052	1952	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00053	1953	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00054	1954	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00055	1955	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00056	1956	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00057	1957	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00058	1958	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00059	1959	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00060	1960	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00061	1961	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00062	1962	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00063	1963	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00064	1964	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00065	1965	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00066	1966	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00067	1967	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00068	1968	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Sample_00069	1969	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00070	1970	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00071	1971	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00072	1972	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00073	1973	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00074	1974	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00075	1975	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00076	1976	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00077	1977	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00078	1978	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00079	1979	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00080	1980	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00081	1981	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00082	1982	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00083	1983	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.81	Intensity Normalized (v.2)
Sample_00084	1984	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00085	1985	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00086	1986	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00087	1987	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00088	1988	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00089	1989	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00090	1990	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
CONTROL_0001	1991	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
CONTROL_0002	1992	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
CONTROL_0003	1993	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
CONTROL_0004	1994	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
CONTROL_0005	1995	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Empty well_01	1996	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Empty well_02	1997	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Empty well_03	1998	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Empty well_04	1999	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Empty well_05	2000	OID00020	P22707	Protein_20	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00001	2001	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00002	2002	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00003	2003	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00004	2004	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00005	2005	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00006	2006	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00007	2007	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Sample_00008	2008	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00009	2009	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00010	2010	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00011	2011	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00012	2012	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00013	2013	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00014	2014	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00015	2015	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00016	2016	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00017	2017	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00018	2018	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00019	2019	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00020	2020	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00021	2021	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00022	2022	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.55	Intensity Normalized (v.2)
Sample_00023	2023	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.5	Intensity Normalized (v.2)
Sample_00024	2024	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00025	2025	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00026	2026	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00027	2027	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00028	2028	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00029	2029	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00030	2030	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00031	2031	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00032	2032	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00033	2033	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00034	2034	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00035	2035	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00036	2036	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
Sample_00037	2037	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00038	2038	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00039	2039	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00040	2040	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00041	2041	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00042	2042	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00043	2043	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00044	2044	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00045	2045	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00046	2046	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
Sample_00047	2047	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00048	2048	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00049	2049	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00050	2050	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00051	2051	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00052	2052	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00053	2053	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00054	2054	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00055	2055	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00056	2056	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00057	2057	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00058	2058	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00059	2059	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00060	2060	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00061	2061	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00062	2062	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00063	2063	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00064	2064	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00065	2065	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00066	2066	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00067	2067	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00068	2068	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00069	2069	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00070	2070	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00071	2071	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00072	2072	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00073	2073	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00074	2074	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00075	2075	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00076	2076	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00077	2077	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00078	2078	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00079	2079	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00080	2080	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.75	Intensity Normalized (v.2)
Sample_00081	2081	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00082	2082	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00083	2083	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00084	2084	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00085	2085	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00086	2086	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00087	2087	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00088	2088	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00089	2089	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00090	2090	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
CONTROL_0001	2091	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
CONTROL_0002	2092	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
CONTROL_0003	2093	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
CONTROL_0004	2094	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
CONTROL_0005	2095	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Empty well_01	2096	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Empty well_02	2097	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Empty well_03	2098	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.19	Intensity Normalized (v.2)
Empty well_04	2099	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Empty well_05	2100	OID00021	P48887	Protein_21	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00001	2101	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00002	2102	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00003	2103	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00004	2104	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00005	2105	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00006	2106	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00007	2107	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00008	2108	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00009	2109	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00010	2110	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00011	2111	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00012	2112	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00013	2113	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00014	2114	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00015	2115	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00016	2116	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00017	2117	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00018	2118	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00019	2119	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00020	2120	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00021	2121	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00022	2122	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00023	2123	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00024	2124	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00025	2125	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00026	2126	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00027	2127	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00028	2128	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00029	2129	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00030	2130	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00031	2131	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00032	2132	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00033	2133	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00034	2134	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00035	2135	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00036	2136	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00037	2137	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00038	2138	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00039	2139	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Sample_00040	2140	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00041	2141	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00042	2142	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00043	2143	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00044	2144	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00045	2145	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00046	2146	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00047	2147	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00048	2148	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00049	2149	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00050	2150	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.46	Intensity Normalized (v.2)
Sample_00051	2151	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00052	2152	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00053	2153	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00054	2154	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00055	2155	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00056	2156	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00057	2157	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00058	2158	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00059	2159	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00060	2160	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00061	2161	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00062	2162	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00063	2163	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00064	2164	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00065	2165	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00066	2166	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00067	2167	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00068	2168	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00069	2169	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00070	2170	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00071	2171	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00072	2172	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00073	2173	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00074	2174	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00075	2175	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00076	2176	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00077	2177	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00078	2178	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00079	2179	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00080	2180	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00081	2181	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00082	2182	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00083	2183	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00084	2184	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00085	2185	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00086	2186	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00087	2187	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00088	2188	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00089	2189	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00090	2190	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
CONTROL_0001	2191	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
CONTROL_0002	2192	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
CONTROL_0003	2193	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
CONTROL_0004	2194	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
CONTROL_0005	2195	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
Empty well_01	2196	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Empty well_02	2197	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Empty well_03	2198	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Empty well_04	2199	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Empty well_05	2200	OID00022	P80250	Protein_22	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00001	2201	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00002	2202	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00003	2203	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00004	2204	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00005	2205	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00006	2206	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00007	2207	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00008	2208	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00009	2209	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00010	2210	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00011	2211	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00012	2212	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00013	2213	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00014	2214	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00015	2215	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00016	2216	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00017	2217	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Sample_00018	2218	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00019	2219	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Sample_00020	2220	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00021	2221	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00022	2222	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00023	2223	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00024	2224	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00025	2225	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00026	2226	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00027	2227	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00028	2228	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00029	2229	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00030	2230	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00031	2231	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00032	2232	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00033	2233	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00034	2234	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00035	2235	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.35	Intensity Normalized (v.2)
Sample_00036	2236	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00037	2237	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00038	2238	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00039	2239	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00040	2240	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00041	2241	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00042	2242	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00043	2243	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00044	2244	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00045	2245	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00046	2246	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00047	2247	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00048	2248	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00049	2249	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00050	2250	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00051	2251	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00052	2252	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00053	2253	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00054	2254	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00055	2255	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00056	2256	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00057	2257	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00058	2258	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00059	2259	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00060	2260	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00061	2261	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00062	2262	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00063	2263	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
Sample_00064	2264	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Sample_00065	2265	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00066	2266	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00067	2267	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00068	2268	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00069	2269	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00070	2270	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00071	2271	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00072	2272	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00073	2273	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00074	2274	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00075	2275	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00076	2276	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00077	2277	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00078	2278	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00079	2279	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00080	2280	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00081	2281	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00082	2282	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.03	Intensity Normalized (v.2)
Sample_00083	2283	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00084	2284	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00085	2285	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00086	2286	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00087	2287	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00088	2288	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.91	Intensity Normalized (v.2)
Sample_00089	2289	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00090	2290	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
CONTROL_0001	2291	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
CONTROL_0002	2292	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
CONTROL_0003	2293	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
CONTROL_0004	2294	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
CONTROL_0005	2295	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Empty well_01	2296	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Empty well_02	2297	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Empty well_03	2298	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Empty well_04	2299	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Empty well_05	2300	OID00023	P91642	Protein_23	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00001	2301	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00002	2302	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00003	2303	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00004	2304	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00005	2305	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00006	2306	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00007	2307	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00008	2308	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.89	Intensity Normalized (v.2)
Sample_00009	2309	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00010	2310	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00011	2311	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00012	2312	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00013	2313	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00014	2314	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00015	2315	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.46	Intensity Normalized (v.2)
Sample_00016	2316	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00017	2317	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00018	2318	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00019	2319	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00020	2320	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00021	2321	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00022	2322	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00023	2323	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00024	2324	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.92	Intensity Normalized (v.2)
Sample_00025	2325	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.31	Intensity Normalized (v.2)
Sample_00026	2326	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00027	2327	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00028	2328	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00029	2329	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00030	2330	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00031	2331	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00032	2332	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00033	2333	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00034	2334	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00035	2335	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.09	Intensity Normalized (v.2)
Sample_00036	2336	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00037	2337	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00038	2338	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00039	2339	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00040	2340	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00041	2341	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00042	2342	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00043	2343	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00044	2344	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00045	2345	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00046	2346	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00047	2347	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Sample_00048	2348	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00049	2349	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00050	2350	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00051	2351	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00052	2352	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00053	2353	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00054	2354	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00055	2355	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00056	2356	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00057	2357	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00058	2358	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00059	2359	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00060	2360	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00061	2361	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.47	Intensity Normalized (v.2)
Sample_00062	2362	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00063	2363	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00064	2364	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00065	2365	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00066	2366	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00067	2367	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00068	2368	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00069	2369	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00070	2370	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00071	2371	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00072	2372	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00073	2373	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00074	2374	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00075	2375	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00076	2376	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00077	2377	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00078	2378	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00079	2379	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00080	2380	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00081	2381	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00082	2382	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00083	2383	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00084	2384	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00085	2385	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00086	2386	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00087	2387	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00088	2388	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00089	2389	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00090	2390	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
CONTROL_0001	2391	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
CONTROL_0002	2392	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
CONTROL_0003	2393	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
CONTROL_0004	2394	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
CONTROL_0005	2395	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Empty well_01	2396	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Empty well_02	2397	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Empty well_03	2398	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Empty well_04	2399	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Empty well_05	2400	OID00024	P92030	Protein_24	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.01	Intensity Normalized (v.2)
Sample_00001	2401	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00002	2402	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00003	2403	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
Sample_00004	2404	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00005	2405	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00006	2406	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00007	2407	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00008	2408	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00009	2409	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00010	2410	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00011	2411	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00012	2412	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00013	2413	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00014	2414	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00015	2415	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00016	2416	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00017	2417	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00018	2418	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00019	2419	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00020	2420	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00021	2421	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00022	2422	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00023	2423	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00024	2424	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00025	2425	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00026	2426	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00027	2427	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00028	2428	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00029	2429	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00030	2430	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00031	2431	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00032	2432	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00033	2433	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00034	2434	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00035	2435	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00036	2436	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00037	2437	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00038	2438	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00039	2439	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00040	2440	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00041	2441	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00042	2442	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.44	Intensity Normalized (v.2)
Sample_00043	2443	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00044	2444	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00045	2445	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00046	2446	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00047	2447	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00048	2448	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Sample_00049	2449	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00050	2450	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00051	2451	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00052	2452	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00053	2453	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00054	2454	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00055	2455	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00056	2456	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00057	2457	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00058	2458	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00059	2459	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00060	2460	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00061	2461	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00062	2462	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00063	2463	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00064	2464	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00065	2465	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00066	2466	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00067	2467	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00068	2468	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00069	2469	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00070	2470	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00071	2471	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00072	2472	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00073	2473	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00074	2474	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00075	2475	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00076	2476	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00077	2477	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00078	2478	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00079	2479	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00080	2480	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00081	2481	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00082	2482	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00083	2483	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00084	2484	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00085	2485	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00086	2486	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00087	2487	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00088	2488	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00089	2489	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00090	2490	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
CONTROL_0001	2491	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.01	Intensity Normalized (v.2)
CONTROL_0002	2492	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
CONTROL_0003	2493	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
CONTROL_0004	2494	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
CONTROL_0005	2495	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Empty well_01	2496	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Empty well_02	2497	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Empty well_03	2498	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Empty well_04	2499	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Empty well_05	2500	OID00025	P57287	Protein_25	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00001	2501	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00002	2502	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00003	2503	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00004	2504	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00005	2505	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00006	2506	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00007	2507	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00008	2508	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00009	2509	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00010	2510	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00011	2511	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00012	2512	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00013	2513	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00014	2514	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00015	2515	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00016	2516	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00017	2517	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00018	2518	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00019	2519	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00020	2520	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00021	2521	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00022	2522	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00023	2523	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00024	2524	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00025	2525	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00026	2526	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00027	2527	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00028	2528	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00029	2529	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00030	2530	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00031	2531	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00032	2532	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00033	2533	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00034	2534	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00035	2535	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00036	2536	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00037	2537	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00038	2538	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00039	2539	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00040	2540	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00041	2541	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00042	2542	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00043	2543	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.91	Intensity Normalized (v.2)
Sample_00044	2544	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00045	2545	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00046	2546	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00047	2547	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00048	2548	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00049	2549	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00050	2550	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00051	2551	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00052	2552	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00053	2553	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00054	2554	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00055	2555	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00056	2556	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00057	2557	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00058	2558	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00059	2559	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00060	2560	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00061	2561	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00062	2562	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00063	2563	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00064	2564	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00065	2565	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00066	2566	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00067	2567	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00068	2568	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00069	2569	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00070	2570	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00071	2571	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00072	2572	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00073	2573	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00074	2574	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Sample_00075	2575	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00076	2576	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00077	2577	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00078	2578	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00079	2579	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00080	2580	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00081	2581	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00082	2582	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00083	2583	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00084	2584	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00085	2585	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00086	2586	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00087	2587	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00088	2588	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00089	2589	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00090	2590	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
CONTROL_0001	2591	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
CONTROL_0002	2592	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
CONTROL_0003	2593	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
CONTROL_0004	2594	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
CONTROL_0005	2595	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Empty well_01	2596	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Empty well_02	2597	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Empty well_03	2598	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Empty well_04	2599	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Empty well_05	2600	OID00026	P67390	Protein_26	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00001	2601	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00002	2602	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00003	2603	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Sample_00004	2604	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Sample_00005	2605	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00006	2606	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00007	2607	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00008	2608	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00009	2609	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00010	2610	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00011	2611	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00012	2612	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00013	2613	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00014	2614	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00015	2615	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00016	2616	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00017	2617	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00018	2618	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00019	2619	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00020	2620	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00021	2621	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00022	2622	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00023	2623	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00024	2624	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00025	2625	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00026	2626	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00027	2627	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00028	2628	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00029	2629	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00030	2630	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00031	2631	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00032	2632	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00033	2633	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00034	2634	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00035	2635	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00036	2636	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00037	2637	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00038	2638	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Sample_00039	2639	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00040	2640	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00041	2641	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00042	2642	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00043	2643	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00044	2644	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00045	2645	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00046	2646	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00047	2647	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00048	2648	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00049	2649	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00050	2650	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00051	2651	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00052	2652	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00053	2653	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00054	2654	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00055	2655	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00056	2656	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00057	2657	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00058	2658	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00059	2659	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00060	2660	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00061	2661	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00062	2662	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00063	2663	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00064	2664	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00065	2665	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00066	2666	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00067	2667	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00068	2668	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00069	2669	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00070	2670	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00071	2671	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00072	2672	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00073	2673	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00074	2674	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00075	2675	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00076	2676	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00077	2677	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00078	2678	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00079	2679	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00080	2680	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00081	2681	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00082	2682	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00083	2683	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00084	2684	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00085	2685	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00086	2686	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00087	2687	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00088	2688	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00089	2689	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00090	2690	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
CONTROL_0001	2691	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
CONTROL_0002	2692	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
CONTROL_0003	2693	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
CONTROL_0004	2694	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
CONTROL_0005	2695	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Empty well_01	2696	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Empty well_02	2697	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Empty well_03	2698	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Empty well_04	2699	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Empty well_05	2700	OID00027	P48905	Protein_27	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00001	2701	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00002	2702	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00003	2703	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00004	2704	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00005	2705	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00006	2706	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00007	2707	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00008	2708	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00009	2709	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00010	2710	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00011	2711	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00012	2712	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Sample_00013	2713	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00014	2714	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00015	2715	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00016	2716	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00017	2717	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00018	2718	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00019	2719	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00020	2720	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00021	2721	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00022	2722	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00023	2723	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00024	2724	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00025	2725	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00026	2726	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00027	2727	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00028	2728	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00029	2729	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00030	2730	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.09	Intensity Normalized (v.2)
Sample_00031	2731	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Sample_00032	2732	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00033	2733	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00034	2734	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.52	Intensity Normalized (v.2)
Sample_00035	2735	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00036	2736	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.03	Intensity Normalized (v.2)
Sample_00037	2737	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
Sample_00038	2738	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00039	2739	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00040	2740	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00041	2741	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00042	2742	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00043	2743	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00044	2744	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00045	2745	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00046	2746	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00047	2747	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00048	2748	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00049	2749	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00050	2750	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00051	2751	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00052	2752	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00053	2753	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00054	2754	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00055	2755	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00056	2756	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00057	2757	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00058	2758	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00059	2759	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00060	2760	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00061	2761	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00062	2762	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00063	2763	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00064	2764	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00065	2765	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00066	2766	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00067	2767	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00068	2768	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00069	2769	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00070	2770	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00071	2771	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00072	2772	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00073	2773	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00074	2774	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00075	2775	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00076	2776	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00077	2777	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00078	2778	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00079	2779	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00080	2780	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00081	2781	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00082	2782	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00083	2783	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00084	2784	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00085	2785	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00086	2786	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00087	2787	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00088	2788	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00089	2789	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
Sample_00090	2790	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
CONTROL_0001	2791	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
CONTROL_0002	2792	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
CONTROL_0003	2793	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
CONTROL_0004	2794	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
CONTROL_0005	2795	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Empty well_01	2796	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Empty well_02	2797	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.69	Intensity Normalized (v.2)
Empty well_03	2798	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Empty well_04	2799	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Empty well_05	2800	OID00028	P18724	Protein_28	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00001	2801	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00002	2802	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00003	2803	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00004	2804	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00005	2805	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00006	2806	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00007	2807	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00008	2808	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00009	2809	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00010	2810	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00011	2811	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00012	2812	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00013	2813	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00014	2814	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00015	2815	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00016	2816	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00017	2817	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00018	2818	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00019	2819	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00020	2820	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00021	2821	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00022	2822	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00023	2823	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00024	2824	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00025	2825	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00026	2826	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00027	2827	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
Sample_00028	2828	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00029	2829	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00030	2830	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00031	2831	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00032	2832	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00033	2833	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.11	Intensity Normalized (v.2)
Sample_00034	2834	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00035	2835	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00036	2836	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00037	2837	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00038	2838	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00039	2839	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00040	2840	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00041	2841	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00042	2842	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00043	2843	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00044	2844	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00045	2845	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00046	2846	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00047	2847	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00048	2848	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00049	2849	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00050	2850	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00051	2851	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00052	2852	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00053	2853	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00054	2854	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00055	2855	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00056	2856	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00057	2857	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00058	2858	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00059	2859	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00060	2860	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00061	2861	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00062	2862	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00063	2863	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00064	2864	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00065	2865	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00066	2866	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00067	2867	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00068	2868	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00069	2869	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00070	2870	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00071	2871	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00072	2872	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00073	2873	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00074	2874	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00075	2875	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00076	2876	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00077	2877	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00078	2878	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00079	2879	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00080	2880	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00081	2881	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00082	2882	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00083	2883	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00084	2884	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00085	2885	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00086	2886	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00087	2887	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00088	2888	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00089	2889	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00090	2890	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
CONTROL_0001	2891	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
CONTROL_0002	2892	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
CONTROL_0003	2893	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
CONTROL_0004	2894	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
CONTROL_0005	2895	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Empty well_01	2896	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Empty well_02	2897	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Empty well_03	2898	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Empty well_04	2899	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Empty well_05	2900	OID00029	P78997	Protein_29	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00001	2901	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00002	2902	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00003	2903	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00004	2904	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00005	2905	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00006	2906	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00007	2907	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00008	2908	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00009	2909	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00010	2910	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00011	2911	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00012	2912	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00013	2913	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00014	2914	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00015	2915	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00016	2916	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Sample_00017	2917	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00018	2918	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00019	2919	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00020	2920	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00021	2921	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00022	2922	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00023	2923	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00024	2924	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00025	2925	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00026	2926	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00027	2927	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00028	2928	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00029	2929	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00030	2930	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00031	2931	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00032	2932	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00033	2933	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00034	2934	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00035	2935	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00036	2936	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00037	2937	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00038	2938	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.69	Intensity Normalized (v.2)
Sample_00039	2939	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00040	2940	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00041	2941	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00042	2942	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00043	2943	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
Sample_00044	2944	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00045	2945	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00046	2946	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00047	2947	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00048	2948	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00049	2949	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00050	2950	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00051	2951	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00052	2952	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00053	2953	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00054	2954	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00055	2955	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00056	2956	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00057	2957	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00058	2958	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
Sample_00059	2959	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00060	2960	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00061	2961	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00062	2962	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00063	2963	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00064	2964	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00065	2965	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00066	2966	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00067	2967	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00068	2968	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00069	2969	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00070	2970	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00071	2971	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00072	2972	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00073	2973	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00074	2974	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00075	2975	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00076	2976	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00077	2977	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00078	2978	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00079	2979	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00080	2980	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00081	2981	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00082	2982	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00083	2983	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00084	2984	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00085	2985	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00086	2986	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00087	2987	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00088	2988	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00089	2989	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00090	2990	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
CONTROL_0001	2991	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
CONTROL_0002	2992	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
CONTROL_0003	2993	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
CONTROL_0004	2994	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
CONTROL_0005	2995	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Empty well_01	2996	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Empty well_02	2997	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Empty well_03	2998	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.55	Intensity Normalized (v.2)
Empty well_04	2999	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Empty well_05	3000	OID00030	P53414	Protein_30	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00001	3001	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00002	3002	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00003	3003	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00004	3004	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00005	3005	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00006	3006	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00007	3007	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00008	3008	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00009	3009	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00010	3010	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00011	3011	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00012	3012	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00013	3013	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00014	3014	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00015	3015	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00016	3016	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00017	3017	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00018	3018	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00019	3019	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00020	3020	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00021	3021	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00022	3022	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00023	3023	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00024	3024	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00025	3025	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00026	3026	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00027	3027	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00028	3028	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00029	3029	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00030	3030	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00031	3031	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00032	3032	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00033	3033	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00034	3034	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00035	3035	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00036	3036	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00037	3037	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00038	3038	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00039	3039	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00040	3040	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00041	3041	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00042	3042	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00043	3043	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00044	3044	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00045	3045	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00046	3046	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00047	3047	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00048	3048	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00049	3049	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00050	3050	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00051	3051	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00052	3052	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00053	3053	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00054	3054	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00055	3055	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.13	Intensity Normalized (v.2)
Sample_00056	3056	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00057	3057	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00058	3058	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00059	3059	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00060	3060	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00061	3061	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00062	3062	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00063	3063	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00064	3064	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00065	3065	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.36	Intensity Normalized (v.2)
Sample_00066	3066	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00067	3067	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00068	3068	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00069	3069	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00070	3070	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00071	3071	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00072	3072	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00073	3073	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00074	3074	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00075	3075	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00076	3076	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00077	3077	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.52	Intensity Normalized (v.2)
Sample_00078	3078	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00079	3079	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00080	3080	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00081	3081	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00082	3082	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00083	3083	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00084	3084	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00085	3085	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00086	3086	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00087	3087	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00088	3088	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00089	3089	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
Sample_00090	3090	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
CONTROL_0001	3091	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
CONTROL_0002	3092	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
CONTROL_0003	3093	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
CONTROL_0004	3094	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
CONTROL_0005	3095	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Empty well_01	3096	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Empty well_02	3097	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Empty well_03	3098	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Empty well_04	3099	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Empty well_05	3100	OID00031	P59664	Protein_31	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00001	3101	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00002	3102	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00003	3103	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00004	3104	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00005	3105	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00006	3106	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00007	3107	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00008	3108	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00009	3109	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00010	3110	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.5	Intensity Normalized (v.2)
Sample_00011	3111	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
Sample_00012	3112	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00013	3113	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00014	3114	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00015	3115	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00016	3116	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00017	3117	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00018	3118	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00019	3119	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00020	3120	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00021	3121	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00022	3122	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00023	3123	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00024	3124	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00025	3125	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00026	3126	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00027	3127	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00028	3128	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00029	3129	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
Sample_00030	3130	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00031	3131	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00032	3132	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00033	3133	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00034	3134	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00035	3135	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00036	3136	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00037	3137	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00038	3138	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00039	3139	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00040	3140	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00041	3141	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00042	3142	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00043	3143	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00044	3144	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
Sample_00045	3145	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00046	3146	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00047	3147	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00048	3148	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00049	3149	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00050	3150	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00051	3151	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00052	3152	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00053	3153	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00054	3154	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00055	3155	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00056	3156	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00057	3157	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00058	3158	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00059	3159	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00060	3160	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00061	3161	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5	Intensity Normalized (v.2)
Sample_00062	3162	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00063	3163	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Sample_00064	3164	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00065	3165	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Sample_00066	3166	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00067	3167	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00068	3168	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00069	3169	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00070	3170	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00071	3171	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.95	Intensity Normalized (v.2)
Sample_00072	3172	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00073	3173	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00074	3174	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00075	3175	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00076	3176	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00077	3177	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00078	3178	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00079	3179	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00080	3180	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00081	3181	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00082	3182	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00083	3183	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00084	3184	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00085	3185	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00086	3186	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00087	3187	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00088	3188	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00089	3189	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
Sample_00090	3190	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
CONTROL_0001	3191	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
CONTROL_0002	3192	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
CONTROL_0003	3193	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
CONTROL_0004	3194	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
CONTROL_0005	3195	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Empty well_01	3196	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Empty well_02	3197	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Empty well_03	3198	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Empty well_04	3199	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Empty well_05	3200	OID00032	P95067	Protein_32	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00001	3201	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00002	3202	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00003	3203	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00004	3204	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Sample_00005	3205	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00006	3206	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00007	3207	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00008	3208	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00009	3209	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.64	Intensity Normalized (v.2)
Sample_00010	3210	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00011	3211	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00012	3212	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00013	3213	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00014	3214	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00015	3215	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00016	3216	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00017	3217	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00018	3218	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00019	3219	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00020	3220	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00021	3221	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00022	3222	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00023	3223	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00024	3224	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00025	3225	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00026	3226	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00027	3227	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Sample_00028	3228	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00029	3229	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00030	3230	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00031	3231	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00032	3232	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00033	3233	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00034	3234	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00035	3235	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00036	3236	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00037	3237	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00038	3238	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00039	3239	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00040	3240	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00041	3241	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00042	3242	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Sample_00043	3243	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00044	3244	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00045	3245	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00046	3246	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00047	3247	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00048	3248	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00049	3249	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00050	3250	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00051	3251	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00052	3252	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00053	3253	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00054	3254	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
Sample_00055	3255	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00056	3256	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00057	3257	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00058	3258	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00059	3259	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00060	3260	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00061	3261	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00062	3262	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00063	3263	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00064	3264	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00065	3265	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00066	3266	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00067	3267	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00068	3268	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00069	3269	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00070	3270	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00071	3271	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00072	3272	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.36	Intensity Normalized (v.2)
Sample_00073	3273	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00074	3274	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00075	3275	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00076	3276	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00077	3277	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00078	3278	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00079	3279	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00080	3280	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00081	3281	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00082	3282	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00083	3283	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00084	3284	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00085	3285	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00086	3286	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00087	3287	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00088	3288	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00089	3289	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00090	3290	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
CONTROL_0001	3291	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
CONTROL_0002	3292	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
CONTROL_0003	3293	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
CONTROL_0004	3294	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
CONTROL_0005	3295	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Empty well_01	3296	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Empty well_02	3297	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Empty well_03	3298	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Empty well_04	3299	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Empty well_05	3300	OID00033	P39501	Protein_33	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00001	3301	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00002	3302	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00003	3303	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Sample_00004	3304	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00005	3305	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00006	3306	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00007	3307	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00008	3308	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00009	3309	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00010	3310	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00011	3311	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00012	3312	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00013	3313	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00014	3314	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00015	3315	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00016	3316	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00017	3317	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00018	3318	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00019	3319	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00020	3320	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00021	3321	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00022	3322	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00023	3323	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00024	3324	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00025	3325	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00026	3326	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00027	3327	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00028	3328	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00029	3329	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00030	3330	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00031	3331	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00032	3332	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00033	3333	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00034	3334	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00035	3335	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Sample_00036	3336	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00037	3337	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00038	3338	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00039	3339	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00040	3340	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.71	Intensity Normalized (v.2)
Sample_00041	3341	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00042	3342	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00043	3343	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00044	3344	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00045	3345	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00046	3346	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00047	3347	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00048	3348	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00049	3349	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00050	3350	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
Sample_00051	3351	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00052	3352	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00053	3353	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00054	3354	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00055	3355	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00056	3356	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00057	3357	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00058	3358	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00059	3359	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00060	3360	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00061	3361	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00062	3362	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00063	3363	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00064	3364	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00065	3365	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00066	3366	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00067	3367	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.2	Intensity Normalized (v.2)
Sample_00068	3368	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00069	3369	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00070	3370	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00071	3371	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00072	3372	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00073	3373	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00074	3374	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00075	3375	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00076	3376	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00077	3377	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00078	3378	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00079	3379	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00080	3380	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00081	3381	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00082	3382	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00083	3383	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00084	3384	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00085	3385	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00086	3386	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00087	3387	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00088	3388	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00089	3389	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00090	3390	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
CONTROL_0001	3391	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
CONTROL_0002	3392	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
CONTROL_0003	3393	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
CONTROL_0004	3394	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
CONTROL_0005	3395	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Empty well_01	3396	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Empty well_02	3397	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Empty well_03	3398	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Empty well_04	3399	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Empty well_05	3400	OID00034	P79190	Protein_34	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00001	3401	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00002	3402	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00003	3403	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00004	3404	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00005	3405	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00006	3406	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00007	3407	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00008	3408	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00009	3409	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00010	3410	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00011	3411	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00012	3412	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
Sample_00013	3413	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00014	3414	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00015	3415	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00016	3416	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00017	3417	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00018	3418	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00019	3419	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00020	3420	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00021	3421	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00022	3422	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00023	3423	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00024	3424	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00025	3425	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
Sample_00026	3426	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00027	3427	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
Sample_00028	3428	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00029	3429	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00030	3430	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00031	3431	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00032	3432	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00033	3433	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00034	3434	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00035	3435	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00036	3436	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00037	3437	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00038	3438	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00039	3439	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00040	3440	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.57	Intensity Normalized (v.2)
Sample_00041	3441	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00042	3442	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00043	3443	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00044	3444	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00045	3445	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00046	3446	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00047	3447	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Sample_00048	3448	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00049	3449	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00050	3450	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00051	3451	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00052	3452	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00053	3453	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.49	Intensity Normalized (v.2)
Sample_00054	3454	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00055	3455	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00056	3456	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00057	3457	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00058	3458	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00059	3459	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00060	3460	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00061	3461	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00062	3462	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00063	3463	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	10	Intensity Normalized (v.2)
Sample_00064	3464	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00065	3465	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00066	3466	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00067	3467	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00068	3468	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00069	3469	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.24	Intensity Normalized (v.2)
Sample_00070	3470	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00071	3471	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00072	3472	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00073	3473	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00074	3474	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00075	3475	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00076	3476	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00077	3477	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00078	3478	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00079	3479	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00080	3480	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00081	3481	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00082	3482	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00083	3483	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00084	3484	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00085	3485	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00086	3486	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00087	3487	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00088	3488	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00089	3489	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00090	3490	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
CONTROL_0001	3491	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
CONTROL_0002	3492	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
CONTROL_0003	3493	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
CONTROL_0004	3494	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
CONTROL_0005	3495	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Empty well_01	3496	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Empty well_02	3497	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Empty well_03	3498	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Empty well_04	3499	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Empty well_05	3500	OID00035	P24947	Protein_35	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00001	3501	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00002	3502	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00003	3503	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00004	3504	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00005	3505	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00006	3506	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00007	3507	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00008	3508	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00009	3509	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00010	3510	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00011	3511	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00012	3512	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00013	3513	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00014	3514	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00015	3515	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00016	3516	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00017	3517	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00018	3518	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00019	3519	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00020	3520	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00021	3521	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00022	3522	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00023	3523	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00024	3524	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00025	3525	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00026	3526	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00027	3527	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00028	3528	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00029	3529	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00030	3530	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00031	3531	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00032	3532	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
Sample_00033	3533	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Sample_00034	3534	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00035	3535	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00036	3536	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00037	3537	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00038	3538	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00039	3539	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00040	3540	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00041	3541	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00042	3542	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00043	3543	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00044	3544	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00045	3545	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00046	3546	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00047	3547	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00048	3548	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00049	3549	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00050	3550	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00051	3551	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00052	3552	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00053	3553	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00054	3554	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00055	3555	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00056	3556	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00057	3557	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00058	3558	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.47	Intensity Normalized (v.2)
Sample_00059	3559	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Sample_00060	3560	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00061	3561	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00062	3562	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00063	3563	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00064	3564	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00065	3565	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00066	3566	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00067	3567	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00068	3568	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00069	3569	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00070	3570	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00071	3571	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00072	3572	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00073	3573	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00074	3574	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00075	3575	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00076	3576	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00077	3577	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00078	3578	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00079	3579	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00080	3580	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00081	3581	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00082	3582	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00083	3583	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00084	3584	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00085	3585	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00086	3586	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
Sample_00087	3587	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00088	3588	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00089	3589	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00090	3590	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
CONTROL_0001	3591	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
CONTROL_0002	3592	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
CONTROL_0003	3593	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
CONTROL_0004	3594	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
CONTROL_0005	3595	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Empty well_01	3596	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Empty well_02	3597	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Empty well_03	3598	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Empty well_04	3599	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
Empty well_05	3600	OID00036	P61796	Protein_36	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00001	3601	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00002	3602	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00003	3603	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5	Intensity Normalized (v.2)
Sample_00004	3604	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00005	3605	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00006	3606	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00007	3607	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00008	3608	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00009	3609	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00010	3610	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00011	3611	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00012	3612	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00013	3613	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00014	3614	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00015	3615	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00016	3616	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00017	3617	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00018	3618	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00019	3619	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.11	Intensity Normalized (v.2)
Sample_00020	3620	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00021	3621	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00022	3622	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00023	3623	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00024	3624	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00025	3625	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00026	3626	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00027	3627	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00028	3628	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00029	3629	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00030	3630	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00031	3631	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00032	3632	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	10	Intensity Normalized (v.2)
Sample_00033	3633	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00034	3634	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00035	3635	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00036	3636	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.59	Intensity Normalized (v.2)
Sample_00037	3637	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00038	3638	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00039	3639	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00040	3640	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00041	3641	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00042	3642	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00043	3643	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00044	3644	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00045	3645	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00046	3646	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00047	3647	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00048	3648	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00049	3649	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00050	3650	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00051	3651	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00052	3652	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00053	3653	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00054	3654	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00055	3655	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00056	3656	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00057	3657	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00058	3658	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00059	3659	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00060	3660	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00061	3661	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00062	3662	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00063	3663	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00064	3664	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00065	3665	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00066	3666	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00067	3667	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00068	3668	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00069	3669	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00070	3670	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00071	3671	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00072	3672	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00073	3673	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00074	3674	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00075	3675	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00076	3676	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00077	3677	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00078	3678	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00079	3679	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00080	3680	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00081	3681	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00082	3682	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00083	3683	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00084	3684	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00085	3685	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00086	3686	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00087	3687	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00088	3688	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00089	3689	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00090	3690	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
CONTROL_0001	3691	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
CONTROL_0002	3692	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
CONTROL_0003	3693	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
CONTROL_0004	3694	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
CONTROL_0005	3695	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Empty well_01	3696	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Empty well_02	3697	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Empty well_03	3698	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Empty well_04	3699	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Empty well_05	3700	OID00037	P18210	Protein_37	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00001	3701	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00002	3702	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00003	3703	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.89	Intensity Normalized (v.2)
Sample_00004	3704	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00005	3705	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00006	3706	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00007	3707	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00008	3708	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00009	3709	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.2	Intensity Normalized (v.2)
Sample_00010	3710	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00011	3711	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00012	3712	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00013	3713	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00014	3714	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00015	3715	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00016	3716	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00017	3717	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00018	3718	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00019	3719	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00020	3720	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00021	3721	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00022	3722	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00023	3723	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00024	3724	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00025	3725	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00026	3726	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00027	3727	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00028	3728	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00029	3729	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00030	3730	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00031	3731	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00032	3732	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00033	3733	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00034	3734	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00035	3735	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00036	3736	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00037	3737	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00038	3738	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00039	3739	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00040	3740	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00041	3741	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00042	3742	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00043	3743	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.55	Intensity Normalized (v.2)
Sample_00044	3744	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00045	3745	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00046	3746	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00047	3747	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00048	3748	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00049	3749	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00050	3750	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00051	3751	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00052	3752	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00053	3753	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00054	3754	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00055	3755	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00056	3756	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00057	3757	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00058	3758	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00059	3759	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00060	3760	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00061	3761	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00062	3762	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00063	3763	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00064	3764	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00065	3765	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.48	Intensity Normalized (v.2)
Sample_00066	3766	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00067	3767	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00068	3768	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00069	3769	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00070	3770	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00071	3771	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00072	3772	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00073	3773	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00074	3774	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.52	Intensity Normalized (v.2)
Sample_00075	3775	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00076	3776	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00077	3777	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00078	3778	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00079	3779	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00080	3780	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00081	3781	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Sample_00082	3782	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00083	3783	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00084	3784	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00085	3785	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00086	3786	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00087	3787	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00088	3788	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00089	3789	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00090	3790	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
CONTROL_0001	3791	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
CONTROL_0002	3792	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
CONTROL_0003	3793	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
CONTROL_0004	3794	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
CONTROL_0005	3795	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Empty well_01	3796	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Empty well_02	3797	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Empty well_03	3798	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Empty well_04	3799	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Empty well_05	3800	OID00038	P50514	Protein_38	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
Sample_00001	3801	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00002	3802	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00003	3803	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00004	3804	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00005	3805	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00006	3806	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Sample_00007	3807	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Sample_00008	3808	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00009	3809	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00010	3810	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00011	3811	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00012	3812	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00013	3813	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00014	3814	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00015	3815	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00016	3816	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00017	3817	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00018	3818	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00019	3819	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00020	3820	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00021	3821	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00022	3822	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00023	3823	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00024	3824	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00025	3825	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00026	3826	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00027	3827	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00028	3828	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.78	Intensity Normalized (v.2)
Sample_00029	3829	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00030	3830	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00031	3831	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00032	3832	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00033	3833	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00034	3834	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00035	3835	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00036	3836	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00037	3837	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00038	3838	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00039	3839	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00040	3840	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00041	3841	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00042	3842	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00043	3843	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00044	3844	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00045	3845	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00046	3846	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00047	3847	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00048	3848	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00049	3849	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00050	3850	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00051	3851	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00052	3852	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00053	3853	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00054	3854	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Sample_00055	3855	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00056	3856	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00057	3857	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
Sample_00058	3858	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00059	3859	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00060	3860	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00061	3861	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00062	3862	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00063	3863	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00064	3864	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00065	3865	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00066	3866	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00067	3867	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00068	3868	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00069	3869	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00070	3870	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00071	3871	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00072	3872	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00073	3873	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00074	3874	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00075	3875	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00076	3876	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00077	3877	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00078	3878	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00079	3879	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00080	3880	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00081	3881	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00082	3882	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00083	3883	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00084	3884	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00085	3885	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00086	3886	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00087	3887	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00088	3888	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00089	3889	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00090	3890	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
CONTROL_0001	3891	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
CONTROL_0002	3892	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
CONTROL_0003	3893	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
CONTROL_0004	3894	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
CONTROL_0005	3895	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.55	Intensity Normalized (v.2)
Empty well_01	3896	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Empty well_02	3897	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Empty well_03	3898	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Empty well_04	3899	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Empty well_05	3900	OID00039	P61773	Protein_39	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00001	3901	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00002	3902	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00003	3903	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00004	3904	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00005	3905	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00006	3906	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.5	Intensity Normalized (v.2)
Sample_00007	3907	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00008	3908	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00009	3909	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00010	3910	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00011	3911	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00012	3912	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00013	3913	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00014	3914	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00015	3915	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00016	3916	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00017	3917	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00018	3918	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00019	3919	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00020	3920	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00021	3921	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00022	3922	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00023	3923	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00024	3924	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00025	3925	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00026	3926	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00027	3927	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00028	3928	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00029	3929	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00030	3930	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00031	3931	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00032	3932	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00033	3933	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00034	3934	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00035	3935	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00036	3936	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00037	3937	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00038	3938	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.69	Intensity Normalized (v.2)
Sample_00039	3939	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00040	3940	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00041	3941	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00042	3942	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00043	3943	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00044	3944	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00045	3945	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00046	3946	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00047	3947	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00048	3948	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00049	3949	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00050	3950	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00051	3951	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00052	3952	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00053	3953	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00054	3954	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00055	3955	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00056	3956	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00057	3957	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00058	3958	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00059	3959	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00060	3960	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00061	3961	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00062	3962	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00063	3963	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00064	3964	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00065	3965	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.91	Intensity Normalized (v.2)
Sample_00066	3966	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00067	3967	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00068	3968	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00069	3969	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00070	3970	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00071	3971	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00072	3972	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00073	3973	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00074	3974	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00075	3975	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00076	3976	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00077	3977	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00078	3978	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00079	3979	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00080	3980	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00081	3981	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00082	3982	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00083	3983	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00084	3984	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00085	3985	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00086	3986	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00087	3987	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00088	3988	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00089	3989	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00090	3990	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
CONTROL_0001	3991	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
CONTROL_0002	3992	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
CONTROL_0003	3993	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
CONTROL_0004	3994	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
CONTROL_0005	3995	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Empty well_01	3996	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Empty well_02	3997	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Empty well_03	3998	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Empty well_04	3999	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Empty well_05	4000	OID00040	P97784	Protein_40	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00001	4001	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
Sample_00002	4002	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00003	4003	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Sample_00004	4004	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
Sample_00005	4005	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00006	4006	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00007	4007	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00008	4008	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00009	4009	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00010	4010	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00011	4011	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00012	4012	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00013	4013	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00014	4014	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00015	4015	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00016	4016	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00017	4017	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00018	4018	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00019	4019	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00020	4020	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00021	4021	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00022	4022	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00023	4023	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00024	4024	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00025	4025	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00026	4026	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00027	4027	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00028	4028	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00029	4029	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00030	4030	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00031	4031	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
Sample_00032	4032	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00033	4033	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00034	4034	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00035	4035	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00036	4036	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00037	4037	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00038	4038	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00039	4039	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00040	4040	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00041	4041	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.75	Intensity Normalized (v.2)
Sample_00042	4042	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00043	4043	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00044	4044	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00045	4045	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00046	4046	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00047	4047	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00048	4048	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00049	4049	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00050	4050	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00051	4051	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00052	4052	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00053	4053	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00054	4054	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00055	4055	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00056	4056	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00057	4057	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00058	4058	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00059	4059	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00060	4060	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00061	4061	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00062	4062	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00063	4063	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00064	4064	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00065	4065	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00066	4066	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00067	4067	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00068	4068	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00069	4069	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00070	4070	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00071	4071	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00072	4072	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00073	4073	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00074	4074	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00075	4075	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00076	4076	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00077	4077	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00078	4078	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00079	4079	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
Sample_00080	4080	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00081	4081	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00082	4082	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00083	4083	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00084	4084	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00085	4085	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00086	4086	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00087	4087	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00088	4088	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00089	4089	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00090	4090	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
CONTROL_0001	4091	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
CONTROL_0002	4092	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
CONTROL_0003	4093	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
CONTROL_0004	4094	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
CONTROL_0005	4095	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Empty well_01	4096	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Empty well_02	4097	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Empty well_03	4098	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Empty well_04	4099	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Empty well_05	4100	OID00041	P87947	Protein_41	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00001	4101	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Sample_00002	4102	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00003	4103	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00004	4104	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00005	4105	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00006	4106	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00007	4107	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00008	4108	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00009	4109	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00010	4110	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00011	4111	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
Sample_00012	4112	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00013	4113	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00014	4114	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00015	4115	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Sample_00016	4116	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00017	4117	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00018	4118	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00019	4119	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00020	4120	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00021	4121	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00022	4122	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00023	4123	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00024	4124	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00025	4125	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00026	4126	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00027	4127	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00028	4128	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00029	4129	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00030	4130	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00031	4131	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00032	4132	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00033	4133	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00034	4134	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00035	4135	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00036	4136	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00037	4137	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00038	4138	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00039	4139	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00040	4140	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00041	4141	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00042	4142	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00043	4143	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00044	4144	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00045	4145	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00046	4146	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00047	4147	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00048	4148	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00049	4149	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00050	4150	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00051	4151	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00052	4152	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00053	4153	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00054	4154	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00055	4155	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00056	4156	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00057	4157	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00058	4158	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00059	4159	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00060	4160	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00061	4161	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00062	4162	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00063	4163	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00064	4164	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00065	4165	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00066	4166	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00067	4167	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00068	4168	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
Sample_00069	4169	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00070	4170	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00071	4171	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00072	4172	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5	Intensity Normalized (v.2)
Sample_00073	4173	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00074	4174	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00075	4175	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00076	4176	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00077	4177	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00078	4178	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00079	4179	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00080	4180	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00081	4181	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.47	Intensity Normalized (v.2)
Sample_00082	4182	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00083	4183	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00084	4184	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00085	4185	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00086	4186	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00087	4187	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00088	4188	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00089	4189	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00090	4190	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
CONTROL_0001	4191	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
CONTROL_0002	4192	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
CONTROL_0003	4193	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
CONTROL_0004	4194	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
CONTROL_0005	4195	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Empty well_01	4196	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Empty well_02	4197	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Empty well_03	4198	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Empty well_04	4199	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Empty well_05	4200	OID00042	P44960	Protein_42	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00001	4201	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00002	4202	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00003	4203	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00004	4204	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00005	4205	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00006	4206	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00007	4207	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00008	4208	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00009	4209	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00010	4210	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00011	4211	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00012	4212	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00013	4213	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00014	4214	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00015	4215	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00016	4216	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00017	4217	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00018	4218	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00019	4219	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00020	4220	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00021	4221	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00022	4222	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00023	4223	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00024	4224	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00025	4225	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00026	4226	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00027	4227	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00028	4228	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00029	4229	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00030	4230	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00031	4231	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00032	4232	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00033	4233	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00034	4234	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00035	4235	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00036	4236	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00037	4237	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00038	4238	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00039	4239	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00040	4240	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00041	4241	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00042	4242	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00043	4243	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00044	4244	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00045	4245	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00046	4246	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00047	4247	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00048	4248	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00049	4249	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00050	4250	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00051	4251	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00052	4252	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00053	4253	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00054	4254	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00055	4255	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00056	4256	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00057	4257	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00058	4258	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00059	4259	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00060	4260	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00061	4261	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00062	4262	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00063	4263	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00064	4264	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00065	4265	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00066	4266	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00067	4267	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00068	4268	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00069	4269	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00070	4270	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00071	4271	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00072	4272	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	10	Intensity Normalized (v.2)
Sample_00073	4273	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00074	4274	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00075	4275	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00076	4276	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00077	4277	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00078	4278	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00079	4279	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00080	4280	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00081	4281	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00082	4282	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00083	4283	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00084	4284	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00085	4285	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Sample_00086	4286	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00087	4287	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00088	4288	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00089	4289	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00090	4290	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
CONTROL_0001	4291	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
CONTROL_0002	4292	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
CONTROL_0003	4293	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
CONTROL_0004	4294	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
CONTROL_0005	4295	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Empty well_01	4296	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Empty well_02	4297	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Empty well_03	4298	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Empty well_04	4299	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Empty well_05	4300	OID00043	P57569	Protein_43	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00001	4301	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00002	4302	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00003	4303	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00004	4304	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00005	4305	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00006	4306	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00007	4307	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00008	4308	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00009	4309	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00010	4310	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00011	4311	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00012	4312	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00013	4313	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00014	4314	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00015	4315	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00016	4316	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00017	4317	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00018	4318	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00019	4319	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00020	4320	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00021	4321	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00022	4322	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.96	Intensity Normalized (v.2)
Sample_00023	4323	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00024	4324	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00025	4325	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00026	4326	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00027	4327	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00028	4328	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.52	Intensity Normalized (v.2)
Sample_00029	4329	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00030	4330	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00031	4331	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00032	4332	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Sample_00033	4333	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.31	Intensity Normalized (v.2)
Sample_00034	4334	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00035	4335	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00036	4336	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00037	4337	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00038	4338	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.96	Intensity Normalized (v.2)
Sample_00039	4339	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00040	4340	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00041	4341	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00042	4342	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00043	4343	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00044	4344	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00045	4345	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00046	4346	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00047	4347	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00048	4348	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00049	4349	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00050	4350	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00051	4351	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00052	4352	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00053	4353	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.97	Intensity Normalized (v.2)
Sample_00054	4354	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00055	4355	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Sample_00056	4356	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00057	4357	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00058	4358	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00059	4359	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00060	4360	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00061	4361	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00062	4362	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00063	4363	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00064	4364	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00065	4365	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00066	4366	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00067	4367	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00068	4368	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00069	4369	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00070	4370	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00071	4371	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00072	4372	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00073	4373	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00074	4374	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00075	4375	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00076	4376	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00077	4377	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00078	4378	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00079	4379	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00080	4380	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00081	4381	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00082	4382	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00083	4383	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00084	4384	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00085	4385	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00086	4386	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00087	4387	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00088	4388	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00089	4389	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00090	4390	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
CONTROL_0001	4391	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
CONTROL_0002	4392	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
CONTROL_0003	4393	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
CONTROL_0004	4394	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
CONTROL_0005	4395	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Empty well_01	4396	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Empty well_02	4397	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Empty well_03	4398	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Empty well_04	4399	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Empty well_05	4400	OID00044	P82404	Protein_44	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00001	4401	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.44	Intensity Normalized (v.2)
Sample_00002	4402	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00003	4403	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00004	4404	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00005	4405	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00006	4406	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00007	4407	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00008	4408	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00009	4409	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00010	4410	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00011	4411	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00012	4412	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00013	4413	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00014	4414	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00015	4415	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00016	4416	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00017	4417	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00018	4418	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00019	4419	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00020	4420	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00021	4421	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00022	4422	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00023	4423	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00024	4424	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00025	4425	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00026	4426	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00027	4427	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00028	4428	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00029	4429	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00030	4430	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00031	4431	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00032	4432	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00033	4433	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00034	4434	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00035	4435	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00036	4436	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00037	4437	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00038	4438	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00039	4439	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00040	4440	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00041	4441	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00042	4442	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00043	4443	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00044	4444	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00045	4445	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00046	4446	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00047	4447	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00048	4448	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00049	4449	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00050	4450	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00051	4451	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00052	4452	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00053	4453	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00054	4454	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00055	4455	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00056	4456	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00057	4457	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00058	4458	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00059	4459	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00060	4460	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00061	4461	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00062	4462	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00063	4463	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00064	4464	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.46	Intensity Normalized (v.2)
Sample_00065	4465	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00066	4466	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00067	4467	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00068	4468	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.2	Intensity Normalized (v.2)
Sample_00069	4469	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00070	4470	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00071	4471	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00072	4472	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00073	4473	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00074	4474	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00075	4475	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00076	4476	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00077	4477	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00078	4478	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00079	4479	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00080	4480	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00081	4481	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00082	4482	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00083	4483	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00084	4484	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00085	4485	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00086	4486	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00087	4487	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00088	4488	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00089	4489	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00090	4490	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
CONTROL_0001	4491	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
CONTROL_0002	4492	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
CONTROL_0003	4493	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
CONTROL_0004	4494	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
CONTROL_0005	4495	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Empty well_01	4496	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Empty well_02	4497	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.41	Intensity Normalized (v.2)
Empty well_03	4498	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Empty well_04	4499	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Empty well_05	4500	OID00045	P80918	Protein_45	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00001	4501	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00002	4502	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00003	4503	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00004	4504	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00005	4505	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00006	4506	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00007	4507	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00008	4508	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00009	4509	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00010	4510	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00011	4511	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00012	4512	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00013	4513	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00014	4514	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00015	4515	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00016	4516	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00017	4517	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00018	4518	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00019	4519	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00020	4520	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.77	Intensity Normalized (v.2)
Sample_00021	4521	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00022	4522	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00023	4523	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00024	4524	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00025	4525	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00026	4526	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00027	4527	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00028	4528	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00029	4529	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00030	4530	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00031	4531	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00032	4532	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00033	4533	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00034	4534	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00035	4535	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00036	4536	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00037	4537	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00038	4538	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00039	4539	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00040	4540	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00041	4541	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00042	4542	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00043	4543	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00044	4544	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00045	4545	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00046	4546	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00047	4547	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00048	4548	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00049	4549	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00050	4550	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00051	4551	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00052	4552	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00053	4553	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00054	4554	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00055	4555	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00056	4556	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00057	4557	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00058	4558	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00059	4559	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00060	4560	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00061	4561	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00062	4562	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.45	Intensity Normalized (v.2)
Sample_00063	4563	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00064	4564	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.03	Intensity Normalized (v.2)
Sample_00065	4565	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00066	4566	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00067	4567	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00068	4568	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00069	4569	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00070	4570	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00071	4571	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00072	4572	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00073	4573	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00074	4574	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00075	4575	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00076	4576	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Sample_00077	4577	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.09	Intensity Normalized (v.2)
Sample_00078	4578	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
Sample_00079	4579	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00080	4580	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00081	4581	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00082	4582	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Sample_00083	4583	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00084	4584	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00085	4585	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00086	4586	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00087	4587	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00088	4588	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00089	4589	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00090	4590	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
CONTROL_0001	4591	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
CONTROL_0002	4592	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
CONTROL_0003	4593	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
CONTROL_0004	4594	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
CONTROL_0005	4595	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Empty well_01	4596	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Empty well_02	4597	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Empty well_03	4598	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Empty well_04	4599	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Empty well_05	4600	OID00046	P80379	Protein_46	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00001	4601	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00002	4602	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00003	4603	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00004	4604	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.19	Intensity Normalized (v.2)
Sample_00005	4605	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00006	4606	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00007	4607	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00008	4608	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00009	4609	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00010	4610	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00011	4611	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00012	4612	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00013	4613	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00014	4614	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00015	4615	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00016	4616	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00017	4617	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00018	4618	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00019	4619	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00020	4620	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.97	Intensity Normalized (v.2)
Sample_00021	4621	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00022	4622	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00023	4623	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00024	4624	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00025	4625	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00026	4626	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00027	4627	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00028	4628	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00029	4629	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00030	4630	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00031	4631	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00032	4632	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00033	4633	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00034	4634	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00035	4635	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00036	4636	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00037	4637	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00038	4638	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00039	4639	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00040	4640	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00041	4641	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00042	4642	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00043	4643	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00044	4644	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00045	4645	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00046	4646	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00047	4647	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00048	4648	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00049	4649	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00050	4650	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00051	4651	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00052	4652	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00053	4653	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00054	4654	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00055	4655	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00056	4656	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00057	4657	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00058	4658	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00059	4659	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00060	4660	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00061	4661	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00062	4662	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00063	4663	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00064	4664	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00065	4665	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00066	4666	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00067	4667	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00068	4668	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Sample_00069	4669	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00070	4670	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00071	4671	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00072	4672	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00073	4673	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00074	4674	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00075	4675	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00076	4676	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00077	4677	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00078	4678	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00079	4679	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00080	4680	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00081	4681	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00082	4682	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00083	4683	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00084	4684	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00085	4685	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00086	4686	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00087	4687	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00088	4688	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00089	4689	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00090	4690	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
CONTROL_0001	4691	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
CONTROL_0002	4692	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
CONTROL_0003	4693	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
CONTROL_0004	4694	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
CONTROL_0005	4695	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Empty well_01	4696	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Empty well_02	4697	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Empty well_03	4698	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Empty well_04	4699	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Empty well_05	4700	OID00047	P67917	Protein_47	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00001	4701	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00002	4702	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00003	4703	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00004	4704	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00005	4705	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00006	4706	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00007	4707	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00008	4708	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00009	4709	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.92	Intensity Normalized (v.2)
Sample_00010	4710	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.81	Intensity Normalized (v.2)
Sample_00011	4711	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00012	4712	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00013	4713	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00014	4714	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00015	4715	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00016	4716	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00017	4717	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00018	4718	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00019	4719	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00020	4720	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00021	4721	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00022	4722	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00023	4723	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00024	4724	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00025	4725	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00026	4726	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00027	4727	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00028	4728	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00029	4729	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00030	4730	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00031	4731	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00032	4732	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00033	4733	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00034	4734	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00035	4735	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00036	4736	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00037	4737	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00038	4738	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00039	4739	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00040	4740	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00041	4741	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00042	4742	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00043	4743	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00044	4744	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
Sample_00045	4745	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00046	4746	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00047	4747	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00048	4748	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00049	4749	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00050	4750	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00051	4751	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00052	4752	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00053	4753	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00054	4754	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00055	4755	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00056	4756	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00057	4757	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00058	4758	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00059	4759	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00060	4760	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00061	4761	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00062	4762	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Sample_00063	4763	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00064	4764	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00065	4765	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00066	4766	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00067	4767	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00068	4768	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00069	4769	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00070	4770	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00071	4771	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00072	4772	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00073	4773	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00074	4774	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00075	4775	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00076	4776	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00077	4777	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00078	4778	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00079	4779	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00080	4780	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00081	4781	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00082	4782	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00083	4783	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00084	4784	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00085	4785	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.77	Intensity Normalized (v.2)
Sample_00086	4786	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00087	4787	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.77	Intensity Normalized (v.2)
Sample_00088	4788	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00089	4789	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00090	4790	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
CONTROL_0001	4791	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
CONTROL_0002	4792	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
CONTROL_0003	4793	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
CONTROL_0004	4794	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
CONTROL_0005	4795	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Empty well_01	4796	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Empty well_02	4797	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Empty well_03	4798	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Empty well_04	4799	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Empty well_05	4800	OID00048	P58172	Protein_48	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00001	4801	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00002	4802	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00003	4803	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00004	4804	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00005	4805	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00006	4806	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00007	4807	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00008	4808	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00009	4809	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00010	4810	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00011	4811	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Sample_00012	4812	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00013	4813	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00014	4814	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00015	4815	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00016	4816	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00017	4817	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00018	4818	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00019	4819	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00020	4820	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00021	4821	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00022	4822	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00023	4823	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00024	4824	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00025	4825	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00026	4826	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00027	4827	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00028	4828	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Sample_00029	4829	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00030	4830	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00031	4831	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00032	4832	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00033	4833	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00034	4834	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00035	4835	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00036	4836	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00037	4837	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
Sample_00038	4838	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00039	4839	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00040	4840	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00041	4841	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00042	4842	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00043	4843	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00044	4844	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00045	4845	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00046	4846	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00047	4847	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00048	4848	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00049	4849	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00050	4850	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Sample_00051	4851	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00052	4852	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00053	4853	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00054	4854	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Sample_00055	4855	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00056	4856	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00057	4857	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00058	4858	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00059	4859	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00060	4860	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.82	Intensity Normalized (v.2)
Sample_00061	4861	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00062	4862	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00063	4863	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00064	4864	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00065	4865	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00066	4866	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00067	4867	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00068	4868	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00069	4869	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00070	4870	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00071	4871	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00072	4872	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00073	4873	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00074	4874	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00075	4875	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00076	4876	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00077	4877	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00078	4878	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00079	4879	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00080	4880	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00081	4881	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00082	4882	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00083	4883	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00084	4884	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.13	Intensity Normalized (v.2)
Sample_00085	4885	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00086	4886	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00087	4887	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00088	4888	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00089	4889	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00090	4890	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
CONTROL_0001	4891	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
CONTROL_0002	4892	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
CONTROL_0003	4893	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
CONTROL_0004	4894	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
CONTROL_0005	4895	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Empty well_01	4896	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Empty well_02	4897	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Empty well_03	4898	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Empty well_04	4899	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Empty well_05	4900	OID00049	P34258	Protein_49	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00001	4901	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00002	4902	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00003	4903	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00004	4904	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00005	4905	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00006	4906	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00007	4907	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00008	4908	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00009	4909	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00010	4910	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00011	4911	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00012	4912	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00013	4913	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00014	4914	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00015	4915	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00016	4916	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00017	4917	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00018	4918	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00019	4919	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00020	4920	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00021	4921	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00022	4922	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00023	4923	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00024	4924	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00025	4925	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00026	4926	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00027	4927	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00028	4928	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00029	4929	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00030	4930	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00031	4931	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00032	4932	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.73	Intensity Normalized (v.2)
Sample_00033	4933	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00034	4934	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00035	4935	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00036	4936	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00037	4937	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00038	4938	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00039	4939	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00040	4940	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00041	4941	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00042	4942	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00043	4943	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00044	4944	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00045	4945	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00046	4946	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00047	4947	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00048	4948	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00049	4949	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00050	4950	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00051	4951	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00052	4952	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00053	4953	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00054	4954	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00055	4955	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00056	4956	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00057	4957	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00058	4958	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00059	4959	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00060	4960	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00061	4961	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00062	4962	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00063	4963	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00064	4964	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00065	4965	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00066	4966	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00067	4967	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00068	4968	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00069	4969	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00070	4970	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00071	4971	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00072	4972	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00073	4973	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00074	4974	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00075	4975	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00076	4976	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00077	4977	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00078	4978	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00079	4979	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00080	4980	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00081	4981	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00082	4982	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00083	4983	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00084	4984	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00085	4985	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00086	4986	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00087	4987	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00088	4988	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00089	4989	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00090	4990	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
CONTROL_0001	4991	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
CONTROL_0002	4992	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
CONTROL_0003	4993	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
CONTROL_0004	4994	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
CONTROL_0005	4995	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Empty well_01	4996	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Empty well_02	4997	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Empty well_03	4998	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Empty well_04	4999	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Empty well_05	5000	OID00050	P42424	Protein_50	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00001	5001	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00002	5002	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00003	5003	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00004	5004	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00005	5005	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00006	5006	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00007	5007	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00008	5008	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00009	5009	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00010	5010	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00011	5011	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00012	5012	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00013	5013	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Sample_00014	5014	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00015	5015	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00016	5016	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Sample_00017	5017	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00018	5018	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00019	5019	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00020	5020	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00021	5021	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00022	5022	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00023	5023	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00024	5024	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.48	Intensity Normalized (v.2)
Sample_00025	5025	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00026	5026	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00027	5027	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00028	5028	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00029	5029	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.48	Intensity Normalized (v.2)
Sample_00030	5030	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00031	5031	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00032	5032	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00033	5033	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00034	5034	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00035	5035	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00036	5036	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00037	5037	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00038	5038	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00039	5039	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00040	5040	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00041	5041	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00042	5042	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00043	5043	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00044	5044	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00045	5045	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00046	5046	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00047	5047	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00048	5048	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00049	5049	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Sample_00050	5050	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00051	5051	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00052	5052	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00053	5053	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00054	5054	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00055	5055	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00056	5056	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.49	Intensity Normalized (v.2)
Sample_00057	5057	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00058	5058	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00059	5059	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.81	Intensity Normalized (v.2)
Sample_00060	5060	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00061	5061	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00062	5062	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00063	5063	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00064	5064	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00065	5065	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00066	5066	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00067	5067	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.47	Intensity Normalized (v.2)
Sample_00068	5068	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00069	5069	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00070	5070	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00071	5071	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00072	5072	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00073	5073	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00074	5074	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00075	5075	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00076	5076	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00077	5077	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00078	5078	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Sample_00079	5079	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00080	5080	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00081	5081	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00082	5082	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00083	5083	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00084	5084	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00085	5085	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00086	5086	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00087	5087	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00088	5088	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00089	5089	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00090	5090	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
CONTROL_0001	5091	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
CONTROL_0002	5092	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
CONTROL_0003	5093	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
CONTROL_0004	5094	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
CONTROL_0005	5095	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Empty well_01	5096	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.75	Intensity Normalized (v.2)
Empty well_02	5097	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Empty well_03	5098	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Empty well_04	5099	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Empty well_05	5100	OID00051	P92925	Protein_51	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00001	5101	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00002	5102	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00003	5103	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00004	5104	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00005	5105	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00006	5106	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00007	5107	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00008	5108	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00009	5109	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00010	5110	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00011	5111	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00012	5112	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00013	5113	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00014	5114	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00015	5115	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00016	5116	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00017	5117	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00018	5118	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00019	5119	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00020	5120	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00021	5121	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00022	5122	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00023	5123	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00024	5124	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00025	5125	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00026	5126	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00027	5127	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00028	5128	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00029	5129	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00030	5130	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00031	5131	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00032	5132	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00033	5133	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00034	5134	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00035	5135	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00036	5136	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00037	5137	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00038	5138	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00039	5139	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00040	5140	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00041	5141	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00042	5142	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00043	5143	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00044	5144	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00045	5145	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00046	5146	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00047	5147	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00048	5148	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00049	5149	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00050	5150	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00051	5151	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00052	5152	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00053	5153	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00054	5154	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00055	5155	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00056	5156	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00057	5157	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00058	5158	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00059	5159	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00060	5160	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00061	5161	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00062	5162	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00063	5163	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00064	5164	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00065	5165	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00066	5166	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00067	5167	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00068	5168	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00069	5169	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00070	5170	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00071	5171	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00072	5172	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00073	5173	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00074	5174	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00075	5175	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00076	5176	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00077	5177	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00078	5178	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00079	5179	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00080	5180	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00081	5181	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00082	5182	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00083	5183	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00084	5184	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00085	5185	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00086	5186	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00087	5187	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00088	5188	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00089	5189	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00090	5190	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
CONTROL_0001	5191	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
CONTROL_0002	5192	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
CONTROL_0003	5193	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.35	Intensity Normalized (v.2)
CONTROL_0004	5194	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
CONTROL_0005	5195	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Empty well_01	5196	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Empty well_02	5197	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Empty well_03	5198	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Empty well_04	5199	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Empty well_05	5200	OID00052	P83170	Protein_52	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00001	5201	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00002	5202	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00003	5203	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00004	5204	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00005	5205	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
Sample_00006	5206	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00007	5207	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00008	5208	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00009	5209	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00010	5210	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00011	5211	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.95	Intensity Normalized (v.2)
Sample_00012	5212	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00013	5213	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00014	5214	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00015	5215	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00016	5216	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00017	5217	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00018	5218	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00019	5219	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00020	5220	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00021	5221	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00022	5222	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00023	5223	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00024	5224	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00025	5225	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00026	5226	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00027	5227	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00028	5228	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00029	5229	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00030	5230	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00031	5231	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00032	5232	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00033	5233	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00034	5234	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00035	5235	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00036	5236	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00037	5237	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Sample_00038	5238	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Sample_00039	5239	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00040	5240	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.64	Intensity Normalized (v.2)
Sample_00041	5241	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.5	Intensity Normalized (v.2)
Sample_00042	5242	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00043	5243	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00044	5244	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Sample_00045	5245	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00046	5246	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00047	5247	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00048	5248	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00049	5249	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00050	5250	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00051	5251	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00052	5252	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00053	5253	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00054	5254	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00055	5255	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00056	5256	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00057	5257	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00058	5258	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00059	5259	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00060	5260	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00061	5261	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00062	5262	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00063	5263	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00064	5264	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00065	5265	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00066	5266	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00067	5267	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00068	5268	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00069	5269	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00070	5270	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00071	5271	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00072	5272	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00073	5273	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00074	5274	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00075	5275	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00076	5276	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00077	5277	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00078	5278	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00079	5279	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00080	5280	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00081	5281	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00082	5282	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00083	5283	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00084	5284	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00085	5285	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00086	5286	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.1	Intensity Normalized (v.2)
Sample_00087	5287	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00088	5288	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00089	5289	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00090	5290	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
CONTROL_0001	5291	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
CONTROL_0002	5292	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
CONTROL_0003	5293	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.57	Intensity Normalized (v.2)
CONTROL_0004	5294	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
CONTROL_0005	5295	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Empty well_01	5296	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Empty well_02	5297	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.19	Intensity Normalized (v.2)
Empty well_03	5298	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Empty well_04	5299	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Empty well_05	5300	OID00053	P52985	Protein_53	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00001	5301	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00002	5302	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00003	5303	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00004	5304	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00005	5305	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00006	5306	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00007	5307	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00008	5308	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00009	5309	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
Sample_00010	5310	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00011	5311	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00012	5312	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00013	5313	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00014	5314	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00015	5315	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00016	5316	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00017	5317	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00018	5318	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00019	5319	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00020	5320	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00021	5321	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00022	5322	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00023	5323	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00024	5324	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
Sample_00025	5325	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00026	5326	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00027	5327	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00028	5328	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00029	5329	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.26	Intensity Normalized (v.2)
Sample_00030	5330	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00031	5331	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00032	5332	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00033	5333	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00034	5334	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00035	5335	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00036	5336	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.65	Intensity Normalized (v.2)
Sample_00037	5337	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00038	5338	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00039	5339	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00040	5340	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00041	5341	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00042	5342	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00043	5343	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00044	5344	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00045	5345	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00046	5346	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00047	5347	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00048	5348	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00049	5349	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00050	5350	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00051	5351	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00052	5352	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00053	5353	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00054	5354	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00055	5355	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00056	5356	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Sample_00057	5357	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00058	5358	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00059	5359	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00060	5360	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00061	5361	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
Sample_00062	5362	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00063	5363	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00064	5364	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00065	5365	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00066	5366	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00067	5367	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00068	5368	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00069	5369	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00070	5370	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00071	5371	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00072	5372	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00073	5373	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00074	5374	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00075	5375	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00076	5376	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.81	Intensity Normalized (v.2)
Sample_00077	5377	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
Sample_00078	5378	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00079	5379	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00080	5380	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
Sample_00081	5381	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Sample_00082	5382	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00083	5383	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00084	5384	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00085	5385	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00086	5386	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00087	5387	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00088	5388	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00089	5389	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00090	5390	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
CONTROL_0001	5391	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
CONTROL_0002	5392	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
CONTROL_0003	5393	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
CONTROL_0004	5394	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
CONTROL_0005	5395	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Empty well_01	5396	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Empty well_02	5397	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Empty well_03	5398	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Empty well_04	5399	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Empty well_05	5400	OID00054	P82191	Protein_54	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00001	5401	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00002	5402	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00003	5403	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
Sample_00004	5404	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00005	5405	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00006	5406	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.5	Intensity Normalized (v.2)
Sample_00007	5407	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00008	5408	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00009	5409	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00010	5410	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00011	5411	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00012	5412	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00013	5413	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00014	5414	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00015	5415	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00016	5416	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.07	Intensity Normalized (v.2)
Sample_00017	5417	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00018	5418	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00019	5419	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00020	5420	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.93	Intensity Normalized (v.2)
Sample_00021	5421	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00022	5422	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00023	5423	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00024	5424	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00025	5425	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00026	5426	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00027	5427	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00028	5428	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00029	5429	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00030	5430	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00031	5431	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00032	5432	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00033	5433	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00034	5434	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00035	5435	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00036	5436	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00037	5437	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00038	5438	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00039	5439	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00040	5440	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00041	5441	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00042	5442	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00043	5443	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00044	5444	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00045	5445	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00046	5446	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00047	5447	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00048	5448	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00049	5449	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.57	Intensity Normalized (v.2)
Sample_00050	5450	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00051	5451	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00052	5452	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00053	5453	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00054	5454	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00055	5455	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00056	5456	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00057	5457	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00058	5458	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
Sample_00059	5459	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00060	5460	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00061	5461	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00062	5462	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00063	5463	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.57	Intensity Normalized (v.2)
Sample_00064	5464	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00065	5465	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00066	5466	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00067	5467	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00068	5468	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00069	5469	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00070	5470	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00071	5471	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00072	5472	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00073	5473	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00074	5474	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00075	5475	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00076	5476	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00077	5477	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00078	5478	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00079	5479	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00080	5480	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.75	Intensity Normalized (v.2)
Sample_00081	5481	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00082	5482	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00083	5483	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00084	5484	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00085	5485	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00086	5486	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00087	5487	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00088	5488	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00089	5489	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00090	5490	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
CONTROL_0001	5491	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
CONTROL_0002	5492	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
CONTROL_0003	5493	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
CONTROL_0004	5494	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
CONTROL_0005	5495	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Empty well_01	5496	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Empty well_02	5497	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Empty well_03	5498	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Empty well_04	5499	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Empty well_05	5500	OID00055	P26226	Protein_55	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00001	5501	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00002	5502	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00003	5503	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.05	Intensity Normalized (v.2)
Sample_00004	5504	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00005	5505	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00006	5506	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00007	5507	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00008	5508	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00009	5509	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00010	5510	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00011	5511	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00012	5512	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.5	Intensity Normalized (v.2)
Sample_00013	5513	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00014	5514	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00015	5515	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00016	5516	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00017	5517	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00018	5518	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00019	5519	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00020	5520	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00021	5521	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00022	5522	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00023	5523	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00024	5524	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00025	5525	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00026	5526	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00027	5527	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00028	5528	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00029	5529	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00030	5530	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00031	5531	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00032	5532	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
Sample_00033	5533	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00034	5534	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00035	5535	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00036	5536	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00037	5537	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00038	5538	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00039	5539	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00040	5540	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00041	5541	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00042	5542	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00043	5543	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00044	5544	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00045	5545	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00046	5546	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00047	5547	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00048	5548	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00049	5549	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00050	5550	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00051	5551	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00052	5552	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00053	5553	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00054	5554	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00055	5555	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00056	5556	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00057	5557	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00058	5558	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00059	5559	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00060	5560	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00061	5561	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00062	5562	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00063	5563	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00064	5564	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00065	5565	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00066	5566	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00067	5567	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00068	5568	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00069	5569	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00070	5570	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00071	5571	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00072	5572	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00073	5573	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00074	5574	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Sample_00075	5575	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00076	5576	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00077	5577	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00078	5578	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00079	5579	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00080	5580	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00081	5581	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00082	5582	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00083	5583	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00084	5584	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00085	5585	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00086	5586	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Sample_00087	5587	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00088	5588	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00089	5589	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00090	5590	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
CONTROL_0001	5591	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
CONTROL_0002	5592	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
CONTROL_0003	5593	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
CONTROL_0004	5594	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
CONTROL_0005	5595	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Empty well_01	5596	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Empty well_02	5597	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Empty well_03	5598	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Empty well_04	5599	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Empty well_05	5600	OID00056	P30552	Protein_56	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00001	5601	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00002	5602	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00003	5603	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00004	5604	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00005	5605	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00006	5606	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00007	5607	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00008	5608	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00009	5609	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00010	5610	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00011	5611	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00012	5612	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00013	5613	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00014	5614	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00015	5615	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00016	5616	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00017	5617	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00018	5618	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00019	5619	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00020	5620	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00021	5621	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00022	5622	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00023	5623	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.48	Intensity Normalized (v.2)
Sample_00024	5624	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00025	5625	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00026	5626	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00027	5627	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00028	5628	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00029	5629	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00030	5630	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00031	5631	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00032	5632	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00033	5633	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00034	5634	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00035	5635	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00036	5636	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00037	5637	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00038	5638	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00039	5639	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00040	5640	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00041	5641	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00042	5642	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00043	5643	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00044	5644	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00045	5645	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00046	5646	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00047	5647	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00048	5648	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00049	5649	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00050	5650	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00051	5651	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00052	5652	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00053	5653	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00054	5654	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Sample_00055	5655	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00056	5656	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00057	5657	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00058	5658	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00059	5659	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Sample_00060	5660	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00061	5661	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00062	5662	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00063	5663	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00064	5664	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00065	5665	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00066	5666	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00067	5667	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00068	5668	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00069	5669	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00070	5670	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00071	5671	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00072	5672	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00073	5673	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00074	5674	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00075	5675	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00076	5676	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00077	5677	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00078	5678	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00079	5679	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00080	5680	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
Sample_00081	5681	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00082	5682	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00083	5683	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00084	5684	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00085	5685	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00086	5686	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00087	5687	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00088	5688	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00089	5689	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00090	5690	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
CONTROL_0001	5691	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
CONTROL_0002	5692	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
CONTROL_0003	5693	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
CONTROL_0004	5694	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
CONTROL_0005	5695	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Empty well_01	5696	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Empty well_02	5697	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Empty well_03	5698	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Empty well_04	5699	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Empty well_05	5700	OID00057	P51040	Protein_57	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00001	5701	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00002	5702	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00003	5703	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00004	5704	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00005	5705	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00006	5706	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00007	5707	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00008	5708	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00009	5709	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00010	5710	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00011	5711	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00012	5712	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00013	5713	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00014	5714	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00015	5715	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00016	5716	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00017	5717	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00018	5718	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00019	5719	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.56	Intensity Normalized (v.2)
Sample_00020	5720	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00021	5721	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00022	5722	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00023	5723	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00024	5724	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00025	5725	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00026	5726	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00027	5727	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00028	5728	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00029	5729	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00030	5730	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00031	5731	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00032	5732	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00033	5733	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00034	5734	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.26	Intensity Normalized (v.2)
Sample_00035	5735	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00036	5736	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00037	5737	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00038	5738	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00039	5739	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00040	5740	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00041	5741	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00042	5742	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00043	5743	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.82	Intensity Normalized (v.2)
Sample_00044	5744	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00045	5745	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00046	5746	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Sample_00047	5747	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00048	5748	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00049	5749	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00050	5750	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00051	5751	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Sample_00052	5752	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00053	5753	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00054	5754	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00055	5755	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00056	5756	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00057	5757	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00058	5758	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00059	5759	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00060	5760	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00061	5761	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00062	5762	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00063	5763	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00064	5764	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00065	5765	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00066	5766	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00067	5767	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00068	5768	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00069	5769	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00070	5770	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00071	5771	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00072	5772	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00073	5773	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00074	5774	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00075	5775	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00076	5776	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00077	5777	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00078	5778	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00079	5779	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00080	5780	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00081	5781	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00082	5782	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00083	5783	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00084	5784	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00085	5785	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00086	5786	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00087	5787	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00088	5788	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00089	5789	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00090	5790	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
CONTROL_0001	5791	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
CONTROL_0002	5792	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
CONTROL_0003	5793	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
CONTROL_0004	5794	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
CONTROL_0005	5795	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Empty well_01	5796	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Empty well_02	5797	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Empty well_03	5798	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Empty well_04	5799	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Empty well_05	5800	OID00058	P65013	Protein_58	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00001	5801	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00002	5802	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00003	5803	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00004	5804	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00005	5805	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00006	5806	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00007	5807	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00008	5808	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00009	5809	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00010	5810	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00011	5811	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00012	5812	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00013	5813	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00014	5814	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00015	5815	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00016	5816	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00017	5817	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00018	5818	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00019	5819	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00020	5820	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00021	5821	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00022	5822	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00023	5823	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00024	5824	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00025	5825	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00026	5826	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00027	5827	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00028	5828	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00029	5829	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00030	5830	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00031	5831	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00032	5832	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00033	5833	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00034	5834	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00035	5835	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00036	5836	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00037	5837	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00038	5838	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00039	5839	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00040	5840	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00041	5841	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00042	5842	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00043	5843	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
Sample_00044	5844	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
Sample_00045	5845	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00046	5846	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00047	5847	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00048	5848	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00049	5849	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00050	5850	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00051	5851	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00052	5852	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00053	5853	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.38	Intensity Normalized (v.2)
Sample_00054	5854	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00055	5855	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00056	5856	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00057	5857	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00058	5858	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00059	5859	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00060	5860	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00061	5861	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00062	5862	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00063	5863	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00064	5864	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00065	5865	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00066	5866	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00067	5867	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00068	5868	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00069	5869	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00070	5870	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00071	5871	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00072	5872	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00073	5873	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00074	5874	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00075	5875	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00076	5876	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00077	5877	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00078	5878	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00079	5879	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00080	5880	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00081	5881	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00082	5882	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00083	5883	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00084	5884	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00085	5885	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00086	5886	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.37	Intensity Normalized (v.2)
Sample_00087	5887	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00088	5888	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00089	5889	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.52	Intensity Normalized (v.2)
Sample_00090	5890	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
CONTROL_0001	5891	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.44	Intensity Normalized (v.2)
CONTROL_0002	5892	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
CONTROL_0003	5893	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
CONTROL_0004	5894	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
CONTROL_0005	5895	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Empty well_01	5896	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Empty well_02	5897	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Empty well_03	5898	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Empty well_04	5899	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Empty well_05	5900	OID00059	P37094	Protein_59	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00001	5901	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00002	5902	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00003	5903	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00004	5904	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00005	5905	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00006	5906	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00007	5907	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00008	5908	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00009	5909	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00010	5910	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00011	5911	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00012	5912	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00013	5913	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00014	5914	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00015	5915	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00016	5916	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00017	5917	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00018	5918	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00019	5919	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00020	5920	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00021	5921	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00022	5922	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00023	5923	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00024	5924	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00025	5925	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00026	5926	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00027	5927	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00028	5928	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00029	5929	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00030	5930	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00031	5931	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00032	5932	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00033	5933	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00034	5934	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.09	Intensity Normalized (v.2)
Sample_00035	5935	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00036	5936	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
Sample_00037	5937	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00038	5938	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00039	5939	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00040	5940	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00041	5941	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00042	5942	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00043	5943	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00044	5944	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00045	5945	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.86	Intensity Normalized (v.2)
Sample_00046	5946	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00047	5947	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00048	5948	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Sample_00049	5949	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00050	5950	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00051	5951	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00052	5952	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00053	5953	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00054	5954	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00055	5955	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00056	5956	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00057	5957	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00058	5958	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00059	5959	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00060	5960	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00061	5961	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00062	5962	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00063	5963	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00064	5964	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00065	5965	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00066	5966	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00067	5967	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00068	5968	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00069	5969	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00070	5970	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00071	5971	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00072	5972	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00073	5973	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00074	5974	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00075	5975	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00076	5976	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00077	5977	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00078	5978	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00079	5979	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00080	5980	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5	Intensity Normalized (v.2)
Sample_00081	5981	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00082	5982	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00083	5983	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00084	5984	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00085	5985	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00086	5986	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00087	5987	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00088	5988	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00089	5989	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00090	5990	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
CONTROL_0001	5991	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
CONTROL_0002	5992	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.86	Intensity Normalized (v.2)
CONTROL_0003	5993	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
CONTROL_0004	5994	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
CONTROL_0005	5995	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
Empty well_01	5996	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Empty well_02	5997	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Empty well_03	5998	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Empty well_04	5999	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Empty well_05	6000	OID00060	P63032	Protein_60	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00001	6001	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00002	6002	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00003	6003	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00004	6004	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00005	6005	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00006	6006	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00007	6007	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00008	6008	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00009	6009	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00010	6010	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00011	6011	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.49	Intensity Normalized (v.2)
Sample_00012	6012	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00013	6013	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00014	6014	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00015	6015	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00016	6016	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00017	6017	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00018	6018	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00019	6019	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00020	6020	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00021	6021	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00022	6022	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00023	6023	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00024	6024	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00025	6025	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00026	6026	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00027	6027	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00028	6028	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00029	6029	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00030	6030	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00031	6031	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00032	6032	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00033	6033	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00034	6034	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00035	6035	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00036	6036	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00037	6037	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00038	6038	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00039	6039	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00040	6040	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00041	6041	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00042	6042	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00043	6043	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00044	6044	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00045	6045	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00046	6046	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00047	6047	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00048	6048	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00049	6049	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
Sample_00050	6050	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00051	6051	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00052	6052	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00053	6053	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00054	6054	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00055	6055	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00056	6056	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00057	6057	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00058	6058	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00059	6059	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00060	6060	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00061	6061	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00062	6062	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00063	6063	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00064	6064	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00065	6065	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00066	6066	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00067	6067	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00068	6068	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00069	6069	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00070	6070	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00071	6071	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00072	6072	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00073	6073	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00074	6074	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00075	6075	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00076	6076	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
Sample_00077	6077	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00078	6078	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00079	6079	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00080	6080	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00081	6081	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00082	6082	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.27	Intensity Normalized (v.2)
Sample_00083	6083	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00084	6084	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00085	6085	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00086	6086	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00087	6087	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00088	6088	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00089	6089	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00090	6090	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
CONTROL_0001	6091	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
CONTROL_0002	6092	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
CONTROL_0003	6093	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
CONTROL_0004	6094	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
CONTROL_0005	6095	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Empty well_01	6096	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Empty well_02	6097	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Empty well_03	6098	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Empty well_04	6099	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Empty well_05	6100	OID00061	P65110	Protein_61	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00001	6101	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00002	6102	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00003	6103	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00004	6104	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00005	6105	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00006	6106	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00007	6107	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00008	6108	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.25	Intensity Normalized (v.2)
Sample_00009	6109	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00010	6110	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00011	6111	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00012	6112	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00013	6113	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00014	6114	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00015	6115	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00016	6116	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00017	6117	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00018	6118	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00019	6119	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00020	6120	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00021	6121	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00022	6122	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00023	6123	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00024	6124	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00025	6125	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00026	6126	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00027	6127	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00028	6128	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00029	6129	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Sample_00030	6130	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00031	6131	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.97	Intensity Normalized (v.2)
Sample_00032	6132	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00033	6133	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00034	6134	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00035	6135	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00036	6136	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00037	6137	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00038	6138	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
Sample_00039	6139	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00040	6140	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
Sample_00041	6141	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00042	6142	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00043	6143	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00044	6144	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00045	6145	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00046	6146	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00047	6147	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Sample_00048	6148	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00049	6149	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00050	6150	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00051	6151	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00052	6152	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.57	Intensity Normalized (v.2)
Sample_00053	6153	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Sample_00054	6154	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00055	6155	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00056	6156	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.66	Intensity Normalized (v.2)
Sample_00057	6157	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00058	6158	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00059	6159	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00060	6160	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00061	6161	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00062	6162	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
Sample_00063	6163	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00064	6164	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00065	6165	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00066	6166	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00067	6167	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00068	6168	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00069	6169	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00070	6170	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00071	6171	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00072	6172	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00073	6173	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00074	6174	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00075	6175	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00076	6176	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00077	6177	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.1	Intensity Normalized (v.2)
Sample_00078	6178	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00079	6179	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00080	6180	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00081	6181	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.59	Intensity Normalized (v.2)
Sample_00082	6182	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00083	6183	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00084	6184	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00085	6185	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00086	6186	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00087	6187	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00088	6188	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
Sample_00089	6189	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00090	6190	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
CONTROL_0001	6191	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
CONTROL_0002	6192	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
CONTROL_0003	6193	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.03	Intensity Normalized (v.2)
CONTROL_0004	6194	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
CONTROL_0005	6195	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Empty well_01	6196	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Empty well_02	6197	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Empty well_03	6198	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Empty well_04	6199	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Empty well_05	6200	OID00062	P25194	Protein_62	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00001	6201	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00002	6202	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00003	6203	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00004	6204	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00005	6205	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00006	6206	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00007	6207	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00008	6208	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00009	6209	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00010	6210	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00011	6211	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00012	6212	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00013	6213	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00014	6214	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00015	6215	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Sample_00016	6216	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00017	6217	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00018	6218	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00019	6219	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00020	6220	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
Sample_00021	6221	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00022	6222	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00023	6223	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00024	6224	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00025	6225	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00026	6226	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00027	6227	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00028	6228	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00029	6229	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00030	6230	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00031	6231	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Sample_00032	6232	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Sample_00033	6233	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00034	6234	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00035	6235	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00036	6236	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00037	6237	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.82	Intensity Normalized (v.2)
Sample_00038	6238	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00039	6239	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00040	6240	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00041	6241	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00042	6242	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00043	6243	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00044	6244	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00045	6245	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00046	6246	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00047	6247	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00048	6248	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00049	6249	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00050	6250	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00051	6251	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.32	Intensity Normalized (v.2)
Sample_00052	6252	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00053	6253	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00054	6254	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00055	6255	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00056	6256	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00057	6257	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00058	6258	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00059	6259	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00060	6260	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00061	6261	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00062	6262	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00063	6263	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00064	6264	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00065	6265	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.33	Intensity Normalized (v.2)
Sample_00066	6266	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00067	6267	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00068	6268	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00069	6269	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00070	6270	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00071	6271	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.73	Intensity Normalized (v.2)
Sample_00072	6272	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00073	6273	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00074	6274	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00075	6275	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00076	6276	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00077	6277	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00078	6278	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00079	6279	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00080	6280	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00081	6281	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00082	6282	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00083	6283	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00084	6284	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00085	6285	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00086	6286	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00087	6287	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00088	6288	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00089	6289	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00090	6290	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
CONTROL_0001	6291	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
CONTROL_0002	6292	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
CONTROL_0003	6293	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
CONTROL_0004	6294	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.1	Intensity Normalized (v.2)
CONTROL_0005	6295	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Empty well_01	6296	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Empty well_02	6297	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Empty well_03	6298	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Empty well_04	6299	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Empty well_05	6300	OID00063	P77849	Protein_63	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00001	6301	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00002	6302	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00003	6303	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00004	6304	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00005	6305	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00006	6306	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00007	6307	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00008	6308	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00009	6309	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00010	6310	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00011	6311	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00012	6312	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00013	6313	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00014	6314	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00015	6315	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00016	6316	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00017	6317	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00018	6318	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00019	6319	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00020	6320	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00021	6321	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00022	6322	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00023	6323	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00024	6324	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00025	6325	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00026	6326	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.31	Intensity Normalized (v.2)
Sample_00027	6327	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00028	6328	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00029	6329	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.38	Intensity Normalized (v.2)
Sample_00030	6330	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00031	6331	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00032	6332	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00033	6333	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00034	6334	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00035	6335	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00036	6336	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00037	6337	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.61	Intensity Normalized (v.2)
Sample_00038	6338	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00039	6339	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.89	Intensity Normalized (v.2)
Sample_00040	6340	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00041	6341	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00042	6342	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00043	6343	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00044	6344	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00045	6345	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00046	6346	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00047	6347	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00048	6348	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00049	6349	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00050	6350	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00051	6351	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00052	6352	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00053	6353	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00054	6354	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.21	Intensity Normalized (v.2)
Sample_00055	6355	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00056	6356	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00057	6357	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00058	6358	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00059	6359	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00060	6360	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.27	Intensity Normalized (v.2)
Sample_00061	6361	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.75	Intensity Normalized (v.2)
Sample_00062	6362	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00063	6363	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00064	6364	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00065	6365	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00066	6366	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00067	6367	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00068	6368	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00069	6369	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00070	6370	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00071	6371	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00072	6372	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00073	6373	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00074	6374	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00075	6375	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00076	6376	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00077	6377	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00078	6378	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00079	6379	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00080	6380	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00081	6381	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00082	6382	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00083	6383	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00084	6384	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00085	6385	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00086	6386	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00087	6387	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.82	Intensity Normalized (v.2)
Sample_00088	6388	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00089	6389	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00090	6390	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
CONTROL_0001	6391	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
CONTROL_0002	6392	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
CONTROL_0003	6393	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
CONTROL_0004	6394	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
CONTROL_0005	6395	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Empty well_01	6396	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Empty well_02	6397	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Empty well_03	6398	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.4	Intensity Normalized (v.2)
Empty well_04	6399	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Empty well_05	6400	OID00064	P47500	Protein_64	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00001	6401	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00002	6402	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00003	6403	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.67	Intensity Normalized (v.2)
Sample_00004	6404	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00005	6405	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00006	6406	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00007	6407	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00008	6408	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00009	6409	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00010	6410	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00011	6411	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00012	6412	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00013	6413	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00014	6414	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00015	6415	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00016	6416	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00017	6417	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00018	6418	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00019	6419	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.16	Intensity Normalized (v.2)
Sample_00020	6420	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00021	6421	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00022	6422	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00023	6423	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00024	6424	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00025	6425	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00026	6426	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00027	6427	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00028	6428	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00029	6429	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00030	6430	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00031	6431	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00032	6432	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
Sample_00033	6433	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00034	6434	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00035	6435	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00036	6436	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00037	6437	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00038	6438	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00039	6439	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00040	6440	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00041	6441	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00042	6442	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00043	6443	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00044	6444	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00045	6445	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00046	6446	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00047	6447	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00048	6448	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00049	6449	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00050	6450	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00051	6451	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00052	6452	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00053	6453	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00054	6454	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00055	6455	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00056	6456	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00057	6457	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00058	6458	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00059	6459	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00060	6460	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00061	6461	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00062	6462	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.89	Intensity Normalized (v.2)
Sample_00063	6463	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00064	6464	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00065	6465	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.38	Intensity Normalized (v.2)
Sample_00066	6466	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00067	6467	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00068	6468	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00069	6469	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00070	6470	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00071	6471	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00072	6472	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00073	6473	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00074	6474	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00075	6475	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00076	6476	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00077	6477	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00078	6478	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00079	6479	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00080	6480	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00081	6481	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00082	6482	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00083	6483	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00084	6484	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00085	6485	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00086	6486	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00087	6487	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00088	6488	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.13	Intensity Normalized (v.2)
Sample_00089	6489	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00090	6490	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
CONTROL_0001	6491	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
CONTROL_0002	6492	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
CONTROL_0003	6493	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
CONTROL_0004	6494	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
CONTROL_0005	6495	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Empty well_01	6496	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Empty well_02	6497	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Empty well_03	6498	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Empty well_04	6499	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Empty well_05	6500	OID00065	P98035	Protein_65	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00001	6501	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00002	6502	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00003	6503	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00004	6504	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00005	6505	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00006	6506	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00007	6507	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00008	6508	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00009	6509	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.46	Intensity Normalized (v.2)
Sample_00010	6510	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00011	6511	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00012	6512	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00013	6513	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00014	6514	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00015	6515	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00016	6516	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00017	6517	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00018	6518	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00019	6519	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00020	6520	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00021	6521	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00022	6522	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00023	6523	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00024	6524	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00025	6525	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00026	6526	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
Sample_00027	6527	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00028	6528	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00029	6529	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00030	6530	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00031	6531	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00032	6532	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00033	6533	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.52	Intensity Normalized (v.2)
Sample_00034	6534	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00035	6535	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00036	6536	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.41	Intensity Normalized (v.2)
Sample_00037	6537	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00038	6538	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00039	6539	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00040	6540	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00041	6541	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00042	6542	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00043	6543	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00044	6544	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00045	6545	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00046	6546	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00047	6547	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
Sample_00048	6548	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00049	6549	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00050	6550	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00051	6551	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00052	6552	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00053	6553	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.72	Intensity Normalized (v.2)
Sample_00054	6554	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00055	6555	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00056	6556	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00057	6557	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00058	6558	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00059	6559	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00060	6560	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.09	Intensity Normalized (v.2)
Sample_00061	6561	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00062	6562	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00063	6563	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00064	6564	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00065	6565	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00066	6566	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00067	6567	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.08	Intensity Normalized (v.2)
Sample_00068	6568	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00069	6569	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00070	6570	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00071	6571	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00072	6572	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00073	6573	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00074	6574	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00075	6575	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00076	6576	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00077	6577	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00078	6578	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00079	6579	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00080	6580	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00081	6581	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00082	6582	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00083	6583	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00084	6584	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00085	6585	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00086	6586	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00087	6587	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Sample_00088	6588	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.02	Intensity Normalized (v.2)
Sample_00089	6589	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00090	6590	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
CONTROL_0001	6591	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
CONTROL_0002	6592	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
CONTROL_0003	6593	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
CONTROL_0004	6594	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
CONTROL_0005	6595	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Empty well_01	6596	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Empty well_02	6597	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Empty well_03	6598	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Empty well_04	6599	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Empty well_05	6600	OID00066	P72789	Protein_66	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00001	6601	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00002	6602	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00003	6603	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00004	6604	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00005	6605	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00006	6606	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00007	6607	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00008	6608	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00009	6609	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00010	6610	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00011	6611	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00012	6612	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00013	6613	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00014	6614	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00015	6615	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00016	6616	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.07	Intensity Normalized (v.2)
Sample_00017	6617	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00018	6618	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00019	6619	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00020	6620	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00021	6621	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00022	6622	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00023	6623	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00024	6624	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00025	6625	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00026	6626	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00027	6627	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00028	6628	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00029	6629	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00030	6630	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00031	6631	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00032	6632	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00033	6633	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00034	6634	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00035	6635	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00036	6636	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00037	6637	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00038	6638	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00039	6639	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00040	6640	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.17	Intensity Normalized (v.2)
Sample_00041	6641	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00042	6642	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00043	6643	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00044	6644	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00045	6645	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00046	6646	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00047	6647	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00048	6648	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00049	6649	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00050	6650	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00051	6651	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00052	6652	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00053	6653	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00054	6654	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00055	6655	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00056	6656	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.79	Intensity Normalized (v.2)
Sample_00057	6657	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00058	6658	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00059	6659	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00060	6660	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00061	6661	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00062	6662	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.73	Intensity Normalized (v.2)
Sample_00063	6663	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00064	6664	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00065	6665	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00066	6666	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00067	6667	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00068	6668	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00069	6669	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00070	6670	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00071	6671	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00072	6672	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00073	6673	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00074	6674	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00075	6675	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00076	6676	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00077	6677	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00078	6678	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00079	6679	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00080	6680	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00081	6681	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00082	6682	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00083	6683	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00084	6684	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00085	6685	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00086	6686	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00087	6687	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00088	6688	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00089	6689	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00090	6690	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
CONTROL_0001	6691	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
CONTROL_0002	6692	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
CONTROL_0003	6693	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
CONTROL_0004	6694	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
CONTROL_0005	6695	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Empty well_01	6696	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Empty well_02	6697	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Empty well_03	6698	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Empty well_04	6699	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Empty well_05	6700	OID00067	P58940	Protein_67	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00001	6701	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00002	6702	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00003	6703	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00004	6704	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00005	6705	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00006	6706	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00007	6707	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00008	6708	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00009	6709	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00010	6710	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00011	6711	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00012	6712	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00013	6713	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00014	6714	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00015	6715	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00016	6716	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00017	6717	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00018	6718	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00019	6719	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00020	6720	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00021	6721	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00022	6722	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.74	Intensity Normalized (v.2)
Sample_00023	6723	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00024	6724	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00025	6725	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00026	6726	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00027	6727	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00028	6728	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00029	6729	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00030	6730	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00031	6731	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00032	6732	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
Sample_00033	6733	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.38	Intensity Normalized (v.2)
Sample_00034	6734	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00035	6735	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00036	6736	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00037	6737	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00038	6738	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00039	6739	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00040	6740	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00041	6741	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00042	6742	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00043	6743	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00044	6744	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00045	6745	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00046	6746	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00047	6747	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
Sample_00048	6748	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00049	6749	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00050	6750	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00051	6751	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00052	6752	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00053	6753	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00054	6754	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Sample_00055	6755	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00056	6756	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00057	6757	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00058	6758	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00059	6759	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00060	6760	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00061	6761	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00062	6762	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00063	6763	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00064	6764	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00065	6765	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00066	6766	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00067	6767	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00068	6768	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00069	6769	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00070	6770	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00071	6771	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00072	6772	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00073	6773	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00074	6774	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00075	6775	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00076	6776	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00077	6777	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00078	6778	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00079	6779	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00080	6780	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00081	6781	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00082	6782	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00083	6783	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00084	6784	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00085	6785	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.52	Intensity Normalized (v.2)
Sample_00086	6786	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00087	6787	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00088	6788	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00089	6789	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00090	6790	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
CONTROL_0001	6791	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
CONTROL_0002	6792	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
CONTROL_0003	6793	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
CONTROL_0004	6794	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
CONTROL_0005	6795	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Empty well_01	6796	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Empty well_02	6797	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Empty well_03	6798	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Empty well_04	6799	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Empty well_05	6800	OID00068	P94978	Protein_68	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00001	6801	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00002	6802	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00003	6803	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00004	6804	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00005	6805	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00006	6806	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00007	6807	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00008	6808	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.89	Intensity Normalized (v.2)
Sample_00009	6809	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00010	6810	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00011	6811	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00012	6812	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00013	6813	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00014	6814	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00015	6815	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00016	6816	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00017	6817	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00018	6818	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00019	6819	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00020	6820	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00021	6821	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
Sample_00022	6822	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00023	6823	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00024	6824	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00025	6825	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00026	6826	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00027	6827	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.93	Intensity Normalized (v.2)
Sample_00028	6828	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00029	6829	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00030	6830	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00031	6831	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.5	Intensity Normalized (v.2)
Sample_00032	6832	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00033	6833	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00034	6834	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00035	6835	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00036	6836	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00037	6837	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00038	6838	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00039	6839	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00040	6840	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00041	6841	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00042	6842	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00043	6843	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00044	6844	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00045	6845	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00046	6846	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00047	6847	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00048	6848	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00049	6849	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.77	Intensity Normalized (v.2)
Sample_00050	6850	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00051	6851	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00052	6852	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00053	6853	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00054	6854	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00055	6855	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00056	6856	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00057	6857	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.15	Intensity Normalized (v.2)
Sample_00058	6858	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00059	6859	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00060	6860	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00061	6861	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00062	6862	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00063	6863	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.06	Intensity Normalized (v.2)
Sample_00064	6864	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00065	6865	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00066	6866	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00067	6867	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00068	6868	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00069	6869	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00070	6870	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00071	6871	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00072	6872	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.26	Intensity Normalized (v.2)
Sample_00073	6873	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00074	6874	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00075	6875	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00076	6876	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.34	Intensity Normalized (v.2)
Sample_00077	6877	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00078	6878	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00079	6879	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00080	6880	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.36	Intensity Normalized (v.2)
Sample_00081	6881	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00082	6882	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00083	6883	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00084	6884	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00085	6885	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00086	6886	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00087	6887	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00088	6888	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00089	6889	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00090	6890	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
CONTROL_0001	6891	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
CONTROL_0002	6892	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
CONTROL_0003	6893	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
CONTROL_0004	6894	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
CONTROL_0005	6895	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.27	Intensity Normalized (v.2)
Empty well_01	6896	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Empty well_02	6897	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Empty well_03	6898	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Empty well_04	6899	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Empty well_05	6900	OID00069	P38537	Protein_69	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00001	6901	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00002	6902	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00003	6903	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00004	6904	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00005	6905	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00006	6906	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00007	6907	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00008	6908	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00009	6909	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00010	6910	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00011	6911	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00012	6912	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00013	6913	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00014	6914	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00015	6915	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00016	6916	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00017	6917	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00018	6918	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00019	6919	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00020	6920	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00021	6921	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00022	6922	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00023	6923	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00024	6924	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.49	Intensity Normalized (v.2)
Sample_00025	6925	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00026	6926	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00027	6927	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00028	6928	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00029	6929	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00030	6930	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00031	6931	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00032	6932	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00033	6933	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00034	6934	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00035	6935	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00036	6936	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00037	6937	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00038	6938	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00039	6939	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00040	6940	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00041	6941	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00042	6942	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00043	6943	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00044	6944	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00045	6945	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00046	6946	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00047	6947	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00048	6948	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00049	6949	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00050	6950	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00051	6951	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00052	6952	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00053	6953	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00054	6954	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
Sample_00055	6955	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00056	6956	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00057	6957	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00058	6958	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.44	Intensity Normalized (v.2)
Sample_00059	6959	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00060	6960	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00061	6961	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00062	6962	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00063	6963	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00064	6964	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00065	6965	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00066	6966	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00067	6967	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00068	6968	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00069	6969	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00070	6970	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00071	6971	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00072	6972	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.2	Intensity Normalized (v.2)
Sample_00073	6973	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00074	6974	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00075	6975	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00076	6976	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00077	6977	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00078	6978	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00079	6979	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00080	6980	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00081	6981	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00082	6982	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00083	6983	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00084	6984	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Sample_00085	6985	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00086	6986	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00087	6987	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00088	6988	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00089	6989	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.81	Intensity Normalized (v.2)
Sample_00090	6990	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
CONTROL_0001	6991	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
CONTROL_0002	6992	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
CONTROL_0003	6993	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
CONTROL_0004	6994	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
CONTROL_0005	6995	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Empty well_01	6996	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Empty well_02	6997	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Empty well_03	6998	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Empty well_04	6999	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Empty well_05	7000	OID00070	P45867	Protein_70	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00001	7001	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00002	7002	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00003	7003	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00004	7004	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00005	7005	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00006	7006	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00007	7007	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00008	7008	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00009	7009	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
Sample_00010	7010	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00011	7011	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00012	7012	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00013	7013	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00014	7014	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00015	7015	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00016	7016	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00017	7017	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Sample_00018	7018	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00019	7019	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00020	7020	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00021	7021	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00022	7022	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00023	7023	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00024	7024	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00025	7025	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00026	7026	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00027	7027	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00028	7028	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00029	7029	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00030	7030	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00031	7031	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00032	7032	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.02	Intensity Normalized (v.2)
Sample_00033	7033	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00034	7034	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00035	7035	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.84	Intensity Normalized (v.2)
Sample_00036	7036	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00037	7037	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00038	7038	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00039	7039	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00040	7040	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00041	7041	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00042	7042	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.28	Intensity Normalized (v.2)
Sample_00043	7043	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00044	7044	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.19	Intensity Normalized (v.2)
Sample_00045	7045	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00046	7046	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.37	Intensity Normalized (v.2)
Sample_00047	7047	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00048	7048	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00049	7049	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00050	7050	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00051	7051	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00052	7052	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Sample_00053	7053	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00054	7054	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00055	7055	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00056	7056	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00057	7057	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00058	7058	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00059	7059	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00060	7060	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Sample_00061	7061	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00062	7062	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00063	7063	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00064	7064	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00065	7065	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00066	7066	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.44	Intensity Normalized (v.2)
Sample_00067	7067	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00068	7068	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00069	7069	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00070	7070	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00071	7071	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00072	7072	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00073	7073	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00074	7074	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00075	7075	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.65	Intensity Normalized (v.2)
Sample_00076	7076	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00077	7077	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00078	7078	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00079	7079	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00080	7080	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00081	7081	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00082	7082	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00083	7083	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00084	7084	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00085	7085	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00086	7086	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00087	7087	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00088	7088	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00089	7089	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00090	7090	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.67	Intensity Normalized (v.2)
CONTROL_0001	7091	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
CONTROL_0002	7092	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
CONTROL_0003	7093	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
CONTROL_0004	7094	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
CONTROL_0005	7095	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Empty well_01	7096	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Empty well_02	7097	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Empty well_03	7098	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Empty well_04	7099	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Empty well_05	7100	OID00071	P37669	Protein_71	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00001	7101	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00002	7102	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00003	7103	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00004	7104	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00005	7105	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00006	7106	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00007	7107	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00008	7108	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00009	7109	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00010	7110	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00011	7111	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00012	7112	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00013	7113	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.03	Intensity Normalized (v.2)
Sample_00014	7114	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00015	7115	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00016	7116	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00017	7117	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00018	7118	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00019	7119	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00020	7120	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.89	Intensity Normalized (v.2)
Sample_00021	7121	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00022	7122	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00023	7123	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00024	7124	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00025	7125	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00026	7126	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.33	Intensity Normalized (v.2)
Sample_00027	7127	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00028	7128	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00029	7129	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00030	7130	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00031	7131	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00032	7132	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00033	7133	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
Sample_00034	7134	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00035	7135	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00036	7136	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00037	7137	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.51	Intensity Normalized (v.2)
Sample_00038	7138	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00039	7139	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00040	7140	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00041	7141	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00042	7142	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00043	7143	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00044	7144	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00045	7145	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00046	7146	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00047	7147	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00048	7148	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00049	7149	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00050	7150	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.26	Intensity Normalized (v.2)
Sample_00051	7151	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00052	7152	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00053	7153	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00054	7154	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00055	7155	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00056	7156	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00057	7157	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.95	Intensity Normalized (v.2)
Sample_00058	7158	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00059	7159	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00060	7160	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
Sample_00061	7161	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00062	7162	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00063	7163	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
Sample_00064	7164	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00065	7165	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00066	7166	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00067	7167	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00068	7168	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00069	7169	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00070	7170	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00071	7171	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00072	7172	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00073	7173	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.69	Intensity Normalized (v.2)
Sample_00074	7174	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00075	7175	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00076	7176	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00077	7177	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00078	7178	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00079	7179	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00080	7180	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00081	7181	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00082	7182	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00083	7183	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00084	7184	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00085	7185	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00086	7186	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00087	7187	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00088	7188	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00089	7189	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00090	7190	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
CONTROL_0001	7191	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
CONTROL_0002	7192	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
CONTROL_0003	7193	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
CONTROL_0004	7194	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
CONTROL_0005	7195	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Empty well_01	7196	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Empty well_02	7197	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Empty well_03	7198	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Empty well_04	7199	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Empty well_05	7200	OID00072	P51446	Protein_72	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.93	Intensity Normalized (v.2)
Sample_00001	7201	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00002	7202	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00003	7203	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.41	Intensity Normalized (v.2)
Sample_00004	7204	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00005	7205	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00006	7206	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00007	7207	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00008	7208	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00009	7209	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00010	7210	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.19	Intensity Normalized (v.2)
Sample_00011	7211	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00012	7212	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00013	7213	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00014	7214	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00015	7215	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00016	7216	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00017	7217	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00018	7218	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00019	7219	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00020	7220	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00021	7221	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00022	7222	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00023	7223	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00024	7224	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00025	7225	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9	Intensity Normalized (v.2)
Sample_00026	7226	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00027	7227	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.32	Intensity Normalized (v.2)
Sample_00028	7228	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00029	7229	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00030	7230	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
Sample_00031	7231	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00032	7232	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00033	7233	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00034	7234	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.91	Intensity Normalized (v.2)
Sample_00035	7235	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00036	7236	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.66	Intensity Normalized (v.2)
Sample_00037	7237	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00038	7238	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00039	7239	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00040	7240	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00041	7241	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00042	7242	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.61	Intensity Normalized (v.2)
Sample_00043	7243	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00044	7244	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00045	7245	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00046	7246	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00047	7247	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00048	7248	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00049	7249	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00050	7250	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00051	7251	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00052	7252	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00053	7253	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00054	7254	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00055	7255	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00056	7256	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00057	7257	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00058	7258	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00059	7259	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00060	7260	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00061	7261	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00062	7262	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00063	7263	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00064	7264	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00065	7265	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00066	7266	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00067	7267	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00068	7268	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00069	7269	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00070	7270	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00071	7271	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00072	7272	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00073	7273	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00074	7274	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00075	7275	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Sample_00076	7276	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00077	7277	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00078	7278	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
Sample_00079	7279	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00080	7280	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00081	7281	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.25	Intensity Normalized (v.2)
Sample_00082	7282	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00083	7283	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00084	7284	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00085	7285	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00086	7286	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00087	7287	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
Sample_00088	7288	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00089	7289	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00090	7290	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
CONTROL_0001	7291	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
CONTROL_0002	7292	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
CONTROL_0003	7293	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
CONTROL_0004	7294	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.1	Intensity Normalized (v.2)
CONTROL_0005	7295	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Empty well_01	7296	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Empty well_02	7297	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Empty well_03	7298	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Empty well_04	7299	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Empty well_05	7300	OID00073	P14049	Protein_73	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00001	7301	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00002	7302	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00003	7303	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00004	7304	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00005	7305	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.52	Intensity Normalized (v.2)
Sample_00006	7306	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00007	7307	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00008	7308	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00009	7309	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00010	7310	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.61	Intensity Normalized (v.2)
Sample_00011	7311	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00012	7312	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00013	7313	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00014	7314	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00015	7315	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00016	7316	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00017	7317	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00018	7318	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00019	7319	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00020	7320	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00021	7321	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00022	7322	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00023	7323	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00024	7324	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00025	7325	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00026	7326	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00027	7327	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00028	7328	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00029	7329	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00030	7330	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00031	7331	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00032	7332	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00033	7333	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.69	Intensity Normalized (v.2)
Sample_00034	7334	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00035	7335	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00036	7336	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00037	7337	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00038	7338	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00039	7339	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00040	7340	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00041	7341	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.47	Intensity Normalized (v.2)
Sample_00042	7342	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00043	7343	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Sample_00044	7344	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00045	7345	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00046	7346	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00047	7347	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.53	Intensity Normalized (v.2)
Sample_00048	7348	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00049	7349	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00050	7350	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00051	7351	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00052	7352	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00053	7353	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00054	7354	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00055	7355	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00056	7356	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00057	7357	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00058	7358	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.49	Intensity Normalized (v.2)
Sample_00059	7359	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00060	7360	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
Sample_00061	7361	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00062	7362	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00063	7363	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00064	7364	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00065	7365	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Sample_00066	7366	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00067	7367	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00068	7368	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00069	7369	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00070	7370	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00071	7371	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.8	Intensity Normalized (v.2)
Sample_00072	7372	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00073	7373	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00074	7374	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00075	7375	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00076	7376	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00077	7377	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00078	7378	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00079	7379	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00080	7380	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00081	7381	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00082	7382	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.07	Intensity Normalized (v.2)
Sample_00083	7383	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00084	7384	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00085	7385	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00086	7386	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00087	7387	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00088	7388	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00089	7389	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00090	7390	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
CONTROL_0001	7391	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
CONTROL_0002	7392	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
CONTROL_0003	7393	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
CONTROL_0004	7394	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
CONTROL_0005	7395	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Empty well_01	7396	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
Empty well_02	7397	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Empty well_03	7398	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Empty well_04	7399	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Empty well_05	7400	OID00074	P83390	Protein_74	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00001	7401	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00002	7402	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00003	7403	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00004	7404	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00005	7405	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00006	7406	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00007	7407	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00008	7408	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00009	7409	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00010	7410	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00011	7411	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00012	7412	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00013	7413	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00014	7414	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00015	7415	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00016	7416	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00017	7417	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.27	Intensity Normalized (v.2)
Sample_00018	7418	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00019	7419	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00020	7420	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.18	Intensity Normalized (v.2)
Sample_00021	7421	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00022	7422	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00023	7423	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00024	7424	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00025	7425	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00026	7426	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00027	7427	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00028	7428	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00029	7429	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00030	7430	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00031	7431	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00032	7432	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00033	7433	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00034	7434	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00035	7435	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00036	7436	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00037	7437	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00038	7438	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00039	7439	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00040	7440	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00041	7441	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00042	7442	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00043	7443	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00044	7444	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00045	7445	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Sample_00046	7446	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.61	Intensity Normalized (v.2)
Sample_00047	7447	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.13	Intensity Normalized (v.2)
Sample_00048	7448	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00049	7449	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00050	7450	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00051	7451	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00052	7452	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00053	7453	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00054	7454	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00055	7455	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00056	7456	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00057	7457	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00058	7458	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00059	7459	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00060	7460	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00061	7461	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00062	7462	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00063	7463	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00064	7464	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00065	7465	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00066	7466	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Sample_00067	7467	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00068	7468	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.52	Intensity Normalized (v.2)
Sample_00069	7469	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00070	7470	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00071	7471	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00072	7472	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00073	7473	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00074	7474	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00075	7475	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00076	7476	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00077	7477	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00078	7478	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00079	7479	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00080	7480	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00081	7481	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00082	7482	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00083	7483	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00084	7484	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00085	7485	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00086	7486	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00087	7487	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00088	7488	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00089	7489	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00090	7490	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
CONTROL_0001	7491	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
CONTROL_0002	7492	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
CONTROL_0003	7493	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
CONTROL_0004	7494	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
CONTROL_0005	7495	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Empty well_01	7496	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Empty well_02	7497	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.36	Intensity Normalized (v.2)
Empty well_03	7498	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Empty well_04	7499	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Empty well_05	7500	OID00075	P73330	Protein_75	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00001	7501	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00002	7502	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.8	Intensity Normalized (v.2)
Sample_00003	7503	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00004	7504	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00005	7505	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00006	7506	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00007	7507	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00008	7508	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00009	7509	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00010	7510	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00011	7511	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
Sample_00012	7512	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00013	7513	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00014	7514	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00015	7515	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00016	7516	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00017	7517	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00018	7518	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00019	7519	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00020	7520	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00021	7521	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00022	7522	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00023	7523	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.86	Intensity Normalized (v.2)
Sample_00024	7524	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00025	7525	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00026	7526	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00027	7527	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00028	7528	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00029	7529	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00030	7530	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00031	7531	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00032	7532	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.31	Intensity Normalized (v.2)
Sample_00033	7533	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.53	Intensity Normalized (v.2)
Sample_00034	7534	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00035	7535	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00036	7536	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Sample_00037	7537	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
Sample_00038	7538	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00039	7539	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Sample_00040	7540	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.81	Intensity Normalized (v.2)
Sample_00041	7541	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00042	7542	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00043	7543	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00044	7544	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00045	7545	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00046	7546	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00047	7547	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00048	7548	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.21	Intensity Normalized (v.2)
Sample_00049	7549	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00050	7550	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00051	7551	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00052	7552	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00053	7553	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00054	7554	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00055	7555	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00056	7556	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00057	7557	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00058	7558	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00059	7559	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00060	7560	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00061	7561	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00062	7562	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00063	7563	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00064	7564	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00065	7565	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00066	7566	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00067	7567	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00068	7568	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.65	Intensity Normalized (v.2)
Sample_00069	7569	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00070	7570	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00071	7571	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00072	7572	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.94	Intensity Normalized (v.2)
Sample_00073	7573	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00074	7574	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00075	7575	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00076	7576	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00077	7577	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.82	Intensity Normalized (v.2)
Sample_00078	7578	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00079	7579	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00080	7580	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00081	7581	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00082	7582	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00083	7583	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00084	7584	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00085	7585	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Sample_00086	7586	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.34	Intensity Normalized (v.2)
Sample_00087	7587	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00088	7588	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00089	7589	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00090	7590	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
CONTROL_0001	7591	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
CONTROL_0002	7592	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
CONTROL_0003	7593	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
CONTROL_0004	7594	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
CONTROL_0005	7595	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Empty well_01	7596	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
Empty well_02	7597	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Empty well_03	7598	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Empty well_04	7599	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Empty well_05	7600	OID00076	P10455	Protein_76	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00001	7601	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.62	Intensity Normalized (v.2)
Sample_00002	7602	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00003	7603	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00004	7604	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.73	Intensity Normalized (v.2)
Sample_00005	7605	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00006	7606	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00007	7607	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.09	Intensity Normalized (v.2)
Sample_00008	7608	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00009	7609	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00010	7610	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00011	7611	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.96	Intensity Normalized (v.2)
Sample_00012	7612	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00013	7613	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00014	7614	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00015	7615	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00016	7616	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00017	7617	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00018	7618	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00019	7619	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.89	Intensity Normalized (v.2)
Sample_00020	7620	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00021	7621	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00022	7622	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00023	7623	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00024	7624	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00025	7625	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00026	7626	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00027	7627	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.67	Intensity Normalized (v.2)
Sample_00028	7628	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00029	7629	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00030	7630	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00031	7631	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00032	7632	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.46	Intensity Normalized (v.2)
Sample_00033	7633	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00034	7634	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00035	7635	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00036	7636	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00037	7637	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00038	7638	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00039	7639	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00040	7640	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00041	7641	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00042	7642	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00043	7643	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00044	7644	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00045	7645	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00046	7646	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00047	7647	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00048	7648	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00049	7649	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Sample_00050	7650	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00051	7651	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00052	7652	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00053	7653	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00054	7654	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.54	Intensity Normalized (v.2)
Sample_00055	7655	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00056	7656	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00057	7657	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00058	7658	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00059	7659	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00060	7660	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00061	7661	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00062	7662	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00063	7663	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.78	Intensity Normalized (v.2)
Sample_00064	7664	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00065	7665	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00066	7666	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.1	Intensity Normalized (v.2)
Sample_00067	7667	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00068	7668	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.9	Intensity Normalized (v.2)
Sample_00069	7669	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00070	7670	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00071	7671	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00072	7672	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00073	7673	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00074	7674	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00075	7675	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00076	7676	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00077	7677	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00078	7678	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00079	7679	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00080	7680	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00081	7681	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00082	7682	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00083	7683	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00084	7684	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00085	7685	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00086	7686	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00087	7687	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00088	7688	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00089	7689	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00090	7690	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
CONTROL_0001	7691	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
CONTROL_0002	7692	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
CONTROL_0003	7693	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
CONTROL_0004	7694	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
CONTROL_0005	7695	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Empty well_01	7696	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Empty well_02	7697	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Empty well_03	7698	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Empty well_04	7699	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Empty well_05	7700	OID00077	P94337	Protein_77	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00001	7701	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00002	7702	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00003	7703	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00004	7704	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00005	7705	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00006	7706	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00007	7707	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00008	7708	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00009	7709	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00010	7710	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Sample_00011	7711	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00012	7712	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00013	7713	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00014	7714	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00015	7715	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Sample_00016	7716	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00017	7717	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00018	7718	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00019	7719	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00020	7720	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00021	7721	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00022	7722	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00023	7723	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00024	7724	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00025	7725	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00026	7726	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00027	7727	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00028	7728	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.17	Intensity Normalized (v.2)
Sample_00029	7729	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00030	7730	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00031	7731	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00032	7732	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00033	7733	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.45	Intensity Normalized (v.2)
Sample_00034	7734	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00035	7735	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00036	7736	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00037	7737	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00038	7738	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00039	7739	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00040	7740	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00041	7741	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00042	7742	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00043	7743	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00044	7744	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00045	7745	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00046	7746	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00047	7747	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.63	Intensity Normalized (v.2)
Sample_00048	7748	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00049	7749	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00050	7750	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00051	7751	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00052	7752	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00053	7753	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00054	7754	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Sample_00055	7755	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00056	7756	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00057	7757	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00058	7758	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00059	7759	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00060	7760	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.59	Intensity Normalized (v.2)
Sample_00061	7761	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00062	7762	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00063	7763	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00064	7764	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00065	7765	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00066	7766	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00067	7767	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00068	7768	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00069	7769	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00070	7770	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00071	7771	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00072	7772	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00073	7773	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00074	7774	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
Sample_00075	7775	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00076	7776	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00077	7777	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00078	7778	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00079	7779	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00080	7780	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.98	Intensity Normalized (v.2)
Sample_00081	7781	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00082	7782	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.54	Intensity Normalized (v.2)
Sample_00083	7783	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.94	Intensity Normalized (v.2)
Sample_00084	7784	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00085	7785	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00086	7786	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00087	7787	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00088	7788	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00089	7789	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00090	7790	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
CONTROL_0001	7791	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
CONTROL_0002	7792	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
CONTROL_0003	7793	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
CONTROL_0004	7794	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
CONTROL_0005	7795	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Empty well_01	7796	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Empty well_02	7797	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Empty well_03	7798	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Empty well_04	7799	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Empty well_05	7800	OID00078	P22087	Protein_78	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00001	7801	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00002	7802	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00003	7803	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.33	Intensity Normalized (v.2)
Sample_00004	7804	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00005	7805	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00006	7806	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00007	7807	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00008	7808	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.21	Intensity Normalized (v.2)
Sample_00009	7809	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00010	7810	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00011	7811	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00012	7812	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00013	7813	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00014	7814	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00015	7815	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00016	7816	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00017	7817	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00018	7818	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00019	7819	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00020	7820	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00021	7821	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00022	7822	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00023	7823	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00024	7824	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Sample_00025	7825	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00026	7826	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00027	7827	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00028	7828	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00029	7829	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
Sample_00030	7830	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00031	7831	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00032	7832	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00033	7833	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00034	7834	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00035	7835	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Sample_00036	7836	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00037	7837	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00038	7838	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00039	7839	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00040	7840	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00041	7841	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00042	7842	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00043	7843	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00044	7844	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.47	Intensity Normalized (v.2)
Sample_00045	7845	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00046	7846	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00047	7847	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00048	7848	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00049	7849	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00050	7850	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00051	7851	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00052	7852	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00053	7853	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00054	7854	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00055	7855	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Sample_00056	7856	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Sample_00057	7857	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00058	7858	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00059	7859	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00060	7860	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00061	7861	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00062	7862	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00063	7863	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00064	7864	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00065	7865	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00066	7866	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00067	7867	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00068	7868	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00069	7869	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00070	7870	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.7	Intensity Normalized (v.2)
Sample_00071	7871	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00072	7872	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00073	7873	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00074	7874	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00075	7875	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00076	7876	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00077	7877	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00078	7878	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00079	7879	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00080	7880	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	10	Intensity Normalized (v.2)
Sample_00081	7881	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00082	7882	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00083	7883	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00084	7884	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.31	Intensity Normalized (v.2)
Sample_00085	7885	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00086	7886	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00087	7887	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.75	Intensity Normalized (v.2)
Sample_00088	7888	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00089	7889	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00090	7890	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
CONTROL_0001	7891	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
CONTROL_0002	7892	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
CONTROL_0003	7893	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
CONTROL_0004	7894	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
CONTROL_0005	7895	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Empty well_01	7896	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Empty well_02	7897	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Empty well_03	7898	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.95	Intensity Normalized (v.2)
Empty well_04	7899	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Empty well_05	7900	OID00079	P28693	Protein_79	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Sample_00001	7901	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00002	7902	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00003	7903	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00004	7904	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.01	Intensity Normalized (v.2)
Sample_00005	7905	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00006	7906	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00007	7907	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00008	7908	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00009	7909	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.79	Intensity Normalized (v.2)
Sample_00010	7910	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00011	7911	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00012	7912	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00013	7913	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.23	Intensity Normalized (v.2)
Sample_00014	7914	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00015	7915	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Sample_00016	7916	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00017	7917	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00018	7918	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00019	7919	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00020	7920	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00021	7921	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00022	7922	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00023	7923	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00024	7924	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00025	7925	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00026	7926	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00027	7927	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.86	Intensity Normalized (v.2)
Sample_00028	7928	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00029	7929	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00030	7930	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00031	7931	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.57	Intensity Normalized (v.2)
Sample_00032	7932	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
Sample_00033	7933	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00034	7934	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00035	7935	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.86	Intensity Normalized (v.2)
Sample_00036	7936	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00037	7937	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00038	7938	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00039	7939	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.41	Intensity Normalized (v.2)
Sample_00040	7940	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00041	7941	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00042	7942	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00043	7943	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00044	7944	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.9	Intensity Normalized (v.2)
Sample_00045	7945	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00046	7946	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00047	7947	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00048	7948	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00049	7949	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.5	Intensity Normalized (v.2)
Sample_00050	7950	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00051	7951	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00052	7952	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00053	7953	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00054	7954	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.24	Intensity Normalized (v.2)
Sample_00055	7955	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00056	7956	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00057	7957	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00058	7958	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00059	7959	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00060	7960	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00061	7961	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00062	7962	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00063	7963	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00064	7964	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00065	7965	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00066	7966	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00067	7967	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.51	Intensity Normalized (v.2)
Sample_00068	7968	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00069	7969	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00070	7970	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00071	7971	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.29	Intensity Normalized (v.2)
Sample_00072	7972	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00073	7973	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00074	7974	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00075	7975	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.15	Intensity Normalized (v.2)
Sample_00076	7976	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00077	7977	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00078	7978	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00079	7979	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.44	Intensity Normalized (v.2)
Sample_00080	7980	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00081	7981	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00082	7982	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.25	Intensity Normalized (v.2)
Sample_00083	7983	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.76	Intensity Normalized (v.2)
Sample_00084	7984	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00085	7985	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00086	7986	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00087	7987	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00088	7988	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00089	7989	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.17	Intensity Normalized (v.2)
Sample_00090	7990	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
CONTROL_0001	7991	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
CONTROL_0002	7992	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
CONTROL_0003	7993	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
CONTROL_0004	7994	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
CONTROL_0005	7995	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Empty well_01	7996	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Empty well_02	7997	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Empty well_03	7998	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Empty well_04	7999	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.18	Intensity Normalized (v.2)
Empty well_05	8000	OID00080	P35874	Protein_80	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00001	8001	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00002	8002	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00003	8003	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00004	8004	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
Sample_00005	8005	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00006	8006	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00007	8007	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00008	8008	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00009	8009	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00010	8010	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00011	8011	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00012	8012	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00013	8013	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00014	8014	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00015	8015	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00016	8016	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00017	8017	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00018	8018	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00019	8019	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00020	8020	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00021	8021	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00022	8022	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00023	8023	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00024	8024	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.72	Intensity Normalized (v.2)
Sample_00025	8025	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00026	8026	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00027	8027	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.17	Intensity Normalized (v.2)
Sample_00028	8028	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.14	Intensity Normalized (v.2)
Sample_00029	8029	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00030	8030	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00031	8031	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00032	8032	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00033	8033	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00034	8034	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00035	8035	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00036	8036	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00037	8037	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00038	8038	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00039	8039	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00040	8040	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00041	8041	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00042	8042	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00043	8043	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00044	8044	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00045	8045	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
Sample_00046	8046	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00047	8047	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00048	8048	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00049	8049	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.28	Intensity Normalized (v.2)
Sample_00050	8050	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00051	8051	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.9	Intensity Normalized (v.2)
Sample_00052	8052	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00053	8053	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00054	8054	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00055	8055	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00056	8056	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00057	8057	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00058	8058	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00059	8059	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00060	8060	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7	Intensity Normalized (v.2)
Sample_00061	8061	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00062	8062	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.63	Intensity Normalized (v.2)
Sample_00063	8063	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00064	8064	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00065	8065	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00066	8066	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00067	8067	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00068	8068	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00069	8069	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Sample_00070	8070	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00071	8071	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00072	8072	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.33	Intensity Normalized (v.2)
Sample_00073	8073	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00074	8074	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00075	8075	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00076	8076	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.64	Intensity Normalized (v.2)
Sample_00077	8077	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00078	8078	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00079	8079	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00080	8080	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00081	8081	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00082	8082	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00083	8083	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.73	Intensity Normalized (v.2)
Sample_00084	8084	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.69	Intensity Normalized (v.2)
Sample_00085	8085	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00086	8086	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00087	8087	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00088	8088	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.79	Intensity Normalized (v.2)
Sample_00089	8089	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00090	8090	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
CONTROL_0001	8091	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
CONTROL_0002	8092	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
CONTROL_0003	8093	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
CONTROL_0004	8094	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
CONTROL_0005	8095	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Empty well_01	8096	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.25	Intensity Normalized (v.2)
Empty well_02	8097	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Empty well_03	8098	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Empty well_04	8099	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Empty well_05	8100	OID00081	P22076	Protein_81	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00001	8101	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00002	8102	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00003	8103	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00004	8104	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.68	Intensity Normalized (v.2)
Sample_00005	8105	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.98	Intensity Normalized (v.2)
Sample_00006	8106	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.59	Intensity Normalized (v.2)
Sample_00007	8107	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00008	8108	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00009	8109	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00010	8110	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00011	8111	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00012	8112	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00013	8113	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00014	8114	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00015	8115	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00016	8116	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.34	Intensity Normalized (v.2)
Sample_00017	8117	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00018	8118	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00019	8119	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00020	8120	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00021	8121	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00022	8122	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00023	8123	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.95	Intensity Normalized (v.2)
Sample_00024	8124	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00025	8125	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
Sample_00026	8126	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00027	8127	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00028	8128	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00029	8129	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00030	8130	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.4	Intensity Normalized (v.2)
Sample_00031	8131	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00032	8132	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00033	8133	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00034	8134	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00035	8135	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00036	8136	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00037	8137	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.02	Intensity Normalized (v.2)
Sample_00038	8138	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00039	8139	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00040	8140	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00041	8141	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00042	8142	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
Sample_00043	8143	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00044	8144	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.44	Intensity Normalized (v.2)
Sample_00045	8145	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00046	8146	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00047	8147	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00048	8148	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00049	8149	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.08	Intensity Normalized (v.2)
Sample_00050	8150	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00051	8151	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.19	Intensity Normalized (v.2)
Sample_00052	8152	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.07	Intensity Normalized (v.2)
Sample_00053	8153	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00054	8154	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
Sample_00055	8155	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00056	8156	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00057	8157	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00058	8158	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00059	8159	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00060	8160	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00061	8161	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.43	Intensity Normalized (v.2)
Sample_00062	8162	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.01	Intensity Normalized (v.2)
Sample_00063	8163	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00064	8164	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00065	8165	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00066	8166	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00067	8167	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00068	8168	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00069	8169	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00070	8170	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00071	8171	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00072	8172	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00073	8173	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00074	8174	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Sample_00075	8175	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00076	8176	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.7	Intensity Normalized (v.2)
Sample_00077	8177	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.53	Intensity Normalized (v.2)
Sample_00078	8178	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.68	Intensity Normalized (v.2)
Sample_00079	8179	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Sample_00080	8180	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.18	Intensity Normalized (v.2)
Sample_00081	8181	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.82	Intensity Normalized (v.2)
Sample_00082	8182	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00083	8183	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Sample_00084	8184	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00085	8185	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.8	Intensity Normalized (v.2)
Sample_00086	8186	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00087	8187	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00088	8188	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00089	8189	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00090	8190	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.2	Intensity Normalized (v.2)
CONTROL_0001	8191	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
CONTROL_0002	8192	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.66	Intensity Normalized (v.2)
CONTROL_0003	8193	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
CONTROL_0004	8194	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
CONTROL_0005	8195	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Empty well_01	8196	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Empty well_02	8197	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Empty well_03	8198	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Empty well_04	8199	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Empty well_05	8200	OID00082	P70109	Protein_82	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00001	8201	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00002	8202	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00003	8203	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00004	8204	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00005	8205	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00006	8206	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00007	8207	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00008	8208	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00009	8209	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.83	Intensity Normalized (v.2)
Sample_00010	8210	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00011	8211	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.66	Intensity Normalized (v.2)
Sample_00012	8212	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00013	8213	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00014	8214	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00015	8215	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00016	8216	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.29	Intensity Normalized (v.2)
Sample_00017	8217	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.48	Intensity Normalized (v.2)
Sample_00018	8218	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.59	Intensity Normalized (v.2)
Sample_00019	8219	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00020	8220	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00021	8221	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00022	8222	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00023	8223	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.44	Intensity Normalized (v.2)
Sample_00024	8224	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00025	8225	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00026	8226	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00027	8227	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00028	8228	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
Sample_00029	8229	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00030	8230	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00031	8231	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00032	8232	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.06	Intensity Normalized (v.2)
Sample_00033	8233	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00034	8234	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00035	8235	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.74	Intensity Normalized (v.2)
Sample_00036	8236	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00037	8237	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00038	8238	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00039	8239	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00040	8240	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00041	8241	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
Sample_00042	8242	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00043	8243	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00044	8244	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00045	8245	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.11	Intensity Normalized (v.2)
Sample_00046	8246	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00047	8247	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00048	8248	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00049	8249	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00050	8250	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00051	8251	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00052	8252	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00053	8253	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00054	8254	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00055	8255	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00056	8256	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00057	8257	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00058	8258	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00059	8259	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00060	8260	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.26	Intensity Normalized (v.2)
Sample_00061	8261	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00062	8262	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00063	8263	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00064	8264	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00065	8265	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00066	8266	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00067	8267	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00068	8268	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
Sample_00069	8269	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00070	8270	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.35	Intensity Normalized (v.2)
Sample_00071	8271	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.51	Intensity Normalized (v.2)
Sample_00072	8272	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00073	8273	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00074	8274	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00075	8275	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00076	8276	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00077	8277	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00078	8278	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00079	8279	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.24	Intensity Normalized (v.2)
Sample_00080	8280	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.47	Intensity Normalized (v.2)
Sample_00081	8281	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.7	Intensity Normalized (v.2)
Sample_00082	8282	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00083	8283	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00084	8284	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00085	8285	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Sample_00086	8286	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00087	8287	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00088	8288	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00089	8289	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00090	8290	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
CONTROL_0001	8291	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
CONTROL_0002	8292	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.89	Intensity Normalized (v.2)
CONTROL_0003	8293	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
CONTROL_0004	8294	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
CONTROL_0005	8295	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Empty well_01	8296	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Empty well_02	8297	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Empty well_03	8298	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Empty well_04	8299	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Empty well_05	8300	OID00083	P21281	Protein_83	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00001	8301	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00002	8302	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.56	Intensity Normalized (v.2)
Sample_00003	8303	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00004	8304	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00005	8305	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00006	8306	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00007	8307	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00008	8308	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00009	8309	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00010	8310	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00011	8311	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00012	8312	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00013	8313	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00014	8314	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00015	8315	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00016	8316	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00017	8317	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00018	8318	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.53	Intensity Normalized (v.2)
Sample_00019	8319	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.75	Intensity Normalized (v.2)
Sample_00020	8320	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00021	8321	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00022	8322	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
Sample_00023	8323	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00024	8324	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00025	8325	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.57	Intensity Normalized (v.2)
Sample_00026	8326	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00027	8327	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00028	8328	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.11	Intensity Normalized (v.2)
Sample_00029	8329	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.44	Intensity Normalized (v.2)
Sample_00030	8330	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00031	8331	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00032	8332	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.47	Intensity Normalized (v.2)
Sample_00033	8333	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00034	8334	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00035	8335	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00036	8336	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00037	8337	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00038	8338	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00039	8339	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00040	8340	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00041	8341	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00042	8342	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00043	8343	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00044	8344	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00045	8345	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00046	8346	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00047	8347	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00048	8348	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00049	8349	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00050	8350	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00051	8351	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.2	Intensity Normalized (v.2)
Sample_00052	8352	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00053	8353	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00054	8354	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00055	8355	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.14	Intensity Normalized (v.2)
Sample_00056	8356	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00057	8357	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
Sample_00058	8358	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00059	8359	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00060	8360	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00061	8361	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00062	8362	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00063	8363	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00064	8364	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00065	8365	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00066	8366	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00067	8367	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.55	Intensity Normalized (v.2)
Sample_00068	8368	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
Sample_00069	8369	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.78	Intensity Normalized (v.2)
Sample_00070	8370	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00071	8371	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00072	8372	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00073	8373	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00074	8374	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00075	8375	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.28	Intensity Normalized (v.2)
Sample_00076	8376	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00077	8377	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00078	8378	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00079	8379	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00080	8380	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00081	8381	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00082	8382	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Sample_00083	8383	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.36	Intensity Normalized (v.2)
Sample_00084	8384	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00085	8385	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.15	Intensity Normalized (v.2)
Sample_00086	8386	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00087	8387	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.71	Intensity Normalized (v.2)
Sample_00088	8388	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00089	8389	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
Sample_00090	8390	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
CONTROL_0001	8391	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.95	Intensity Normalized (v.2)
CONTROL_0002	8392	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
CONTROL_0003	8393	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
CONTROL_0004	8394	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
CONTROL_0005	8395	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Empty well_01	8396	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.47	Intensity Normalized (v.2)
Empty well_02	8397	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Empty well_03	8398	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Empty well_04	8399	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Empty well_05	8400	OID00084	P27048	Protein_84	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.35	Intensity Normalized (v.2)
Sample_00001	8401	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00002	8402	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Sample_00003	8403	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00004	8404	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00005	8405	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
Sample_00006	8406	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00007	8407	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00008	8408	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.74	Intensity Normalized (v.2)
Sample_00009	8409	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00010	8410	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.67	Intensity Normalized (v.2)
Sample_00011	8411	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00012	8412	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00013	8413	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00014	8414	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
Sample_00015	8415	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00016	8416	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00017	8417	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00018	8418	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00019	8419	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.02	Intensity Normalized (v.2)
Sample_00020	8420	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.43	Intensity Normalized (v.2)
Sample_00021	8421	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00022	8422	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00023	8423	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00024	8424	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.18	Intensity Normalized (v.2)
Sample_00025	8425	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00026	8426	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.53	Intensity Normalized (v.2)
Sample_00027	8427	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00028	8428	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00029	8429	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.45	Intensity Normalized (v.2)
Sample_00030	8430	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00031	8431	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.32	Intensity Normalized (v.2)
Sample_00032	8432	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
Sample_00033	8433	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00034	8434	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00035	8435	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Sample_00036	8436	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.21	Intensity Normalized (v.2)
Sample_00037	8437	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00038	8438	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.21	Intensity Normalized (v.2)
Sample_00039	8439	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00040	8440	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.8	Intensity Normalized (v.2)
Sample_00041	8441	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00042	8442	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.87	Intensity Normalized (v.2)
Sample_00043	8443	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00044	8444	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00045	8445	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00046	8446	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.3	Intensity Normalized (v.2)
Sample_00047	8447	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00048	8448	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00049	8449	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
Sample_00050	8450	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00051	8451	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00052	8452	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00053	8453	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00054	8454	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00055	8455	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.09	Intensity Normalized (v.2)
Sample_00056	8456	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Sample_00057	8457	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00058	8458	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00059	8459	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00060	8460	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00061	8461	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00062	8462	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00063	8463	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00064	8464	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00065	8465	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00066	8466	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00067	8467	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00068	8468	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00069	8469	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00070	8470	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00071	8471	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00072	8472	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.35	Intensity Normalized (v.2)
Sample_00073	8473	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.05	Intensity Normalized (v.2)
Sample_00074	8474	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00075	8475	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00076	8476	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.98	Intensity Normalized (v.2)
Sample_00077	8477	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00078	8478	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Sample_00079	8479	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.42	Intensity Normalized (v.2)
Sample_00080	8480	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00081	8481	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.21	Intensity Normalized (v.2)
Sample_00082	8482	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.3	Intensity Normalized (v.2)
Sample_00083	8483	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00084	8484	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00085	8485	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00086	8486	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.01	Intensity Normalized (v.2)
Sample_00087	8487	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00088	8488	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00089	8489	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00090	8490	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
CONTROL_0001	8491	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.05	Intensity Normalized (v.2)
CONTROL_0002	8492	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
CONTROL_0003	8493	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.12	Intensity Normalized (v.2)
CONTROL_0004	8494	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
CONTROL_0005	8495	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.21	Intensity Normalized (v.2)
Empty well_01	8496	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
Empty well_02	8497	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Empty well_03	8498	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.28	Intensity Normalized (v.2)
Empty well_04	8499	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Empty well_05	8500	OID00085	P15157	Protein_85	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00001	8501	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00002	8502	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00003	8503	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.15	Intensity Normalized (v.2)
Sample_00004	8504	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00005	8505	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.32	Intensity Normalized (v.2)
Sample_00006	8506	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00007	8507	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00008	8508	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00009	8509	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00010	8510	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00011	8511	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00012	8512	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00013	8513	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00014	8514	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00015	8515	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00016	8516	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00017	8517	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00018	8518	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00019	8519	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.58	Intensity Normalized (v.2)
Sample_00020	8520	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00021	8521	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.23	Intensity Normalized (v.2)
Sample_00022	8522	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00023	8523	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00024	8524	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00025	8525	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00026	8526	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00027	8527	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00028	8528	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00029	8529	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00030	8530	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00031	8531	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00032	8532	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00033	8533	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00034	8534	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.6	Intensity Normalized (v.2)
Sample_00035	8535	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00036	8536	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00037	8537	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00038	8538	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00039	8539	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00040	8540	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.66	Intensity Normalized (v.2)
Sample_00041	8541	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00042	8542	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00043	8543	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00044	8544	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00045	8545	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.65	Intensity Normalized (v.2)
Sample_00046	8546	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00047	8547	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00048	8548	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00049	8549	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00050	8550	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00051	8551	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00052	8552	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.63	Intensity Normalized (v.2)
Sample_00053	8553	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00054	8554	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00055	8555	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00056	8556	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00057	8557	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00058	8558	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.36	Intensity Normalized (v.2)
Sample_00059	8559	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00060	8560	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00061	8561	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00062	8562	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00063	8563	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00064	8564	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00065	8565	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.93	Intensity Normalized (v.2)
Sample_00066	8566	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00067	8567	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.95	Intensity Normalized (v.2)
Sample_00068	8568	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00069	8569	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00070	8570	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Sample_00071	8571	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00072	8572	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00073	8573	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00074	8574	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00075	8575	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.71	Intensity Normalized (v.2)
Sample_00076	8576	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00077	8577	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00078	8578	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00079	8579	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00080	8580	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00081	8581	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00082	8582	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00083	8583	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00084	8584	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00085	8585	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00086	8586	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00087	8587	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.09	Intensity Normalized (v.2)
Sample_00088	8588	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.38	Intensity Normalized (v.2)
Sample_00089	8589	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.68	Intensity Normalized (v.2)
Sample_00090	8590	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.72	Intensity Normalized (v.2)
CONTROL_0001	8591	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.64	Intensity Normalized (v.2)
CONTROL_0002	8592	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
CONTROL_0003	8593	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.16	Intensity Normalized (v.2)
CONTROL_0004	8594	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
CONTROL_0005	8595	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Empty well_01	8596	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Empty well_02	8597	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.24	Intensity Normalized (v.2)
Empty well_03	8598	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Empty well_04	8599	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Empty well_05	8600	OID00086	P70709	Protein_86	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00001	8601	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00002	8602	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.05	Intensity Normalized (v.2)
Sample_00003	8603	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.69	Intensity Normalized (v.2)
Sample_00004	8604	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.64	Intensity Normalized (v.2)
Sample_00005	8605	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.67	Intensity Normalized (v.2)
Sample_00006	8606	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00007	8607	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.05	Intensity Normalized (v.2)
Sample_00008	8608	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00009	8609	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.46	Intensity Normalized (v.2)
Sample_00010	8610	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00011	8611	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00012	8612	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00013	8613	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00014	8614	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00015	8615	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00016	8616	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.35	Intensity Normalized (v.2)
Sample_00017	8617	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00018	8618	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00019	8619	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00020	8620	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00021	8621	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00022	8622	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.77	Intensity Normalized (v.2)
Sample_00023	8623	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00024	8624	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.15	Intensity Normalized (v.2)
Sample_00025	8625	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00026	8626	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00027	8627	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.91	Intensity Normalized (v.2)
Sample_00028	8628	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00029	8629	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00030	8630	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00031	8631	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.74	Intensity Normalized (v.2)
Sample_00032	8632	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00033	8633	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00034	8634	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
Sample_00035	8635	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00036	8636	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.99	Intensity Normalized (v.2)
Sample_00037	8637	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00038	8638	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00039	8639	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00040	8640	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00041	8641	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.52	Intensity Normalized (v.2)
Sample_00042	8642	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00043	8643	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
Sample_00044	8644	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00045	8645	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.71	Intensity Normalized (v.2)
Sample_00046	8646	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.69	Intensity Normalized (v.2)
Sample_00047	8647	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00048	8648	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00049	8649	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00050	8650	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00051	8651	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.13	Intensity Normalized (v.2)
Sample_00052	8652	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00053	8653	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.4	Intensity Normalized (v.2)
Sample_00054	8654	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00055	8655	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00056	8656	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
Sample_00057	8657	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.78	Intensity Normalized (v.2)
Sample_00058	8658	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.48	Intensity Normalized (v.2)
Sample_00059	8659	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.3	Intensity Normalized (v.2)
Sample_00060	8660	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00061	8661	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00062	8662	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00063	8663	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00064	8664	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.25	Intensity Normalized (v.2)
Sample_00065	8665	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.32	Intensity Normalized (v.2)
Sample_00066	8666	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.16	Intensity Normalized (v.2)
Sample_00067	8667	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
Sample_00068	8668	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00069	8669	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.18	Intensity Normalized (v.2)
Sample_00070	8670	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00071	8671	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00072	8672	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00073	8673	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.63	Intensity Normalized (v.2)
Sample_00074	8674	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00075	8675	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00076	8676	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00077	8677	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00078	8678	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00079	8679	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00080	8680	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00081	8681	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.48	Intensity Normalized (v.2)
Sample_00082	8682	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00083	8683	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00084	8684	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00085	8685	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00086	8686	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.92	Intensity Normalized (v.2)
Sample_00087	8687	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00088	8688	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
Sample_00089	8689	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.69	Intensity Normalized (v.2)
Sample_00090	8690	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
CONTROL_0001	8691	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
CONTROL_0002	8692	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
CONTROL_0003	8693	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
CONTROL_0004	8694	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.19	Intensity Normalized (v.2)
CONTROL_0005	8695	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Empty well_01	8696	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Empty well_02	8697	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.23	Intensity Normalized (v.2)
Empty well_03	8698	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.01	Intensity Normalized (v.2)
Empty well_04	8699	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Empty well_05	8700	OID00087	P86970	Protein_87	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.29	Intensity Normalized (v.2)
Sample_00001	8701	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00002	8702	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Sample_00003	8703	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00004	8704	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
Sample_00005	8705	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00006	8706	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.16	Intensity Normalized (v.2)
Sample_00007	8707	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00008	8708	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00009	8709	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00010	8710	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00011	8711	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00012	8712	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.79	Intensity Normalized (v.2)
Sample_00013	8713	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.91	Intensity Normalized (v.2)
Sample_00014	8714	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00015	8715	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.23	Intensity Normalized (v.2)
Sample_00016	8716	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.84	Intensity Normalized (v.2)
Sample_00017	8717	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00018	8718	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00019	8719	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.44	Intensity Normalized (v.2)
Sample_00020	8720	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00021	8721	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00022	8722	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.13	Intensity Normalized (v.2)
Sample_00023	8723	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.54	Intensity Normalized (v.2)
Sample_00024	8724	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.98	Intensity Normalized (v.2)
Sample_00025	8725	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00026	8726	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00027	8727	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.49	Intensity Normalized (v.2)
Sample_00028	8728	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.64	Intensity Normalized (v.2)
Sample_00029	8729	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00030	8730	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00031	8731	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00032	8732	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00033	8733	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
Sample_00034	8734	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00035	8735	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.88	Intensity Normalized (v.2)
Sample_00036	8736	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00037	8737	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00038	8738	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00039	8739	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.14	Intensity Normalized (v.2)
Sample_00040	8740	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Sample_00041	8741	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.51	Intensity Normalized (v.2)
Sample_00042	8742	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00043	8743	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00044	8744	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00045	8745	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00046	8746	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Sample_00047	8747	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00048	8748	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.18	Intensity Normalized (v.2)
Sample_00049	8749	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00050	8750	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00051	8751	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00052	8752	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00053	8753	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Sample_00054	8754	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00055	8755	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00056	8756	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00057	8757	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00058	8758	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00059	8759	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.99	Intensity Normalized (v.2)
Sample_00060	8760	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00061	8761	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.86	Intensity Normalized (v.2)
Sample_00062	8762	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.38	Intensity Normalized (v.2)
Sample_00063	8763	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.1	Intensity Normalized (v.2)
Sample_00064	8764	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00065	8765	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00066	8766	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00067	8767	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.94	Intensity Normalized (v.2)
Sample_00068	8768	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
Sample_00069	8769	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00070	8770	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00071	8771	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00072	8772	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00073	8773	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.47	Intensity Normalized (v.2)
Sample_00074	8774	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00075	8775	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00076	8776	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
Sample_00077	8777	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00078	8778	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.62	Intensity Normalized (v.2)
Sample_00079	8779	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00080	8780	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00081	8781	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00082	8782	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00083	8783	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00084	8784	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00085	8785	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00086	8786	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00087	8787	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00088	8788	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00089	8789	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00090	8790	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.31	Intensity Normalized (v.2)
CONTROL_0001	8791	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
CONTROL_0002	8792	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
CONTROL_0003	8793	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.06	Intensity Normalized (v.2)
CONTROL_0004	8794	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
CONTROL_0005	8795	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Empty well_01	8796	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Empty well_02	8797	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.26	Intensity Normalized (v.2)
Empty well_03	8798	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.04	Intensity Normalized (v.2)
Empty well_04	8799	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.74	Intensity Normalized (v.2)
Empty well_05	8800	OID00088	P37196	Protein_88	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.17	Intensity Normalized (v.2)
Sample_00001	8801	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00002	8802	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00003	8803	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00004	8804	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00005	8805	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.24	Intensity Normalized (v.2)
Sample_00006	8806	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00007	8807	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00008	8808	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.9	Intensity Normalized (v.2)
Sample_00009	8809	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00010	8810	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.88	Intensity Normalized (v.2)
Sample_00011	8811	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.56	Intensity Normalized (v.2)
Sample_00012	8812	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00013	8813	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00014	8814	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00015	8815	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00016	8816	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.55	Intensity Normalized (v.2)
Sample_00017	8817	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00018	8818	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00019	8819	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.75	Intensity Normalized (v.2)
Sample_00020	8820	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00021	8821	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00022	8822	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.54	Intensity Normalized (v.2)
Sample_00023	8823	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00024	8824	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00025	8825	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.18	Intensity Normalized (v.2)
Sample_00026	8826	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.91	Intensity Normalized (v.2)
Sample_00027	8827	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.25	Intensity Normalized (v.2)
Sample_00028	8828	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.04	Intensity Normalized (v.2)
Sample_00029	8829	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00030	8830	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.58	Intensity Normalized (v.2)
Sample_00031	8831	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
Sample_00032	8832	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.92	Intensity Normalized (v.2)
Sample_00033	8833	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00034	8834	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00035	8835	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00036	8836	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.55	Intensity Normalized (v.2)
Sample_00037	8837	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.93	Intensity Normalized (v.2)
Sample_00038	8838	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00039	8839	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00040	8840	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00041	8841	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00042	8842	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00043	8843	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.28	Intensity Normalized (v.2)
Sample_00044	8844	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00045	8845	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00046	8846	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.55	Intensity Normalized (v.2)
Sample_00047	8847	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Sample_00048	8848	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00049	8849	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00050	8850	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.3	Intensity Normalized (v.2)
Sample_00051	8851	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00052	8852	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.44	Intensity Normalized (v.2)
Sample_00053	8853	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.01	Intensity Normalized (v.2)
Sample_00054	8854	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.81	Intensity Normalized (v.2)
Sample_00055	8855	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Sample_00056	8856	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.44	Intensity Normalized (v.2)
Sample_00057	8857	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00058	8858	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.31	Intensity Normalized (v.2)
Sample_00059	8859	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00060	8860	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00061	8861	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00062	8862	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00063	8863	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00064	8864	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.82	Intensity Normalized (v.2)
Sample_00065	8865	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00066	8866	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00067	8867	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.26	Intensity Normalized (v.2)
Sample_00068	8868	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.1	Intensity Normalized (v.2)
Sample_00069	8869	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.74	Intensity Normalized (v.2)
Sample_00070	8870	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00071	8871	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00072	8872	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00073	8873	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.49	Intensity Normalized (v.2)
Sample_00074	8874	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.08	Intensity Normalized (v.2)
Sample_00075	8875	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00076	8876	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00077	8877	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.5	Intensity Normalized (v.2)
Sample_00078	8878	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.82	Intensity Normalized (v.2)
Sample_00079	8879	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.2	Intensity Normalized (v.2)
Sample_00080	8880	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.3	Intensity Normalized (v.2)
Sample_00081	8881	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00082	8882	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00083	8883	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6	Intensity Normalized (v.2)
Sample_00084	8884	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.8	Intensity Normalized (v.2)
Sample_00085	8885	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00086	8886	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.96	Intensity Normalized (v.2)
Sample_00087	8887	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.87	Intensity Normalized (v.2)
Sample_00088	8888	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.12	Intensity Normalized (v.2)
Sample_00089	8889	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00090	8890	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
CONTROL_0001	8891	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
CONTROL_0002	8892	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
CONTROL_0003	8893	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
CONTROL_0004	8894	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
CONTROL_0005	8895	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Empty well_01	8896	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Empty well_02	8897	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Empty well_03	8898	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Empty well_04	8899	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Empty well_05	8900	OID00089	P36937	Protein_89	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00001	8901	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00002	8902	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00003	8903	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00004	8904	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.48	Intensity Normalized (v.2)
Sample_00005	8905	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00006	8906	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.39	Intensity Normalized (v.2)
Sample_00007	8907	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00008	8908	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.95	Intensity Normalized (v.2)
Sample_00009	8909	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00010	8910	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00011	8911	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00012	8912	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00013	8913	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.14	Intensity Normalized (v.2)
Sample_00014	8914	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.96	Intensity Normalized (v.2)
Sample_00015	8915	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00016	8916	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00017	8917	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.66	Intensity Normalized (v.2)
Sample_00018	8918	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.76	Intensity Normalized (v.2)
Sample_00019	8919	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.48	Intensity Normalized (v.2)
Sample_00020	8920	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00021	8921	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.22	Intensity Normalized (v.2)
Sample_00022	8922	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00023	8923	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.2	Intensity Normalized (v.2)
Sample_00024	8924	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.07	Intensity Normalized (v.2)
Sample_00025	8925	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00026	8926	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.59	Intensity Normalized (v.2)
Sample_00027	8927	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.99	Intensity Normalized (v.2)
Sample_00028	8928	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00029	8929	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Sample_00030	8930	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.35	Intensity Normalized (v.2)
Sample_00031	8931	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.96	Intensity Normalized (v.2)
Sample_00032	8932	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00033	8933	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.37	Intensity Normalized (v.2)
Sample_00034	8934	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00035	8935	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00036	8936	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00037	8937	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00038	8938	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Sample_00039	8939	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00040	8940	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.01	Intensity Normalized (v.2)
Sample_00041	8941	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00042	8942	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.95	Intensity Normalized (v.2)
Sample_00043	8943	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.86	Intensity Normalized (v.2)
Sample_00044	8944	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00045	8945	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00046	8946	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5	Intensity Normalized (v.2)
Sample_00047	8947	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.69	Intensity Normalized (v.2)
Sample_00048	8948	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00049	8949	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00050	8950	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00051	8951	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00052	8952	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00053	8953	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.25	Intensity Normalized (v.2)
Sample_00054	8954	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00055	8955	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00056	8956	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00057	8957	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00058	8958	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00059	8959	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.7	Intensity Normalized (v.2)
Sample_00060	8960	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00061	8961	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00062	8962	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00063	8963	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00064	8964	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.92	Intensity Normalized (v.2)
Sample_00065	8965	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00066	8966	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00067	8967	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.96	Intensity Normalized (v.2)
Sample_00068	8968	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00069	8969	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00070	8970	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.53	Intensity Normalized (v.2)
Sample_00071	8971	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00072	8972	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00073	8973	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.62	Intensity Normalized (v.2)
Sample_00074	8974	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00075	8975	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.58	Intensity Normalized (v.2)
Sample_00076	8976	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00077	8977	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00078	8978	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00079	8979	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.27	Intensity Normalized (v.2)
Sample_00080	8980	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.41	Intensity Normalized (v.2)
Sample_00081	8981	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00082	8982	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.92	Intensity Normalized (v.2)
Sample_00083	8983	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00084	8984	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00085	8985	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.6	Intensity Normalized (v.2)
Sample_00086	8986	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.73	Intensity Normalized (v.2)
Sample_00087	8987	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.22	Intensity Normalized (v.2)
Sample_00088	8988	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.63	Intensity Normalized (v.2)
Sample_00089	8989	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.75	Intensity Normalized (v.2)
Sample_00090	8990	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
CONTROL_0001	8991	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
CONTROL_0002	8992	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.94	Intensity Normalized (v.2)
CONTROL_0003	8993	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.36	Intensity Normalized (v.2)
CONTROL_0004	8994	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
CONTROL_0005	8995	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.76	Intensity Normalized (v.2)
Empty well_01	8996	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Empty well_02	8997	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Empty well_03	8998	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.71	Intensity Normalized (v.2)
Empty well_04	8999	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.66	Intensity Normalized (v.2)
Empty well_05	9000	OID00090	P82180	Protein_90	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Sample_00001	9001	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.11	Intensity Normalized (v.2)
Sample_00002	9002	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Sample_00003	9003	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
Sample_00004	9004	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Sample_00005	9005	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00006	9006	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.68	Intensity Normalized (v.2)
Sample_00007	9007	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.97	Intensity Normalized (v.2)
Sample_00008	9008	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00009	9009	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.54	Intensity Normalized (v.2)
Sample_00010	9010	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00011	9011	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00012	9012	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.1	Intensity Normalized (v.2)
Sample_00013	9013	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.93	Intensity Normalized (v.2)
Sample_00014	9014	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Sample_00015	9015	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00016	9016	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.85	Intensity Normalized (v.2)
Sample_00017	9017	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.97	Intensity Normalized (v.2)
Sample_00018	9018	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00019	9019	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.72	Intensity Normalized (v.2)
Sample_00020	9020	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00021	9021	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00022	9022	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.31	Intensity Normalized (v.2)
Sample_00023	9023	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.52	Intensity Normalized (v.2)
Sample_00024	9024	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00025	9025	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00026	9026	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00027	9027	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.88	Intensity Normalized (v.2)
Sample_00028	9028	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.3	Intensity Normalized (v.2)
Sample_00029	9029	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00030	9030	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.83	Intensity Normalized (v.2)
Sample_00031	9031	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.71	Intensity Normalized (v.2)
Sample_00032	9032	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.22	Intensity Normalized (v.2)
Sample_00033	9033	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00034	9034	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.11	Intensity Normalized (v.2)
Sample_00035	9035	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.31	Intensity Normalized (v.2)
Sample_00036	9036	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00037	9037	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.22	Intensity Normalized (v.2)
Sample_00038	9038	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00039	9039	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
Sample_00040	9040	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00041	9041	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.98	Intensity Normalized (v.2)
Sample_00042	9042	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00043	9043	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00044	9044	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.96	Intensity Normalized (v.2)
Sample_00045	9045	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.07	Intensity Normalized (v.2)
Sample_00046	9046	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00047	9047	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.47	Intensity Normalized (v.2)
Sample_00048	9048	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00049	9049	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.45	Intensity Normalized (v.2)
Sample_00050	9050	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00051	9051	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.5	Intensity Normalized (v.2)
Sample_00052	9052	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.42	Intensity Normalized (v.2)
Sample_00053	9053	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.94	Intensity Normalized (v.2)
Sample_00054	9054	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.72	Intensity Normalized (v.2)
Sample_00055	9055	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
Sample_00056	9056	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00057	9057	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.29	Intensity Normalized (v.2)
Sample_00058	9058	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.78	Intensity Normalized (v.2)
Sample_00059	9059	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.39	Intensity Normalized (v.2)
Sample_00060	9060	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00061	9061	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.12	Intensity Normalized (v.2)
Sample_00062	9062	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00063	9063	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.45	Intensity Normalized (v.2)
Sample_00064	9064	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00065	9065	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00066	9066	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.17	Intensity Normalized (v.2)
Sample_00067	9067	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.73	Intensity Normalized (v.2)
Sample_00068	9068	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00069	9069	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.57	Intensity Normalized (v.2)
Sample_00070	9070	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.56	Intensity Normalized (v.2)
Sample_00071	9071	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00072	9072	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.09	Intensity Normalized (v.2)
Sample_00073	9073	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00074	9074	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.37	Intensity Normalized (v.2)
Sample_00075	9075	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00076	9076	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.65	Intensity Normalized (v.2)
Sample_00077	9077	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00078	9078	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.08	Intensity Normalized (v.2)
Sample_00079	9079	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00080	9080	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00081	9081	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.99	Intensity Normalized (v.2)
Sample_00082	9082	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00083	9083	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00084	9084	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.33	Intensity Normalized (v.2)
Sample_00085	9085	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.9	Intensity Normalized (v.2)
Sample_00086	9086	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.34	Intensity Normalized (v.2)
Sample_00087	9087	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00088	9088	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
Sample_00089	9089	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.77	Intensity Normalized (v.2)
Sample_00090	9090	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
CONTROL_0001	9091	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
CONTROL_0002	9092	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.82	Intensity Normalized (v.2)
CONTROL_0003	9093	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.97	Intensity Normalized (v.2)
CONTROL_0004	9094	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
CONTROL_0005	9095	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Empty well_01	9096	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Empty well_02	9097	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.27	Intensity Normalized (v.2)
Empty well_03	9098	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Empty well_04	9099	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Empty well_05	9100	OID00091	P75140	Protein_91	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.42	Intensity Normalized (v.2)
Sample_00001	9101	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00002	9102	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00003	9103	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00004	9104	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.21	Intensity Normalized (v.2)
Sample_00005	9105	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
Sample_00006	9106	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00007	9107	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00008	9108	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.39	Intensity Normalized (v.2)
Sample_00009	9109	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
Sample_00010	9110	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00011	9111	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00012	9112	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.53	Intensity Normalized (v.2)
Sample_00013	9113	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Sample_00014	9114	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Sample_00015	9115	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00016	9116	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.72	Intensity Normalized (v.2)
Sample_00017	9117	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Sample_00018	9118	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00019	9119	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
Sample_00020	9120	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00021	9121	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.42	Intensity Normalized (v.2)
Sample_00022	9122	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00023	9123	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00024	9124	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00025	9125	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.36	Intensity Normalized (v.2)
Sample_00026	9126	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00027	9127	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.96	Intensity Normalized (v.2)
Sample_00028	9128	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00029	9129	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00030	9130	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.01	Intensity Normalized (v.2)
Sample_00031	9131	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00032	9132	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00033	9133	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Sample_00034	9134	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00035	9135	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.65	Intensity Normalized (v.2)
Sample_00036	9136	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00037	9137	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.37	Intensity Normalized (v.2)
Sample_00038	9138	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.89	Intensity Normalized (v.2)
Sample_00039	9139	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00040	9140	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.2	Intensity Normalized (v.2)
Sample_00041	9141	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00042	9142	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00043	9143	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.51	Intensity Normalized (v.2)
Sample_00044	9144	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.4	Intensity Normalized (v.2)
Sample_00045	9145	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.85	Intensity Normalized (v.2)
Sample_00046	9146	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00047	9147	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
Sample_00048	9148	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00049	9149	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.4	Intensity Normalized (v.2)
Sample_00050	9150	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Sample_00051	9151	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.57	Intensity Normalized (v.2)
Sample_00052	9152	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00053	9153	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.18	Intensity Normalized (v.2)
Sample_00054	9154	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.04	Intensity Normalized (v.2)
Sample_00055	9155	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.08	Intensity Normalized (v.2)
Sample_00056	9156	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.09	Intensity Normalized (v.2)
Sample_00057	9157	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.08	Intensity Normalized (v.2)
Sample_00058	9158	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.23	Intensity Normalized (v.2)
Sample_00059	9159	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00060	9160	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00061	9161	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00062	9162	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00063	9163	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00064	9164	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00065	9165	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.92	Intensity Normalized (v.2)
Sample_00066	9166	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.41	Intensity Normalized (v.2)
Sample_00067	9167	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.76	Intensity Normalized (v.2)
Sample_00068	9168	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00069	9169	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.69	Intensity Normalized (v.2)
Sample_00070	9170	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00071	9171	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.06	Intensity Normalized (v.2)
Sample_00072	9172	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.8	Intensity Normalized (v.2)
Sample_00073	9173	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00074	9174	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00075	9175	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.67	Intensity Normalized (v.2)
Sample_00076	9176	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00077	9177	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00078	9178	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00079	9179	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00080	9180	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00081	9181	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5	Intensity Normalized (v.2)
Sample_00082	9182	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.75	Intensity Normalized (v.2)
Sample_00083	9183	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.97	Intensity Normalized (v.2)
Sample_00084	9184	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
Sample_00085	9185	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.98	Intensity Normalized (v.2)
Sample_00086	9186	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Sample_00087	9187	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.83	Intensity Normalized (v.2)
Sample_00088	9188	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.87	Intensity Normalized (v.2)
Sample_00089	9189	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00090	9190	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.79	Intensity Normalized (v.2)
CONTROL_0001	9191	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
CONTROL_0002	9192	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
CONTROL_0003	9193	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.99	Intensity Normalized (v.2)
CONTROL_0004	9194	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.03	Intensity Normalized (v.2)
CONTROL_0005	9195	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.35	Intensity Normalized (v.2)
Empty well_01	9196	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Empty well_02	9197	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Empty well_03	9198	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Empty well_04	9199	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.61	Intensity Normalized (v.2)
Empty well_05	9200	OID00092	P62610	Protein_92	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.47	Intensity Normalized (v.2)
Sample_00001	9201	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00002	9202	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.71	Intensity Normalized (v.2)
Sample_00003	9203	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.43	Intensity Normalized (v.2)
Sample_00004	9204	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00005	9205	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
Sample_00006	9206	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.6	Intensity Normalized (v.2)
Sample_00007	9207	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00008	9208	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00009	9209	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.39	Intensity Normalized (v.2)
Sample_00010	9210	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00011	9211	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.68	Intensity Normalized (v.2)
Sample_00012	9212	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.07	Intensity Normalized (v.2)
Sample_00013	9213	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.05	Intensity Normalized (v.2)
Sample_00014	9214	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.34	Intensity Normalized (v.2)
Sample_00015	9215	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00016	9216	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00017	9217	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.15	Intensity Normalized (v.2)
Sample_00018	9218	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.32	Intensity Normalized (v.2)
Sample_00019	9219	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.08	Intensity Normalized (v.2)
Sample_00020	9220	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00021	9221	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.73	Intensity Normalized (v.2)
Sample_00022	9222	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00023	9223	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00024	9224	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00025	9225	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00026	9226	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.01	Intensity Normalized (v.2)
Sample_00027	9227	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.81	Intensity Normalized (v.2)
Sample_00028	9228	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.69	Intensity Normalized (v.2)
Sample_00029	9229	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00030	9230	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00031	9231	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Sample_00032	9232	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00033	9233	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.66	Intensity Normalized (v.2)
Sample_00034	9234	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.3	Intensity Normalized (v.2)
Sample_00035	9235	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00036	9236	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.64	Intensity Normalized (v.2)
Sample_00037	9237	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.77	Intensity Normalized (v.2)
Sample_00038	9238	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.34	Intensity Normalized (v.2)
Sample_00039	9239	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00040	9240	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.87	Intensity Normalized (v.2)
Sample_00041	9241	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.39	Intensity Normalized (v.2)
Sample_00042	9242	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00043	9243	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.84	Intensity Normalized (v.2)
Sample_00044	9244	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
Sample_00045	9245	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.85	Intensity Normalized (v.2)
Sample_00046	9246	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00047	9247	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00048	9248	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.4	Intensity Normalized (v.2)
Sample_00049	9249	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00050	9250	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.49	Intensity Normalized (v.2)
Sample_00051	9251	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.86	Intensity Normalized (v.2)
Sample_00052	9252	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00053	9253	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00054	9254	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00055	9255	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00056	9256	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00057	9257	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.62	Intensity Normalized (v.2)
Sample_00058	9258	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.3	Intensity Normalized (v.2)
Sample_00059	9259	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.49	Intensity Normalized (v.2)
Sample_00060	9260	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00061	9261	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.88	Intensity Normalized (v.2)
Sample_00062	9262	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.11	Intensity Normalized (v.2)
Sample_00063	9263	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00064	9264	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00065	9265	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.09	Intensity Normalized (v.2)
Sample_00066	9266	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.58	Intensity Normalized (v.2)
Sample_00067	9267	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.95	Intensity Normalized (v.2)
Sample_00068	9268	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00069	9269	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.82	Intensity Normalized (v.2)
Sample_00070	9270	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.38	Intensity Normalized (v.2)
Sample_00071	9271	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00072	9272	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00073	9273	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00074	9274	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.48	Intensity Normalized (v.2)
Sample_00075	9275	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.41	Intensity Normalized (v.2)
Sample_00076	9276	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00077	9277	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00078	9278	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.5	Intensity Normalized (v.2)
Sample_00079	9279	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.39	Intensity Normalized (v.2)
Sample_00080	9280	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00081	9281	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.44	Intensity Normalized (v.2)
Sample_00082	9282	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00083	9283	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.31	Intensity Normalized (v.2)
Sample_00084	9284	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00085	9285	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00086	9286	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.12	Intensity Normalized (v.2)
Sample_00087	9287	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00088	9288	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00089	9289	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.07	Intensity Normalized (v.2)
Sample_00090	9290	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.12	Intensity Normalized (v.2)
CONTROL_0001	9291	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.41	Intensity Normalized (v.2)
CONTROL_0002	9292	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.01	Intensity Normalized (v.2)
CONTROL_0003	9293	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
CONTROL_0004	9294	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.13	Intensity Normalized (v.2)
CONTROL_0005	9295	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.16	Intensity Normalized (v.2)
Empty well_01	9296	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.41	Intensity Normalized (v.2)
Empty well_02	9297	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.14	Intensity Normalized (v.2)
Empty well_03	9298	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.68	Intensity Normalized (v.2)
Empty well_04	9299	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.44	Intensity Normalized (v.2)
Empty well_05	9300	OID00093	P44006	Protein_93	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00001	9301	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00002	9302	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.81	Intensity Normalized (v.2)
Sample_00003	9303	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00004	9304	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.1	Intensity Normalized (v.2)
Sample_00005	9305	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.45	Intensity Normalized (v.2)
Sample_00006	9306	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00007	9307	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
Sample_00008	9308	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00009	9309	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
Sample_00010	9310	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.92	Intensity Normalized (v.2)
Sample_00011	9311	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00012	9312	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.04	Intensity Normalized (v.2)
Sample_00013	9313	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00014	9314	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.99	Intensity Normalized (v.2)
Sample_00015	9315	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00016	9316	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00017	9317	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.29	Intensity Normalized (v.2)
Sample_00018	9318	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00019	9319	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00020	9320	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.1	Intensity Normalized (v.2)
Sample_00021	9321	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.23	Intensity Normalized (v.2)
Sample_00022	9322	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.13	Intensity Normalized (v.2)
Sample_00023	9323	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Sample_00024	9324	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.98	Intensity Normalized (v.2)
Sample_00025	9325	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00026	9326	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00027	9327	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00028	9328	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.97	Intensity Normalized (v.2)
Sample_00029	9329	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.86	Intensity Normalized (v.2)
Sample_00030	9330	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00031	9331	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.02	Intensity Normalized (v.2)
Sample_00032	9332	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
Sample_00033	9333	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.72	Intensity Normalized (v.2)
Sample_00034	9334	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.74	Intensity Normalized (v.2)
Sample_00035	9335	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00036	9336	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.89	Intensity Normalized (v.2)
Sample_00037	9337	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.56	Intensity Normalized (v.2)
Sample_00038	9338	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00039	9339	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.05	Intensity Normalized (v.2)
Sample_00040	9340	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.68	Intensity Normalized (v.2)
Sample_00041	9341	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00042	9342	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.42	Intensity Normalized (v.2)
Sample_00043	9343	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00044	9344	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00045	9345	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00046	9346	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00047	9347	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.6	Intensity Normalized (v.2)
Sample_00048	9348	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00049	9349	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.55	Intensity Normalized (v.2)
Sample_00050	9350	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00051	9351	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.57	Intensity Normalized (v.2)
Sample_00052	9352	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.58	Intensity Normalized (v.2)
Sample_00053	9353	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00054	9354	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00055	9355	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00056	9356	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00057	9357	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00058	9358	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00059	9359	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00060	9360	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.86	Intensity Normalized (v.2)
Sample_00061	9361	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.76	Intensity Normalized (v.2)
Sample_00062	9362	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.93	Intensity Normalized (v.2)
Sample_00063	9363	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.17	Intensity Normalized (v.2)
Sample_00064	9364	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.55	Intensity Normalized (v.2)
Sample_00065	9365	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00066	9366	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.55	Intensity Normalized (v.2)
Sample_00067	9367	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00068	9368	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.37	Intensity Normalized (v.2)
Sample_00069	9369	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00070	9370	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00071	9371	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.19	Intensity Normalized (v.2)
Sample_00072	9372	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.92	Intensity Normalized (v.2)
Sample_00073	9373	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00074	9374	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.87	Intensity Normalized (v.2)
Sample_00075	9375	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00076	9376	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.99	Intensity Normalized (v.2)
Sample_00077	9377	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00078	9378	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.91	Intensity Normalized (v.2)
Sample_00079	9379	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.09	Intensity Normalized (v.2)
Sample_00080	9380	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.3	Intensity Normalized (v.2)
Sample_00081	9381	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.86	Intensity Normalized (v.2)
Sample_00082	9382	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.85	Intensity Normalized (v.2)
Sample_00083	9383	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.58	Intensity Normalized (v.2)
Sample_00084	9384	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.69	Intensity Normalized (v.2)
Sample_00085	9385	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.06	Intensity Normalized (v.2)
Sample_00086	9386	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00087	9387	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.57	Intensity Normalized (v.2)
Sample_00088	9388	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00089	9389	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.84	Intensity Normalized (v.2)
Sample_00090	9390	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.59	Intensity Normalized (v.2)
CONTROL_0001	9391	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
CONTROL_0002	9392	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.66	Intensity Normalized (v.2)
CONTROL_0003	9393	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.08	Intensity Normalized (v.2)
CONTROL_0004	9394	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.73	Intensity Normalized (v.2)
CONTROL_0005	9395	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Empty well_01	9396	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Empty well_02	9397	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.47	Intensity Normalized (v.2)
Empty well_03	9398	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Empty well_04	9399	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Empty well_05	9400	OID00094	P37451	Protein_94	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00001	9401	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00002	9402	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.59	Intensity Normalized (v.2)
Sample_00003	9403	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00004	9404	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00005	9405	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.6	Intensity Normalized (v.2)
Sample_00006	9406	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.39	Intensity Normalized (v.2)
Sample_00007	9407	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00008	9408	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00009	9409	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.75	Intensity Normalized (v.2)
Sample_00010	9410	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00011	9411	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00012	9412	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.56	Intensity Normalized (v.2)
Sample_00013	9413	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00014	9414	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00015	9415	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.28	Intensity Normalized (v.2)
Sample_00016	9416	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.46	Intensity Normalized (v.2)
Sample_00017	9417	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.84	Intensity Normalized (v.2)
Sample_00018	9418	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00019	9419	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.59	Intensity Normalized (v.2)
Sample_00020	9420	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.84	Intensity Normalized (v.2)
Sample_00021	9421	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00022	9422	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.83	Intensity Normalized (v.2)
Sample_00023	9423	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.31	Intensity Normalized (v.2)
Sample_00024	9424	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00025	9425	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00026	9426	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.83	Intensity Normalized (v.2)
Sample_00027	9427	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00028	9428	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.51	Intensity Normalized (v.2)
Sample_00029	9429	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.26	Intensity Normalized (v.2)
Sample_00030	9430	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00031	9431	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.62	Intensity Normalized (v.2)
Sample_00032	9432	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00033	9433	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00034	9434	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00035	9435	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00036	9436	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.99	Intensity Normalized (v.2)
Sample_00037	9437	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.93	Intensity Normalized (v.2)
Sample_00038	9438	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00039	9439	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.28	Intensity Normalized (v.2)
Sample_00040	9440	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00041	9441	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.42	Intensity Normalized (v.2)
Sample_00042	9442	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.77	Intensity Normalized (v.2)
Sample_00043	9443	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00044	9444	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00045	9445	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00046	9446	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.05	Intensity Normalized (v.2)
Sample_00047	9447	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.9	Intensity Normalized (v.2)
Sample_00048	9448	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00049	9449	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
Sample_00050	9450	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00051	9451	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.59	Intensity Normalized (v.2)
Sample_00052	9452	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.09	Intensity Normalized (v.2)
Sample_00053	9453	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.79	Intensity Normalized (v.2)
Sample_00054	9454	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00055	9455	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.89	Intensity Normalized (v.2)
Sample_00056	9456	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00057	9457	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.81	Intensity Normalized (v.2)
Sample_00058	9458	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.18	Intensity Normalized (v.2)
Sample_00059	9459	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00060	9460	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00061	9461	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.81	Intensity Normalized (v.2)
Sample_00062	9462	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00063	9463	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.41	Intensity Normalized (v.2)
Sample_00064	9464	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00065	9465	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.97	Intensity Normalized (v.2)
Sample_00066	9466	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
Sample_00067	9467	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.85	Intensity Normalized (v.2)
Sample_00068	9468	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.93	Intensity Normalized (v.2)
Sample_00069	9469	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00070	9470	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.03	Intensity Normalized (v.2)
Sample_00071	9471	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.89	Intensity Normalized (v.2)
Sample_00072	9472	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00073	9473	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00074	9474	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00075	9475	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.24	Intensity Normalized (v.2)
Sample_00076	9476	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.06	Intensity Normalized (v.2)
Sample_00077	9477	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.06	Intensity Normalized (v.2)
Sample_00078	9478	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.6	Intensity Normalized (v.2)
Sample_00079	9479	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.39	Intensity Normalized (v.2)
Sample_00080	9480	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00081	9481	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.24	Intensity Normalized (v.2)
Sample_00082	9482	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.88	Intensity Normalized (v.2)
Sample_00083	9483	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.33	Intensity Normalized (v.2)
Sample_00084	9484	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00085	9485	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.88	Intensity Normalized (v.2)
Sample_00086	9486	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Sample_00087	9487	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.63	Intensity Normalized (v.2)
Sample_00088	9488	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00089	9489	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.14	Intensity Normalized (v.2)
Sample_00090	9490	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.46	Intensity Normalized (v.2)
CONTROL_0001	9491	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.11	Intensity Normalized (v.2)
CONTROL_0002	9492	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
CONTROL_0003	9493	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.13	Intensity Normalized (v.2)
CONTROL_0004	9494	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
CONTROL_0005	9495	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.57	Intensity Normalized (v.2)
Empty well_01	9496	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Empty well_02	9497	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Empty well_03	9498	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Empty well_04	9499	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.46	Intensity Normalized (v.2)
Empty well_05	9500	OID00095	P32748	Protein_95	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.15	Intensity Normalized (v.2)
Sample_00001	9501	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00002	9502	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.78	Intensity Normalized (v.2)
Sample_00003	9503	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.58	Intensity Normalized (v.2)
Sample_00004	9504	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.84	Intensity Normalized (v.2)
Sample_00005	9505	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.08	Intensity Normalized (v.2)
Sample_00006	9506	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00007	9507	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00008	9508	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00009	9509	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.86	Intensity Normalized (v.2)
Sample_00010	9510	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.5	Intensity Normalized (v.2)
Sample_00011	9511	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00012	9512	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.18	Intensity Normalized (v.2)
Sample_00013	9513	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00014	9514	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.05	Intensity Normalized (v.2)
Sample_00015	9515	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00016	9516	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.8	Intensity Normalized (v.2)
Sample_00017	9517	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.97	Intensity Normalized (v.2)
Sample_00018	9518	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00019	9519	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.86	Intensity Normalized (v.2)
Sample_00020	9520	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.25	Intensity Normalized (v.2)
Sample_00021	9521	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00022	9522	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00023	9523	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00024	9524	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00025	9525	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8	Intensity Normalized (v.2)
Sample_00026	9526	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00027	9527	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
Sample_00028	9528	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.77	Intensity Normalized (v.2)
Sample_00029	9529	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.36	Intensity Normalized (v.2)
Sample_00030	9530	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.55	Intensity Normalized (v.2)
Sample_00031	9531	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.24	Intensity Normalized (v.2)
Sample_00032	9532	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.19	Intensity Normalized (v.2)
Sample_00033	9533	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.82	Intensity Normalized (v.2)
Sample_00034	9534	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00035	9535	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00036	9536	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.23	Intensity Normalized (v.2)
Sample_00037	9537	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.7	Intensity Normalized (v.2)
Sample_00038	9538	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.92	Intensity Normalized (v.2)
Sample_00039	9539	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.6	Intensity Normalized (v.2)
Sample_00040	9540	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00041	9541	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00042	9542	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.98	Intensity Normalized (v.2)
Sample_00043	9543	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00044	9544	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.47	Intensity Normalized (v.2)
Sample_00045	9545	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.36	Intensity Normalized (v.2)
Sample_00046	9546	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.68	Intensity Normalized (v.2)
Sample_00047	9547	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.08	Intensity Normalized (v.2)
Sample_00048	9548	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00049	9549	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.71	Intensity Normalized (v.2)
Sample_00050	9550	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.33	Intensity Normalized (v.2)
Sample_00051	9551	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.52	Intensity Normalized (v.2)
Sample_00052	9552	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00053	9553	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.84	Intensity Normalized (v.2)
Sample_00054	9554	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.96	Intensity Normalized (v.2)
Sample_00055	9555	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.56	Intensity Normalized (v.2)
Sample_00056	9556	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.94	Intensity Normalized (v.2)
Sample_00057	9557	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.4	Intensity Normalized (v.2)
Sample_00058	9558	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00059	9559	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.26	Intensity Normalized (v.2)
Sample_00060	9560	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.35	Intensity Normalized (v.2)
Sample_00061	9561	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.37	Intensity Normalized (v.2)
Sample_00062	9562	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.64	Intensity Normalized (v.2)
Sample_00063	9563	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.62	Intensity Normalized (v.2)
Sample_00064	9564	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00065	9565	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00066	9566	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.61	Intensity Normalized (v.2)
Sample_00067	9567	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.51	Intensity Normalized (v.2)
Sample_00068	9568	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.62	Intensity Normalized (v.2)
Sample_00069	9569	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.63	Intensity Normalized (v.2)
Sample_00070	9570	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.16	Intensity Normalized (v.2)
Sample_00071	9571	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.95	Intensity Normalized (v.2)
Sample_00072	9572	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00073	9573	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00074	9574	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.11	Intensity Normalized (v.2)
Sample_00075	9575	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.95	Intensity Normalized (v.2)
Sample_00076	9576	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00077	9577	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.54	Intensity Normalized (v.2)
Sample_00078	9578	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00079	9579	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.96	Intensity Normalized (v.2)
Sample_00080	9580	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.31	Intensity Normalized (v.2)
Sample_00081	9581	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.06	Intensity Normalized (v.2)
Sample_00082	9582	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.54	Intensity Normalized (v.2)
Sample_00083	9583	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.83	Intensity Normalized (v.2)
Sample_00084	9584	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.57	Intensity Normalized (v.2)
Sample_00085	9585	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.77	Intensity Normalized (v.2)
Sample_00086	9586	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00087	9587	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.4	Intensity Normalized (v.2)
Sample_00088	9588	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00089	9589	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.64	Intensity Normalized (v.2)
Sample_00090	9590	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.4	Intensity Normalized (v.2)
CONTROL_0001	9591	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
CONTROL_0002	9592	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.86	Intensity Normalized (v.2)
CONTROL_0003	9593	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
CONTROL_0004	9594	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.46	Intensity Normalized (v.2)
CONTROL_0005	9595	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.3	Intensity Normalized (v.2)
Empty well_01	9596	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.62	Intensity Normalized (v.2)
Empty well_02	9597	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.41	Intensity Normalized (v.2)
Empty well_03	9598	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.56	Intensity Normalized (v.2)
Empty well_04	9599	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.28	Intensity Normalized (v.2)
Empty well_05	9600	OID00096	P42485	Protein_96	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00001	9601	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.65	Intensity Normalized (v.2)
Sample_00002	9602	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.19	Intensity Normalized (v.2)
Sample_00003	9603	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.27	Intensity Normalized (v.2)
Sample_00004	9604	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00005	9605	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.81	Intensity Normalized (v.2)
Sample_00006	9606	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.33	Intensity Normalized (v.2)
Sample_00007	9607	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00008	9608	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00009	9609	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00010	9610	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00011	9611	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00012	9612	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.46	Intensity Normalized (v.2)
Sample_00013	9613	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00014	9614	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.11	Intensity Normalized (v.2)
Sample_00015	9615	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00016	9616	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.36	Intensity Normalized (v.2)
Sample_00017	9617	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00018	9618	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00019	9619	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00020	9620	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00021	9621	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.63	Intensity Normalized (v.2)
Sample_00022	9622	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.33	Intensity Normalized (v.2)
Sample_00023	9623	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00024	9624	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.8	Intensity Normalized (v.2)
Sample_00025	9625	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	10	Intensity Normalized (v.2)
Sample_00026	9626	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00027	9627	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00028	9628	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.46	Intensity Normalized (v.2)
Sample_00029	9629	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.34	Intensity Normalized (v.2)
Sample_00030	9630	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00031	9631	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00032	9632	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00033	9633	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.06	Intensity Normalized (v.2)
Sample_00034	9634	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00035	9635	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.29	Intensity Normalized (v.2)
Sample_00036	9636	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00037	9637	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00038	9638	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00039	9639	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.95	Intensity Normalized (v.2)
Sample_00040	9640	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00041	9641	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.61	Intensity Normalized (v.2)
Sample_00042	9642	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.44	Intensity Normalized (v.2)
Sample_00043	9643	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.61	Intensity Normalized (v.2)
Sample_00044	9644	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.27	Intensity Normalized (v.2)
Sample_00045	9645	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.84	Intensity Normalized (v.2)
Sample_00046	9646	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.93	Intensity Normalized (v.2)
Sample_00047	9647	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.21	Intensity Normalized (v.2)
Sample_00048	9648	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00049	9649	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00050	9650	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.02	Intensity Normalized (v.2)
Sample_00051	9651	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.03	Intensity Normalized (v.2)
Sample_00052	9652	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.72	Intensity Normalized (v.2)
Sample_00053	9653	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.49	Intensity Normalized (v.2)
Sample_00054	9654	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00055	9655	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.95	Intensity Normalized (v.2)
Sample_00056	9656	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.67	Intensity Normalized (v.2)
Sample_00057	9657	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.25	Intensity Normalized (v.2)
Sample_00058	9658	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.03	Intensity Normalized (v.2)
Sample_00059	9659	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.54	Intensity Normalized (v.2)
Sample_00060	9660	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.79	Intensity Normalized (v.2)
Sample_00061	9661	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.62	Intensity Normalized (v.2)
Sample_00062	9662	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.62	Intensity Normalized (v.2)
Sample_00063	9663	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00064	9664	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.68	Intensity Normalized (v.2)
Sample_00065	9665	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00066	9666	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.25	Intensity Normalized (v.2)
Sample_00067	9667	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.73	Intensity Normalized (v.2)
Sample_00068	9668	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.07	Intensity Normalized (v.2)
Sample_00069	9669	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.23	Intensity Normalized (v.2)
Sample_00070	9670	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.94	Intensity Normalized (v.2)
Sample_00071	9671	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.5	Intensity Normalized (v.2)
Sample_00072	9672	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.12	Intensity Normalized (v.2)
Sample_00073	9673	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.73	Intensity Normalized (v.2)
Sample_00074	9674	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.12	Intensity Normalized (v.2)
Sample_00075	9675	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.83	Intensity Normalized (v.2)
Sample_00076	9676	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00077	9677	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.24	Intensity Normalized (v.2)
Sample_00078	9678	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.84	Intensity Normalized (v.2)
Sample_00079	9679	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.87	Intensity Normalized (v.2)
Sample_00080	9680	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.15	Intensity Normalized (v.2)
Sample_00081	9681	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.85	Intensity Normalized (v.2)
Sample_00082	9682	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.13	Intensity Normalized (v.2)
Sample_00083	9683	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.14	Intensity Normalized (v.2)
Sample_00084	9684	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.59	Intensity Normalized (v.2)
Sample_00085	9685	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00086	9686	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.38	Intensity Normalized (v.2)
Sample_00087	9687	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.45	Intensity Normalized (v.2)
Sample_00088	9688	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.47	Intensity Normalized (v.2)
Sample_00089	9689	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.5	Intensity Normalized (v.2)
Sample_00090	9690	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.71	Intensity Normalized (v.2)
CONTROL_0001	9691	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.71	Intensity Normalized (v.2)
CONTROL_0002	9692	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.8	Intensity Normalized (v.2)
CONTROL_0003	9693	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.82	Intensity Normalized (v.2)
CONTROL_0004	9694	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.54	Intensity Normalized (v.2)
CONTROL_0005	9695	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Empty well_01	9696	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.22	Intensity Normalized (v.2)
Empty well_02	9697	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Empty well_03	9698	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.31	Intensity Normalized (v.2)
Empty well_04	9699	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.01	Intensity Normalized (v.2)
Empty well_05	9700	OID00097	P98148	Protein_97	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.53	Intensity Normalized (v.2)
Sample_00001	9701	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.81	Intensity Normalized (v.2)
Sample_00002	9702	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.24	Intensity Normalized (v.2)
Sample_00003	9703	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.9	Intensity Normalized (v.2)
Sample_00004	9704	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.12	Intensity Normalized (v.2)
Sample_00005	9705	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6	Intensity Normalized (v.2)
Sample_00006	9706	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.89	Intensity Normalized (v.2)
Sample_00007	9707	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.64	Intensity Normalized (v.2)
Sample_00008	9708	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00009	9709	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.23	Intensity Normalized (v.2)
Sample_00010	9710	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00011	9711	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.21	Intensity Normalized (v.2)
Sample_00012	9712	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.64	Intensity Normalized (v.2)
Sample_00013	9713	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.63	Intensity Normalized (v.2)
Sample_00014	9714	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.75	Intensity Normalized (v.2)
Sample_00015	9715	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.04	Intensity Normalized (v.2)
Sample_00016	9716	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.88	Intensity Normalized (v.2)
Sample_00017	9717	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00018	9718	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.02	Intensity Normalized (v.2)
Sample_00019	9719	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.45	Intensity Normalized (v.2)
Sample_00020	9720	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.49	Intensity Normalized (v.2)
Sample_00021	9721	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.42	Intensity Normalized (v.2)
Sample_00022	9722	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.58	Intensity Normalized (v.2)
Sample_00023	9723	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00024	9724	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
Sample_00025	9725	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.99	Intensity Normalized (v.2)
Sample_00026	9726	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.91	Intensity Normalized (v.2)
Sample_00027	9727	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.19	Intensity Normalized (v.2)
Sample_00028	9728	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.02	Intensity Normalized (v.2)
Sample_00029	9729	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.29	Intensity Normalized (v.2)
Sample_00030	9730	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.49	Intensity Normalized (v.2)
Sample_00031	9731	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00032	9732	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.91	Intensity Normalized (v.2)
Sample_00033	9733	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00034	9734	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
Sample_00035	9735	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00036	9736	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.77	Intensity Normalized (v.2)
Sample_00037	9737	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.07	Intensity Normalized (v.2)
Sample_00038	9738	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.78	Intensity Normalized (v.2)
Sample_00039	9739	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00040	9740	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.24	Intensity Normalized (v.2)
Sample_00041	9741	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.74	Intensity Normalized (v.2)
Sample_00042	9742	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.82	Intensity Normalized (v.2)
Sample_00043	9743	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.82	Intensity Normalized (v.2)
Sample_00044	9744	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.6	Intensity Normalized (v.2)
Sample_00045	9745	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.92	Intensity Normalized (v.2)
Sample_00046	9746	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.21	Intensity Normalized (v.2)
Sample_00047	9747	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.21	Intensity Normalized (v.2)
Sample_00048	9748	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00049	9749	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.89	Intensity Normalized (v.2)
Sample_00050	9750	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.02	Intensity Normalized (v.2)
Sample_00051	9751	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
Sample_00052	9752	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.03	Intensity Normalized (v.2)
Sample_00053	9753	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.17	Intensity Normalized (v.2)
Sample_00054	9754	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.61	Intensity Normalized (v.2)
Sample_00055	9755	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.26	Intensity Normalized (v.2)
Sample_00056	9756	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.74	Intensity Normalized (v.2)
Sample_00057	9757	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00058	9758	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.43	Intensity Normalized (v.2)
Sample_00059	9759	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00060	9760	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.07	Intensity Normalized (v.2)
Sample_00061	9761	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.44	Intensity Normalized (v.2)
Sample_00062	9762	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.38	Intensity Normalized (v.2)
Sample_00063	9763	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.43	Intensity Normalized (v.2)
Sample_00064	9764	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.38	Intensity Normalized (v.2)
Sample_00065	9765	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.07	Intensity Normalized (v.2)
Sample_00066	9766	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.56	Intensity Normalized (v.2)
Sample_00067	9767	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.42	Intensity Normalized (v.2)
Sample_00068	9768	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.54	Intensity Normalized (v.2)
Sample_00069	9769	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00070	9770	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.43	Intensity Normalized (v.2)
Sample_00071	9771	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.9	Intensity Normalized (v.2)
Sample_00072	9772	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00073	9773	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.56	Intensity Normalized (v.2)
Sample_00074	9774	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.37	Intensity Normalized (v.2)
Sample_00075	9775	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00076	9776	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00077	9777	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.32	Intensity Normalized (v.2)
Sample_00078	9778	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.35	Intensity Normalized (v.2)
Sample_00079	9779	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.14	Intensity Normalized (v.2)
Sample_00080	9780	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.8	Intensity Normalized (v.2)
Sample_00081	9781	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.04	Intensity Normalized (v.2)
Sample_00082	9782	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.26	Intensity Normalized (v.2)
Sample_00083	9783	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.43	Intensity Normalized (v.2)
Sample_00084	9784	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.09	Intensity Normalized (v.2)
Sample_00085	9785	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
Sample_00086	9786	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.73	Intensity Normalized (v.2)
Sample_00087	9787	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.52	Intensity Normalized (v.2)
Sample_00088	9788	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00089	9789	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.11	Intensity Normalized (v.2)
Sample_00090	9790	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.32	Intensity Normalized (v.2)
CONTROL_0001	9791	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.75	Intensity Normalized (v.2)
CONTROL_0002	9792	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.43	Intensity Normalized (v.2)
CONTROL_0003	9793	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.68	Intensity Normalized (v.2)
CONTROL_0004	9794	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.29	Intensity Normalized (v.2)
CONTROL_0005	9795	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.22	Intensity Normalized (v.2)
Empty well_01	9796	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.87	Intensity Normalized (v.2)
Empty well_02	9797	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.22	Intensity Normalized (v.2)
Empty well_03	9798	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Empty well_04	9799	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Empty well_05	9800	OID00098	P14645	Protein_98	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.58	Intensity Normalized (v.2)
Sample_00001	9801	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.14	Intensity Normalized (v.2)
Sample_00002	9802	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00003	9803	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.9	Intensity Normalized (v.2)
Sample_00004	9804	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.42	Intensity Normalized (v.2)
Sample_00005	9805	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.78	Intensity Normalized (v.2)
Sample_00006	9806	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.48	Intensity Normalized (v.2)
Sample_00007	9807	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.2	Intensity Normalized (v.2)
Sample_00008	9808	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.97	Intensity Normalized (v.2)
Sample_00009	9809	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.26	Intensity Normalized (v.2)
Sample_00010	9810	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.7	Intensity Normalized (v.2)
Sample_00011	9811	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.15	Intensity Normalized (v.2)
Sample_00012	9812	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.36	Intensity Normalized (v.2)
Sample_00013	9813	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00014	9814	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00015	9815	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.34	Intensity Normalized (v.2)
Sample_00016	9816	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00017	9817	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.19	Intensity Normalized (v.2)
Sample_00018	9818	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.76	Intensity Normalized (v.2)
Sample_00019	9819	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.28	Intensity Normalized (v.2)
Sample_00020	9820	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.23	Intensity Normalized (v.2)
Sample_00021	9821	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.44	Intensity Normalized (v.2)
Sample_00022	9822	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00023	9823	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.64	Intensity Normalized (v.2)
Sample_00024	9824	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.22	Intensity Normalized (v.2)
Sample_00025	9825	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.12	Intensity Normalized (v.2)
Sample_00026	9826	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.76	Intensity Normalized (v.2)
Sample_00027	9827	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00028	9828	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.97	Intensity Normalized (v.2)
Sample_00029	9829	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.75	Intensity Normalized (v.2)
Sample_00030	9830	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.13	Intensity Normalized (v.2)
Sample_00031	9831	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.16	Intensity Normalized (v.2)
Sample_00032	9832	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.76	Intensity Normalized (v.2)
Sample_00033	9833	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.04	Intensity Normalized (v.2)
Sample_00034	9834	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.22	Intensity Normalized (v.2)
Sample_00035	9835	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.38	Intensity Normalized (v.2)
Sample_00036	9836	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00037	9837	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00038	9838	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.72	Intensity Normalized (v.2)
Sample_00039	9839	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5	Intensity Normalized (v.2)
Sample_00040	9840	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00041	9841	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.21	Intensity Normalized (v.2)
Sample_00042	9842	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.11	Intensity Normalized (v.2)
Sample_00043	9843	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.43	Intensity Normalized (v.2)
Sample_00044	9844	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.65	Intensity Normalized (v.2)
Sample_00045	9845	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.92	Intensity Normalized (v.2)
Sample_00046	9846	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.32	Intensity Normalized (v.2)
Sample_00047	9847	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.96	Intensity Normalized (v.2)
Sample_00048	9848	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00049	9849	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.65	Intensity Normalized (v.2)
Sample_00050	9850	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00051	9851	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.98	Intensity Normalized (v.2)
Sample_00052	9852	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.93	Intensity Normalized (v.2)
Sample_00053	9853	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.29	Intensity Normalized (v.2)
Sample_00054	9854	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.29	Intensity Normalized (v.2)
Sample_00055	9855	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.42	Intensity Normalized (v.2)
Sample_00056	9856	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.37	Intensity Normalized (v.2)
Sample_00057	9857	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.9	Intensity Normalized (v.2)
Sample_00058	9858	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.36	Intensity Normalized (v.2)
Sample_00059	9859	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.87	Intensity Normalized (v.2)
Sample_00060	9860	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.78	Intensity Normalized (v.2)
Sample_00061	9861	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.69	Intensity Normalized (v.2)
Sample_00062	9862	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.2	Intensity Normalized (v.2)
Sample_00063	9863	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.15	Intensity Normalized (v.2)
Sample_00064	9864	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.83	Intensity Normalized (v.2)
Sample_00065	9865	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.27	Intensity Normalized (v.2)
Sample_00066	9866	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.39	Intensity Normalized (v.2)
Sample_00067	9867	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.19	Intensity Normalized (v.2)
Sample_00068	9868	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.88	Intensity Normalized (v.2)
Sample_00069	9869	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.67	Intensity Normalized (v.2)
Sample_00070	9870	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.59	Intensity Normalized (v.2)
Sample_00071	9871	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.77	Intensity Normalized (v.2)
Sample_00072	9872	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.7	Intensity Normalized (v.2)
Sample_00073	9873	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.77	Intensity Normalized (v.2)
Sample_00074	9874	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.16	Intensity Normalized (v.2)
Sample_00075	9875	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.79	Intensity Normalized (v.2)
Sample_00076	9876	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.73	Intensity Normalized (v.2)
Sample_00077	9877	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.13	Intensity Normalized (v.2)
Sample_00078	9878	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.94	Intensity Normalized (v.2)
Sample_00079	9879	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.51	Intensity Normalized (v.2)
Sample_00080	9880	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.94	Intensity Normalized (v.2)
Sample_00081	9881	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.79	Intensity Normalized (v.2)
Sample_00082	9882	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.17	Intensity Normalized (v.2)
Sample_00083	9883	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00084	9884	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.4	Intensity Normalized (v.2)
Sample_00085	9885	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.26	Intensity Normalized (v.2)
Sample_00086	9886	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.46	Intensity Normalized (v.2)
Sample_00087	9887	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.98	Intensity Normalized (v.2)
Sample_00088	9888	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.81	Intensity Normalized (v.2)
Sample_00089	9889	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.34	Intensity Normalized (v.2)
Sample_00090	9890	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.43	Intensity Normalized (v.2)
CONTROL_0001	9891	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.76	Intensity Normalized (v.2)
CONTROL_0002	9892	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.03	Intensity Normalized (v.2)
CONTROL_0003	9893	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.64	Intensity Normalized (v.2)
CONTROL_0004	9894	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.67	Intensity Normalized (v.2)
CONTROL_0005	9895	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.52	Intensity Normalized (v.2)
Empty well_01	9896	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.93	Intensity Normalized (v.2)
Empty well_02	9897	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.17	Intensity Normalized (v.2)
Empty well_03	9898	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.04	Intensity Normalized (v.2)
Empty well_04	9899	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Empty well_05	9900	OID00099	P17492	Protein_99	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.78	Intensity Normalized (v.2)
Sample_00001	9901	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00002	9902	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.05	Intensity Normalized (v.2)
Sample_00003	9903	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.1	Intensity Normalized (v.2)
Sample_00004	9904	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.27	Intensity Normalized (v.2)
Sample_00005	9905	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.45	Intensity Normalized (v.2)
Sample_00006	9906	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.44	Intensity Normalized (v.2)
Sample_00007	9907	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.85	Intensity Normalized (v.2)
Sample_00008	9908	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.2	Intensity Normalized (v.2)
Sample_00009	9909	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.74	Intensity Normalized (v.2)
Sample_00010	9910	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.37	Intensity Normalized (v.2)
Sample_00011	9911	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.5	Intensity Normalized (v.2)
Sample_00012	9912	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00013	9913	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.64	Intensity Normalized (v.2)
Sample_00014	9914	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9	Intensity Normalized (v.2)
Sample_00015	9915	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.85	Intensity Normalized (v.2)
Sample_00016	9916	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00017	9917	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.45	Intensity Normalized (v.2)
Sample_00018	9918	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.7	Intensity Normalized (v.2)
Sample_00019	9919	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.2	Intensity Normalized (v.2)
Sample_00020	9920	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.6	Intensity Normalized (v.2)
Sample_00021	9921	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.97	Intensity Normalized (v.2)
Sample_00022	9922	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.58	Intensity Normalized (v.2)
Sample_00023	9923	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.53	Intensity Normalized (v.2)
Sample_00024	9924	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.47	Intensity Normalized (v.2)
Sample_00025	9925	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.35	Intensity Normalized (v.2)
Sample_00026	9926	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.94	Intensity Normalized (v.2)
Sample_00027	9927	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.55	Intensity Normalized (v.2)
Sample_00028	9928	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.7	Intensity Normalized (v.2)
Sample_00029	9929	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.79	Intensity Normalized (v.2)
Sample_00030	9930	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.07	Intensity Normalized (v.2)
Sample_00031	9931	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.03	Intensity Normalized (v.2)
Sample_00032	9932	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00033	9933	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8	Intensity Normalized (v.2)
Sample_00034	9934	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.99	Intensity Normalized (v.2)
Sample_00035	9935	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.02	Intensity Normalized (v.2)
Sample_00036	9936	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.36	Intensity Normalized (v.2)
Sample_00037	9937	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.34	Intensity Normalized (v.2)
Sample_00038	9938	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.13	Intensity Normalized (v.2)
Sample_00039	9939	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00040	9940	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.65	Intensity Normalized (v.2)
Sample_00041	9941	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00042	9942	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.52	Intensity Normalized (v.2)
Sample_00043	9943	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.49	Intensity Normalized (v.2)
Sample_00044	9944	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.83	Intensity Normalized (v.2)
Sample_00045	9945	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.26	Intensity Normalized (v.2)
Sample_00046	9946	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.07	Intensity Normalized (v.2)
Sample_00047	9947	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.32	Intensity Normalized (v.2)
Sample_00048	9948	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.57	Intensity Normalized (v.2)
Sample_00049	9949	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.69	Intensity Normalized (v.2)
Sample_00050	9950	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.35	Intensity Normalized (v.2)
Sample_00051	9951	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.11	Intensity Normalized (v.2)
Sample_00052	9952	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.28	Intensity Normalized (v.2)
Sample_00053	9953	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.88	Intensity Normalized (v.2)
Sample_00054	9954	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.52	Intensity Normalized (v.2)
Sample_00055	9955	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.87	Intensity Normalized (v.2)
Sample_00056	9956	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7	Intensity Normalized (v.2)
Sample_00057	9957	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.18	Intensity Normalized (v.2)
Sample_00058	9958	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.59	Intensity Normalized (v.2)
Sample_00059	9959	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.39	Intensity Normalized (v.2)
Sample_00060	9960	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.5	Intensity Normalized (v.2)
Sample_00061	9961	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.85	Intensity Normalized (v.2)
Sample_00062	9962	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.41	Intensity Normalized (v.2)
Sample_00063	9963	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.83	Intensity Normalized (v.2)
Sample_00064	9964	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.16	Intensity Normalized (v.2)
Sample_00065	9965	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.87	Intensity Normalized (v.2)
Sample_00066	9966	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.72	Intensity Normalized (v.2)
Sample_00067	9967	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.51	Intensity Normalized (v.2)
Sample_00068	9968	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.48	Intensity Normalized (v.2)
Sample_00069	9969	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.76	Intensity Normalized (v.2)
Sample_00070	9970	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.53	Intensity Normalized (v.2)
Sample_00071	9971	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.57	Intensity Normalized (v.2)
Sample_00072	9972	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.33	Intensity Normalized (v.2)
Sample_00073	9973	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.06	Intensity Normalized (v.2)
Sample_00074	9974	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.38	Intensity Normalized (v.2)
Sample_00075	9975	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.91	Intensity Normalized (v.2)
Sample_00076	9976	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	9.63	Intensity Normalized (v.2)
Sample_00077	9977	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00078	9978	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.49	Intensity Normalized (v.2)
Sample_00079	9979	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.78	Intensity Normalized (v.2)
Sample_00080	9980	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.67	Intensity Normalized (v.2)
Sample_00081	9981	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.22	Intensity Normalized (v.2)
Sample_00082	9982	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.1	Intensity Normalized (v.2)
Sample_00083	9983	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.71	Intensity Normalized (v.2)
Sample_00084	9984	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.51	Intensity Normalized (v.2)
Sample_00085	9985	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.85	Intensity Normalized (v.2)
Sample_00086	9986	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.66	Intensity Normalized (v.2)
Sample_00087	9987	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.69	Intensity Normalized (v.2)
Sample_00088	9988	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.12	Intensity Normalized (v.2)
Sample_00089	9989	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	7.7	Intensity Normalized (v.2)
Sample_00090	9990	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.04	Intensity Normalized (v.2)
CONTROL_0001	9991	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.5	Intensity Normalized (v.2)
CONTROL_0002	9992	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	8.14	Intensity Normalized (v.2)
CONTROL_0003	9993	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	5.01	Intensity Normalized (v.2)
CONTROL_0004	9994	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.37	Intensity Normalized (v.2)
CONTROL_0005	9995	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	8.6	Intensity Normalized (v.2)
Empty well_01	9996	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	5.61	Intensity Normalized (v.2)
Empty well_02	9997	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Warning	2.14	6.88	Intensity Normalized (v.2)
Empty well_03	9998	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	7.16	Intensity Normalized (v.2)
Empty well_04	9999	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	6.04	Intensity Normalized (v.2)
Empty well_05	10000	OID00100	P68811	Protein_100	1.47E-3	Olink Immuno-Oncology	v.3112	20211440-001_SP211650_IMO	Pass	2.14	9.91	Intensity Normalized (v.2)
